{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# The Social Returns to Risk Taking\n",
    "\n",
    "If you're trying to improve the world, should you avoid uncertainty or embrace it?  Is it better to spend money on a temporary health intervention or fund research to eventually find a cure?  [In a previous post](https://pstblog.com/2017/12/02/risk-return), I tried to answer these questions by looking at standalone data from a variety of sources. Some of the sources shared similar enough units that they could be combined, so I tried to do so below.   "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import numpy as np\n",
    "\n",
    "import statsmodels.formula.api as smf\n",
    "import statsmodels.api as sm\n",
    "from scipy import stats as st\n",
    "import matplotlib.pyplot as plt\n",
    "import matplotlib\n",
    "import seaborn as sns\n",
    "import altair as alt\n",
    "\n",
    "import cvxopt as opt\n",
    "from cvxopt import blas, solvers\n",
    "\n",
    "matplotlib.style.use('ggplot')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "#Helper function for viewing df\n",
    "def ends(df, x=5):\n",
    "    fill = ['...' for i in range(len(df.columns))]\n",
    "    fill_df = pd.DataFrame([fill], columns=list(df))\n",
    "    return df.head(x).append(fill_df).append(df.tail(x))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Data Imports\n",
    "\n",
    "The FHI, NICE, GiveWell, and DCP2 data are all pretty straightforward to import. There's more information on the sources of these data in the other notebook, `returns.ipynb`.   "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 83,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>group</th>\n",
       "      <th>disease</th>\n",
       "      <th>mu</th>\n",
       "      <th>sigma</th>\n",
       "      <th>median</th>\n",
       "      <th>mean</th>\n",
       "      <th>stdev</th>\n",
       "      <th>downside_risk</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Diarrhoeal disease</td>\n",
       "      <td>Diarrhoeal diseases</td>\n",
       "      <td>-1.466692</td>\n",
       "      <td>4.391203</td>\n",
       "      <td>0.230687</td>\n",
       "      <td>3549.783221</td>\n",
       "      <td>80857.231707</td>\n",
       "      <td>632.112167</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>Meningitis</td>\n",
       "      <td>Meningititis</td>\n",
       "      <td>-2.503745</td>\n",
       "      <td>4.463425</td>\n",
       "      <td>0.081778</td>\n",
       "      <td>1732.527683</td>\n",
       "      <td>41075.262076</td>\n",
       "      <td>642.530437</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>Parasitic and vector diseases</td>\n",
       "      <td>Leishmaniasis</td>\n",
       "      <td>-3.706662</td>\n",
       "      <td>4.721702</td>\n",
       "      <td>0.024559</td>\n",
       "      <td>1703.723172</td>\n",
       "      <td>8363.477589</td>\n",
       "      <td>646.906104</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>Leprosy</td>\n",
       "      <td>Leprosy</td>\n",
       "      <td>-5.014960</td>\n",
       "      <td>4.843504</td>\n",
       "      <td>0.006638</td>\n",
       "      <td>824.521890</td>\n",
       "      <td>71250.250787</td>\n",
       "      <td>652.197810</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>Parasitic and vector diseases</td>\n",
       "      <td>Trypanosomiasis</td>\n",
       "      <td>-5.296044</td>\n",
       "      <td>4.895739</td>\n",
       "      <td>0.005011</td>\n",
       "      <td>802.785665</td>\n",
       "      <td>110366.393439</td>\n",
       "      <td>651.497217</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Malaria</td>\n",
       "      <td>Malaria</td>\n",
       "      <td>-3.161076</td>\n",
       "      <td>4.437962</td>\n",
       "      <td>0.042380</td>\n",
       "      <td>801.655755</td>\n",
       "      <td>7066.975304</td>\n",
       "      <td>647.010323</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>Meningitis</td>\n",
       "      <td>Multiple salmonella infections</td>\n",
       "      <td>-1.895189</td>\n",
       "      <td>4.127971</td>\n",
       "      <td>0.150290</td>\n",
       "      <td>753.616047</td>\n",
       "      <td>16466.171159</td>\n",
       "      <td>641.149853</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>Meningitis</td>\n",
       "      <td>Typhoid and paratyphoid fever</td>\n",
       "      <td>-2.798470</td>\n",
       "      <td>4.327229</td>\n",
       "      <td>0.060903</td>\n",
       "      <td>709.092672</td>\n",
       "      <td>30713.464549</td>\n",
       "      <td>645.129099</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>Parasitic and vector diseases</td>\n",
       "      <td>Chagas disease</td>\n",
       "      <td>-4.955053</td>\n",
       "      <td>4.740730</td>\n",
       "      <td>0.007048</td>\n",
       "      <td>534.967344</td>\n",
       "      <td>6210.949437</td>\n",
       "      <td>652.382644</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>HIV</td>\n",
       "      <td>HIV</td>\n",
       "      <td>-3.783888</td>\n",
       "      <td>4.358867</td>\n",
       "      <td>0.022734</td>\n",
       "      <td>303.678832</td>\n",
       "      <td>2132.474086</td>\n",
       "      <td>650.364612</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>Helminths</td>\n",
       "      <td>Trichuriasis</td>\n",
       "      <td>-1.937768</td>\n",
       "      <td>3.863822</td>\n",
       "      <td>0.144025</td>\n",
       "      <td>251.336051</td>\n",
       "      <td>13978.148011</td>\n",
       "      <td>644.677877</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Helminths</td>\n",
       "      <td>Ascariasis</td>\n",
       "      <td>-1.894481</td>\n",
       "      <td>3.776170</td>\n",
       "      <td>0.150396</td>\n",
       "      <td>187.775769</td>\n",
       "      <td>1946.785732</td>\n",
       "      <td>646.199513</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Helminths</td>\n",
       "      <td>Hookworm</td>\n",
       "      <td>-2.221467</td>\n",
       "      <td>3.745220</td>\n",
       "      <td>0.108450</td>\n",
       "      <td>120.526560</td>\n",
       "      <td>937.080144</td>\n",
       "      <td>648.293959</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>TB</td>\n",
       "      <td>TB</td>\n",
       "      <td>-3.587428</td>\n",
       "      <td>4.086304</td>\n",
       "      <td>0.027669</td>\n",
       "      <td>116.922570</td>\n",
       "      <td>5881.619343</td>\n",
       "      <td>652.171061</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>Parasitic and vector diseases</td>\n",
       "      <td>Lymphatic filariasis</td>\n",
       "      <td>-2.843354</td>\n",
       "      <td>3.724580</td>\n",
       "      <td>0.058230</td>\n",
       "      <td>59.913072</td>\n",
       "      <td>988.919951</td>\n",
       "      <td>652.262809</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>Parasitic and vector diseases</td>\n",
       "      <td>Schistosomiasis</td>\n",
       "      <td>-3.354314</td>\n",
       "      <td>3.742827</td>\n",
       "      <td>0.034933</td>\n",
       "      <td>38.477140</td>\n",
       "      <td>511.897449</td>\n",
       "      <td>653.557945</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>Parasitic and vector diseases</td>\n",
       "      <td>Onchocerciasis</td>\n",
       "      <td>-4.002002</td>\n",
       "      <td>3.718195</td>\n",
       "      <td>0.018279</td>\n",
       "      <td>18.365718</td>\n",
       "      <td>271.158409</td>\n",
       "      <td>655.722323</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>Trachoma</td>\n",
       "      <td>Trachoma</td>\n",
       "      <td>-3.984676</td>\n",
       "      <td>3.693719</td>\n",
       "      <td>0.018598</td>\n",
       "      <td>17.066256</td>\n",
       "      <td>252.773685</td>\n",
       "      <td>656.248836</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>Parasitic and vector diseases</td>\n",
       "      <td>Dengue</td>\n",
       "      <td>-5.767322</td>\n",
       "      <td>3.092770</td>\n",
       "      <td>0.003128</td>\n",
       "      <td>0.373548</td>\n",
       "      <td>2.190507</td>\n",
       "      <td>659.080934</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                            group                         disease        mu  \\\n",
       "3              Diarrhoeal disease             Diarrhoeal diseases -1.466692   \n",
       "14                     Meningitis                    Meningititis -2.503745   \n",
       "11  Parasitic and vector diseases                   Leishmaniasis -3.706662   \n",
       "17                        Leprosy                         Leprosy -5.014960   \n",
       "13  Parasitic and vector diseases                 Trypanosomiasis -5.296044   \n",
       "1                         Malaria                         Malaria -3.161076   \n",
       "16                     Meningitis  Multiple salmonella infections -1.895189   \n",
       "15                     Meningitis   Typhoid and paratyphoid fever -2.798470   \n",
       "12  Parasitic and vector diseases                  Chagas disease -4.955053   \n",
       "0                             HIV                             HIV -3.783888   \n",
       "6                       Helminths                    Trichuriasis -1.937768   \n",
       "5                       Helminths                      Ascariasis -1.894481   \n",
       "4                       Helminths                        Hookworm -2.221467   \n",
       "2                              TB                              TB -3.587428   \n",
       "7   Parasitic and vector diseases            Lymphatic filariasis -2.843354   \n",
       "8   Parasitic and vector diseases                 Schistosomiasis -3.354314   \n",
       "9   Parasitic and vector diseases                  Onchocerciasis -4.002002   \n",
       "18                       Trachoma                        Trachoma -3.984676   \n",
       "10  Parasitic and vector diseases                          Dengue -5.767322   \n",
       "\n",
       "       sigma    median         mean          stdev  downside_risk  \n",
       "3   4.391203  0.230687  3549.783221   80857.231707     632.112167  \n",
       "14  4.463425  0.081778  1732.527683   41075.262076     642.530437  \n",
       "11  4.721702  0.024559  1703.723172    8363.477589     646.906104  \n",
       "17  4.843504  0.006638   824.521890   71250.250787     652.197810  \n",
       "13  4.895739  0.005011   802.785665  110366.393439     651.497217  \n",
       "1   4.437962  0.042380   801.655755    7066.975304     647.010323  \n",
       "16  4.127971  0.150290   753.616047   16466.171159     641.149853  \n",
       "15  4.327229  0.060903   709.092672   30713.464549     645.129099  \n",
       "12  4.740730  0.007048   534.967344    6210.949437     652.382644  \n",
       "0   4.358867  0.022734   303.678832    2132.474086     650.364612  \n",
       "6   3.863822  0.144025   251.336051   13978.148011     644.677877  \n",
       "5   3.776170  0.150396   187.775769    1946.785732     646.199513  \n",
       "4   3.745220  0.108450   120.526560     937.080144     648.293959  \n",
       "2   4.086304  0.027669   116.922570    5881.619343     652.171061  \n",
       "7   3.724580  0.058230    59.913072     988.919951     652.262809  \n",
       "8   3.742827  0.034933    38.477140     511.897449     653.557945  \n",
       "9   3.718195  0.018279    18.365718     271.158409     655.722323  \n",
       "18  3.693719  0.018598    17.066256     252.773685     656.248836  \n",
       "10  3.092770  0.003128     0.373548       2.190507     659.080934  "
      ]
     },
     "execution_count": 83,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "fhi_df = pd.read_csv('./data/fhi_data.csv')\n",
    "\n",
    "# Not sure if I'm applying this correctly, just sample and calculate instead.\n",
    "# https://en.wikipedia.org/wiki/Log-normal_distribution\n",
    "# https://en.wikipedia.org/wiki/Chebyshev's_inequality\n",
    "# https://stats.stackexchange.com/questions/173715\n",
    "# https://brilliant.org/wiki/log-normal-distribution/\n",
    "# fhi_df['stdev'] = np.sqrt((np.exp(fhi_df['sigma'])**2 - 1) * fhi_df['mean']**2) \n",
    "\n",
    "class_mean = fhi_df['mean'].mean()\n",
    "def sample_params(r):\n",
    "    n = 10000\n",
    "    # https://stackoverflow.com/questions/8870982\n",
    "#     dist = st.lognorm(s=r['sigma'], scale=np.exp(r['mu']))\n",
    "#     samples = dist.rvs(size=n)\n",
    "#     downside = np.sqrt((np.minimum(0.0, samples - class_mean)**2).sum()/n)\n",
    "#     stdev = np.sqrt(dist.var())\n",
    "    samples = np.random.lognormal(r['mu'], r['sigma'], n)\n",
    "    # Downside risk is underperformance of the mean intervention\n",
    "    downside = np.sqrt((np.minimum(0.0, samples - class_mean)**2).sum()/n)\n",
    "    # Standard deviation of lognormal sample\n",
    "    stdev = np.std(samples)\n",
    "    return stdev, downside\n",
    "\n",
    "fhi_df[['stdev', 'downside_risk']] = fhi_df.apply(sample_params, axis=1, result_type='expand')\n",
    "fhi_df.sort_values(by='mean', ascending=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 53,
   "metadata": {},
   "outputs": [],
   "source": [
    "# class_mean = fhi_df['mean'].mean()\n",
    "# def sample_params(r):\n",
    "#     n = 10000\n",
    "#     samples = np.random.lognormal(r['mu'], r['sigma'], n)\n",
    "#     # Downside risk is underperformance of the mean intervention\n",
    "#     downside = np.sqrt((np.minimum(0.0, samples - class_mean)**2).sum()/n)\n",
    "#     # Standard deviation of lognormal sample\n",
    "#     stdev = np.stdev(samples)\n",
    "#     return stdev, downside\n",
    "\n",
    "\n",
    "# def downside_risk(series):\n",
    "#     return np.sqrt((np.minimum(0.0, series - t)**2).sum()/series.size)\n",
    "\n",
    "# def estimate_stdev():\n",
    "    \n",
    "# # Convert sigma to stdev, still meaningful for non-normal distributions:\n",
    "# # https://en.wikipedia.org/wiki/Log-normal_distribution\n",
    "# # https://en.wikipedia.org/wiki/Chebyshev's_inequality\n",
    "# # https://stats.stackexchange.com/questions/173715\n",
    "# fhi_df['stdev'] = np.sqrt((np.exp(fhi_df['sigma'])**2 - 1) * fhi_df['mean']**2)\n",
    "\n",
    "\n",
    "# # Sample from probability distributions to generate downside risk estimates:\n",
    "# columns = fhi_df['disease']\n",
    "# samples = []\n",
    "# n = 10000\n",
    "# for i,r in fhi_df.iterrows():\n",
    "#     samples.append(np.random.lognormal(r['mu'], r['sigma'], n))\n",
    "\n",
    "# data = np.array(samples).transpose()\n",
    "# sample_df = pd.DataFrame(data, columns=columns)\n",
    "# sample_df = sample_df.agg(downside_risk).to_frame(name=\"downside_risk\")\n",
    "# fhi_df = fhi_df.join(sample_df, on='disease')\n",
    "\n",
    "# fhi_df.sort_values(by='mean', ascending=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 54,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>condition</th>\n",
       "      <th>intervention</th>\n",
       "      <th>cost_effectiveness</th>\n",
       "      <th>spread</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>Malaria</td>\n",
       "      <td>Intermittent preventive treatment in pregnancy...</td>\n",
       "      <td>142.857143</td>\n",
       "      <td>111.111111</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>Malaria</td>\n",
       "      <td>Insecticidetreated bednets</td>\n",
       "      <td>90.909091</td>\n",
       "      <td>83.333333</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Lymphatic filariasis</td>\n",
       "      <td>Annual mass drug administration</td>\n",
       "      <td>66.666667</td>\n",
       "      <td>43.478261</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>41</th>\n",
       "      <td>Malaria</td>\n",
       "      <td>Residual household spraying</td>\n",
       "      <td>58.823529</td>\n",
       "      <td>66.666667</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>30</th>\n",
       "      <td>Malaria</td>\n",
       "      <td>Intermittent preventive treatment in pregnancy...</td>\n",
       "      <td>52.631579</td>\n",
       "      <td>90.909091</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>Traffic accidents</td>\n",
       "      <td>Increased speeding penalties, enforcement, med...</td>\n",
       "      <td>47.619048</td>\n",
       "      <td>28.571429</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>Lymphatic filariasis</td>\n",
       "      <td>Diethyl carbamazine salt</td>\n",
       "      <td>45.454545</td>\n",
       "      <td>23.809524</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>39</th>\n",
       "      <td>HIV/AIDS</td>\n",
       "      <td>Peer and education programs for high-risk groups</td>\n",
       "      <td>27.027027</td>\n",
       "      <td>16.129032</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>52</th>\n",
       "      <td>HIV/AIDS</td>\n",
       "      <td>Voluntary counseling and testing</td>\n",
       "      <td>21.276596</td>\n",
       "      <td>13.333333</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>Tuberculosis (endemic)</td>\n",
       "      <td>BCG vaccine</td>\n",
       "      <td>14.705882</td>\n",
       "      <td>37.037037</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>Stroke (recurrent)</td>\n",
       "      <td>Aspirin and dipyridamole</td>\n",
       "      <td>12.345679</td>\n",
       "      <td>43.478261</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>HIV/AIDS</td>\n",
       "      <td>Condom promotion and distribution</td>\n",
       "      <td>12.195122</td>\n",
       "      <td>16.666667</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>HIV/AIDS</td>\n",
       "      <td>Blood and needle safety</td>\n",
       "      <td>11.904762</td>\n",
       "      <td>18.518519</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>Tuberculosis (epidemic, infectious)</td>\n",
       "      <td>Directly observed short-course chemotherapy</td>\n",
       "      <td>9.803922</td>\n",
       "      <td>5.747126</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>43</th>\n",
       "      <td>Emergency medical care</td>\n",
       "      <td>Staffed community ambulance</td>\n",
       "      <td>8.333333</td>\n",
       "      <td>8.403361</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49</th>\n",
       "      <td>HIV/AIDS</td>\n",
       "      <td>Tuberculosis coinfection prevention and treatment</td>\n",
       "      <td>8.264463</td>\n",
       "      <td>34.482759</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>Lower acute respiratory infections (nonsevere)</td>\n",
       "      <td>Case management at community or facility level</td>\n",
       "      <td>7.751938</td>\n",
       "      <td>6.329114</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>45</th>\n",
       "      <td>Problems requiring surgery</td>\n",
       "      <td>Surgical ward or services in district hospital...</td>\n",
       "      <td>7.352941</td>\n",
       "      <td>6.134969</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>Diarrheal disease</td>\n",
       "      <td>Construction and promotion of basic sanitation...</td>\n",
       "      <td>7.092199</td>\n",
       "      <td>3.861004</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Congestive heart failure</td>\n",
       "      <td>ACE inhibitor and beta-blocker, with diuretics</td>\n",
       "      <td>6.666667</td>\n",
       "      <td>4.048583</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>48</th>\n",
       "      <td>HIV/AIDS</td>\n",
       "      <td>Treatment of opportunistic infections</td>\n",
       "      <td>6.410256</td>\n",
       "      <td>3.257329</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>51</th>\n",
       "      <td>Lymphatic filariasis</td>\n",
       "      <td>Vector control</td>\n",
       "      <td>6.250000</td>\n",
       "      <td>4.273504</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>38</th>\n",
       "      <td>HIV/AIDS</td>\n",
       "      <td>Mother-to-child transmission prevention</td>\n",
       "      <td>5.208333</td>\n",
       "      <td>2.702703</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32</th>\n",
       "      <td>Tuberculosis (epidemic, latent)</td>\n",
       "      <td>Isoniazid treatment</td>\n",
       "      <td>5.076142</td>\n",
       "      <td>3.300330</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>37</th>\n",
       "      <td>Tuberculosis (epidemic)</td>\n",
       "      <td>Management of drug resistance</td>\n",
       "      <td>4.830918</td>\n",
       "      <td>90.909091</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>Tuberculosis (endemic, infectious or noninfect...</td>\n",
       "      <td>Directly observed short-course chemotherapy</td>\n",
       "      <td>3.322259</td>\n",
       "      <td>2.141328</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36</th>\n",
       "      <td>Tuberculosis (endemic)</td>\n",
       "      <td>Management of drug resistance</td>\n",
       "      <td>3.144654</td>\n",
       "      <td>4.524887</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>Neonatal mortality</td>\n",
       "      <td>Family, community, or clinical neonatal package</td>\n",
       "      <td>2.898551</td>\n",
       "      <td>76.923077</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Alcohol abuse</td>\n",
       "      <td>Advertising ban and reduced access to beverage...</td>\n",
       "      <td>2.475248</td>\n",
       "      <td>13.513514</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>Alcohol abuse</td>\n",
       "      <td>Excise tax, advertising ban, with brief advice</td>\n",
       "      <td>1.584786</td>\n",
       "      <td>16.666667</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>Ischemic heart disease</td>\n",
       "      <td>Aspirin, betablocker, and optional ACE inhibitor</td>\n",
       "      <td>1.453488</td>\n",
       "      <td>2.105263</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>Panic disorder</td>\n",
       "      <td>Drugs with optional psychosocial treatment</td>\n",
       "      <td>1.362398</td>\n",
       "      <td>1.428571</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>33</th>\n",
       "      <td>Coronary artery disease</td>\n",
       "      <td>Legislation substituting 2% of trans fat with ...</td>\n",
       "      <td>1.193317</td>\n",
       "      <td>0.781861</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>HIV/AIDS</td>\n",
       "      <td>Antiretroviral therapy</td>\n",
       "      <td>1.084599</td>\n",
       "      <td>0.874126</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>Parkinson's disease</td>\n",
       "      <td>Ayurvedic treatment and levodopa or carbidopa</td>\n",
       "      <td>0.883392</td>\n",
       "      <td>1.315789</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>Alcohol abuse</td>\n",
       "      <td>Excise tax</td>\n",
       "      <td>0.726216</td>\n",
       "      <td>3.921569</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>Depression</td>\n",
       "      <td>Drugs with optional episodic or maintenance ps...</td>\n",
       "      <td>0.588582</td>\n",
       "      <td>0.479846</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>Stroke (ischemic)</td>\n",
       "      <td>Heparin and recombinant tissue plasminogen act...</td>\n",
       "      <td>0.505817</td>\n",
       "      <td>0.715820</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>44</th>\n",
       "      <td>Ischemic heart disease</td>\n",
       "      <td>Statin, with aspirin and betablocker with ACE ...</td>\n",
       "      <td>0.493097</td>\n",
       "      <td>3.039514</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>40</th>\n",
       "      <td>Stroke and ischemic and hypertensive heart dis...</td>\n",
       "      <td>Polypill by absolute risk approach</td>\n",
       "      <td>0.469925</td>\n",
       "      <td>0.369004</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>Traffic accidents</td>\n",
       "      <td>Enforcement of seatbelt laws, promotion of chi...</td>\n",
       "      <td>0.408330</td>\n",
       "      <td>0.344828</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>50</th>\n",
       "      <td>Dengue</td>\n",
       "      <td>Vector control</td>\n",
       "      <td>0.389712</td>\n",
       "      <td>0.871840</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>Diarrheal disease</td>\n",
       "      <td>Cholera or rotavirus immunization</td>\n",
       "      <td>0.368732</td>\n",
       "      <td>2.183406</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>42</th>\n",
       "      <td>Epilepsy (refractory)</td>\n",
       "      <td>Second-line treatment with phenobarbital and l...</td>\n",
       "      <td>0.330360</td>\n",
       "      <td>15.151515</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>34</th>\n",
       "      <td>Bipolar disorder</td>\n",
       "      <td>Lithium, valproate, with optional psy-chosocia...</td>\n",
       "      <td>0.321234</td>\n",
       "      <td>0.813008</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>Diarrheal disease</td>\n",
       "      <td>Improved water and sanitation at current cover...</td>\n",
       "      <td>0.238949</td>\n",
       "      <td>0.226449</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>35</th>\n",
       "      <td>Bipolar disorder</td>\n",
       "      <td>Lithium, valproate, with optional psychosocial...</td>\n",
       "      <td>0.226398</td>\n",
       "      <td>0.604595</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>Lower acute respiratory infections (severe and...</td>\n",
       "      <td>Case management at hospital level</td>\n",
       "      <td>0.220751</td>\n",
       "      <td>0.309789</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>46</th>\n",
       "      <td>Trachoma</td>\n",
       "      <td>Tetracycline or azithromycin</td>\n",
       "      <td>0.159515</td>\n",
       "      <td>0.198689</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Schizophrenia</td>\n",
       "      <td>Antipsychotic drugs with optional psychosocial...</td>\n",
       "      <td>0.101688</td>\n",
       "      <td>0.067912</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Schizophrenia</td>\n",
       "      <td>Antipsychotic drugs with optional psychosocial...</td>\n",
       "      <td>0.083893</td>\n",
       "      <td>0.063975</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>31</th>\n",
       "      <td>Tuberculosis (endemic, latent)</td>\n",
       "      <td>Isoniazid treatment</td>\n",
       "      <td>0.075999</td>\n",
       "      <td>0.134825</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>47</th>\n",
       "      <td>HIV/AIDS</td>\n",
       "      <td>Treatment of Kaposi's sarcoma</td>\n",
       "      <td>0.019066</td>\n",
       "      <td>0.028602</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                            condition  \\\n",
       "29                                            Malaria   \n",
       "28                                            Malaria   \n",
       "2                                Lymphatic filariasis   \n",
       "41                                            Malaria   \n",
       "30                                            Malaria   \n",
       "27                                  Traffic accidents   \n",
       "16                               Lymphatic filariasis   \n",
       "39                                           HIV/AIDS   \n",
       "52                                           HIV/AIDS   \n",
       "9                              Tuberculosis (endemic)   \n",
       "6                                  Stroke (recurrent)   \n",
       "14                                           HIV/AIDS   \n",
       "10                                           HIV/AIDS   \n",
       "18                Tuberculosis (epidemic, infectious)   \n",
       "43                             Emergency medical care   \n",
       "49                                           HIV/AIDS   \n",
       "11     Lower acute respiratory infections (nonsevere)   \n",
       "45                         Problems requiring surgery   \n",
       "15                                  Diarrheal disease   \n",
       "0                            Congestive heart failure   \n",
       "48                                           HIV/AIDS   \n",
       "51                               Lymphatic filariasis   \n",
       "38                                           HIV/AIDS   \n",
       "32                    Tuberculosis (epidemic, latent)   \n",
       "37                            Tuberculosis (epidemic)   \n",
       "17  Tuberculosis (endemic, infectious or noninfect...   \n",
       "36                             Tuberculosis (endemic)   \n",
       "24                                 Neonatal mortality   \n",
       "1                                       Alcohol abuse   \n",
       "23                                      Alcohol abuse   \n",
       "7                              Ischemic heart disease   \n",
       "20                                     Panic disorder   \n",
       "33                            Coronary artery disease   \n",
       "5                                            HIV/AIDS   \n",
       "8                                 Parkinson's disease   \n",
       "22                                      Alcohol abuse   \n",
       "19                                         Depression   \n",
       "25                                  Stroke (ischemic)   \n",
       "44                             Ischemic heart disease   \n",
       "40  Stroke and ischemic and hypertensive heart dis...   \n",
       "21                                  Traffic accidents   \n",
       "50                                             Dengue   \n",
       "13                                  Diarrheal disease   \n",
       "42                              Epilepsy (refractory)   \n",
       "34                                   Bipolar disorder   \n",
       "26                                  Diarrheal disease   \n",
       "35                                   Bipolar disorder   \n",
       "12  Lower acute respiratory infections (severe and...   \n",
       "46                                           Trachoma   \n",
       "3                                       Schizophrenia   \n",
       "4                                       Schizophrenia   \n",
       "31                     Tuberculosis (endemic, latent)   \n",
       "47                                           HIV/AIDS   \n",
       "\n",
       "                                         intervention  cost_effectiveness  \\\n",
       "29  Intermittent preventive treatment in pregnancy...          142.857143   \n",
       "28                         Insecticidetreated bednets           90.909091   \n",
       "2                     Annual mass drug administration           66.666667   \n",
       "41                        Residual household spraying           58.823529   \n",
       "30  Intermittent preventive treatment in pregnancy...           52.631579   \n",
       "27  Increased speeding penalties, enforcement, med...           47.619048   \n",
       "16                           Diethyl carbamazine salt           45.454545   \n",
       "39   Peer and education programs for high-risk groups           27.027027   \n",
       "52                   Voluntary counseling and testing           21.276596   \n",
       "9                                         BCG vaccine           14.705882   \n",
       "6                            Aspirin and dipyridamole           12.345679   \n",
       "14                  Condom promotion and distribution           12.195122   \n",
       "10                            Blood and needle safety           11.904762   \n",
       "18        Directly observed short-course chemotherapy            9.803922   \n",
       "43                        Staffed community ambulance            8.333333   \n",
       "49  Tuberculosis coinfection prevention and treatment            8.264463   \n",
       "11     Case management at community or facility level            7.751938   \n",
       "45  Surgical ward or services in district hospital...            7.352941   \n",
       "15  Construction and promotion of basic sanitation...            7.092199   \n",
       "0      ACE inhibitor and beta-blocker, with diuretics            6.666667   \n",
       "48              Treatment of opportunistic infections            6.410256   \n",
       "51                                     Vector control            6.250000   \n",
       "38            Mother-to-child transmission prevention            5.208333   \n",
       "32                                Isoniazid treatment            5.076142   \n",
       "37                      Management of drug resistance            4.830918   \n",
       "17        Directly observed short-course chemotherapy            3.322259   \n",
       "36                      Management of drug resistance            3.144654   \n",
       "24    Family, community, or clinical neonatal package            2.898551   \n",
       "1   Advertising ban and reduced access to beverage...            2.475248   \n",
       "23     Excise tax, advertising ban, with brief advice            1.584786   \n",
       "7    Aspirin, betablocker, and optional ACE inhibitor            1.453488   \n",
       "20         Drugs with optional psychosocial treatment            1.362398   \n",
       "33  Legislation substituting 2% of trans fat with ...            1.193317   \n",
       "5                              Antiretroviral therapy            1.084599   \n",
       "8       Ayurvedic treatment and levodopa or carbidopa            0.883392   \n",
       "22                                         Excise tax            0.726216   \n",
       "19  Drugs with optional episodic or maintenance ps...            0.588582   \n",
       "25  Heparin and recombinant tissue plasminogen act...            0.505817   \n",
       "44  Statin, with aspirin and betablocker with ACE ...            0.493097   \n",
       "40                 Polypill by absolute risk approach            0.469925   \n",
       "21  Enforcement of seatbelt laws, promotion of chi...            0.408330   \n",
       "50                                     Vector control            0.389712   \n",
       "13                  Cholera or rotavirus immunization            0.368732   \n",
       "42  Second-line treatment with phenobarbital and l...            0.330360   \n",
       "34  Lithium, valproate, with optional psy-chosocia...            0.321234   \n",
       "26  Improved water and sanitation at current cover...            0.238949   \n",
       "35  Lithium, valproate, with optional psychosocial...            0.226398   \n",
       "12                  Case management at hospital level            0.220751   \n",
       "46                       Tetracycline or azithromycin            0.159515   \n",
       "3   Antipsychotic drugs with optional psychosocial...            0.101688   \n",
       "4   Antipsychotic drugs with optional psychosocial...            0.083893   \n",
       "31                                Isoniazid treatment            0.075999   \n",
       "47                      Treatment of Kaposi's sarcoma            0.019066   \n",
       "\n",
       "        spread  \n",
       "29  111.111111  \n",
       "28   83.333333  \n",
       "2    43.478261  \n",
       "41   66.666667  \n",
       "30   90.909091  \n",
       "27   28.571429  \n",
       "16   23.809524  \n",
       "39   16.129032  \n",
       "52   13.333333  \n",
       "9    37.037037  \n",
       "6    43.478261  \n",
       "14   16.666667  \n",
       "10   18.518519  \n",
       "18    5.747126  \n",
       "43    8.403361  \n",
       "49   34.482759  \n",
       "11    6.329114  \n",
       "45    6.134969  \n",
       "15    3.861004  \n",
       "0     4.048583  \n",
       "48    3.257329  \n",
       "51    4.273504  \n",
       "38    2.702703  \n",
       "32    3.300330  \n",
       "37   90.909091  \n",
       "17    2.141328  \n",
       "36    4.524887  \n",
       "24   76.923077  \n",
       "1    13.513514  \n",
       "23   16.666667  \n",
       "7     2.105263  \n",
       "20    1.428571  \n",
       "33    0.781861  \n",
       "5     0.874126  \n",
       "8     1.315789  \n",
       "22    3.921569  \n",
       "19    0.479846  \n",
       "25    0.715820  \n",
       "44    3.039514  \n",
       "40    0.369004  \n",
       "21    0.344828  \n",
       "50    0.871840  \n",
       "13    2.183406  \n",
       "42   15.151515  \n",
       "34    0.813008  \n",
       "26    0.226449  \n",
       "35    0.604595  \n",
       "12    0.309789  \n",
       "46    0.198689  \n",
       "3     0.067912  \n",
       "4     0.063975  \n",
       "31    0.134825  \n",
       "47    0.028602  "
      ]
     },
     "execution_count": 54,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "ph_df = pd.read_csv('./data/DCP2_data.csv')\n",
    "ph_df = ph_df.apply(pd.to_numeric, errors='ignore')\n",
    "ph_df.rename(columns={'Spread(DALY/1000USD)': 'spread', \n",
    "                      'cost_effectiveness(DALY/1000USD)': 'cost_effectiveness'}, \n",
    "             inplace=True)\n",
    "\n",
    "ph_df[['condition', 'intervention','cost_effectiveness', 'spread']] \\\n",
    "    .sort_values('cost_effectiveness', ascending=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 55,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>guidance_topic</th>\n",
       "      <th>comparator</th>\n",
       "      <th>median</th>\n",
       "      <th>num_estimates</th>\n",
       "      <th>spread</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>53</th>\n",
       "      <td>Smoking cessation—general population: client c...</td>\n",
       "      <td>Background quit rate; no intervention or usua...</td>\n",
       "      <td>20.000000</td>\n",
       "      <td>8.0</td>\n",
       "      <td>2.288330</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Exercise prescriptions</td>\n",
       "      <td>Advice</td>\n",
       "      <td>12.987013</td>\n",
       "      <td>4.0</td>\n",
       "      <td>7.194245</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>56</th>\n",
       "      <td>Smoking cessation—general population: recruitm...</td>\n",
       "      <td>Background quit rate; no intervention or advice</td>\n",
       "      <td>3.846154</td>\n",
       "      <td>15.0</td>\n",
       "      <td>0.074499</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>62</th>\n",
       "      <td>Smoking cessation —general population: dentist...</td>\n",
       "      <td>Usual care</td>\n",
       "      <td>3.311258</td>\n",
       "      <td>3.0</td>\n",
       "      <td>10.989011</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>51</th>\n",
       "      <td>Smoking cessation—general population: incentiv...</td>\n",
       "      <td>Intervention no NRT</td>\n",
       "      <td>2.793296</td>\n",
       "      <td>2.0</td>\n",
       "      <td>1.597444</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>BA (5 min plus self-help)</td>\n",
       "      <td>Background quit rate</td>\n",
       "      <td>2.702703</td>\n",
       "      <td>8.0</td>\n",
       "      <td>1.801802</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>54</th>\n",
       "      <td>Smoking cessation—general population: proactiv...</td>\n",
       "      <td>Usual care or intervention but no telephone c...</td>\n",
       "      <td>2.341920</td>\n",
       "      <td>9.0</td>\n",
       "      <td>0.683527</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>58</th>\n",
       "      <td>Smoking cessation—general population: identify...</td>\n",
       "      <td>No intervention</td>\n",
       "      <td>1.984127</td>\n",
       "      <td>4.0</td>\n",
       "      <td>0.243902</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>61</th>\n",
       "      <td>Smoking cessation—general population: pharmaci...</td>\n",
       "      <td>Usual care</td>\n",
       "      <td>1.831502</td>\n",
       "      <td>2.0</td>\n",
       "      <td>4.608295</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>BA only (5 min)</td>\n",
       "      <td>Background quit rate</td>\n",
       "      <td>1.366120</td>\n",
       "      <td>8.0</td>\n",
       "      <td>0.909091</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>46</th>\n",
       "      <td>PA counselling</td>\n",
       "      <td>No intervention</td>\n",
       "      <td>1.157407</td>\n",
       "      <td>2.0</td>\n",
       "      <td>1.353180</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>64</th>\n",
       "      <td>Smoking cessation—disadvantaged groups: client...</td>\n",
       "      <td>No intervention</td>\n",
       "      <td>0.639386</td>\n",
       "      <td>3.0</td>\n",
       "      <td>0.166889</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>BA [5 min plus nicotine replacement therapy (N...</td>\n",
       "      <td>Background quit rate</td>\n",
       "      <td>0.473934</td>\n",
       "      <td>8.0</td>\n",
       "      <td>0.315557</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70</th>\n",
       "      <td>Smoking cessation—disadvantaged groups: NHS SSS</td>\n",
       "      <td>No intervention</td>\n",
       "      <td>0.372301</td>\n",
       "      <td>2.0</td>\n",
       "      <td>3.311258</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>71</th>\n",
       "      <td>Smoking cessation—disadvantaged groups: pharma...</td>\n",
       "      <td>No intervention</td>\n",
       "      <td>0.317360</td>\n",
       "      <td>2.0</td>\n",
       "      <td>0.235738</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>90</th>\n",
       "      <td>Screening and BA during GP consultation</td>\n",
       "      <td>No intervention</td>\n",
       "      <td>0.303030</td>\n",
       "      <td>3.0</td>\n",
       "      <td>0.151515</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>Life-skills training</td>\n",
       "      <td>Normal education</td>\n",
       "      <td>0.286369</td>\n",
       "      <td>3.0</td>\n",
       "      <td>0.180180</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>74</th>\n",
       "      <td>Statins—disadvantaged groups: invitation for s...</td>\n",
       "      <td>Usual care or no intervention</td>\n",
       "      <td>0.230097</td>\n",
       "      <td>2.0</td>\n",
       "      <td>1.445087</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>72</th>\n",
       "      <td>Statins—general population: pharmacist based</td>\n",
       "      <td>Usual care or no intervention</td>\n",
       "      <td>0.204415</td>\n",
       "      <td>4.0</td>\n",
       "      <td>0.151837</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>86</th>\n",
       "      <td>Individual stress management</td>\n",
       "      <td>No intervention</td>\n",
       "      <td>0.200080</td>\n",
       "      <td>3.0</td>\n",
       "      <td>0.086498</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>87</th>\n",
       "      <td>Curricular</td>\n",
       "      <td>No intervention or standard education</td>\n",
       "      <td>0.138889</td>\n",
       "      <td>4.0</td>\n",
       "      <td>0.093721</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>30</th>\n",
       "      <td>Urban trail</td>\n",
       "      <td>No intervention</td>\n",
       "      <td>0.095740</td>\n",
       "      <td>4.0</td>\n",
       "      <td>0.044425</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>Brief counselling</td>\n",
       "      <td>Didactic messages</td>\n",
       "      <td>0.082008</td>\n",
       "      <td>2.0</td>\n",
       "      <td>4.385965</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>Accelerated partner therapy—doxycycline</td>\n",
       "      <td>Patient referral</td>\n",
       "      <td>0.071301</td>\n",
       "      <td>2.0</td>\n",
       "      <td>0.106952</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>Information motivation and behaviour skills</td>\n",
       "      <td>Didactic information</td>\n",
       "      <td>0.070706</td>\n",
       "      <td>2.0</td>\n",
       "      <td>0.129634</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>Accelerated partner therapy—azithromycin</td>\n",
       "      <td>Patient referral</td>\n",
       "      <td>0.051480</td>\n",
       "      <td>2.0</td>\n",
       "      <td>0.077220</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>76</th>\n",
       "      <td>Advice about PA</td>\n",
       "      <td>Usual care</td>\n",
       "      <td>0.027855</td>\n",
       "      <td>2.0</td>\n",
       "      <td>0.051546</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>Enhanced counselling</td>\n",
       "      <td>Didactic messages</td>\n",
       "      <td>0.021927</td>\n",
       "      <td>2.0</td>\n",
       "      <td>0.083243</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                       guidance_topic  \\\n",
       "53  Smoking cessation—general population: client c...   \n",
       "4                              Exercise prescriptions   \n",
       "56  Smoking cessation—general population: recruitm...   \n",
       "62  Smoking cessation —general population: dentist...   \n",
       "51  Smoking cessation—general population: incentiv...   \n",
       "2                           BA (5 min plus self-help)   \n",
       "54  Smoking cessation—general population: proactiv...   \n",
       "58  Smoking cessation—general population: identify...   \n",
       "61  Smoking cessation—general population: pharmaci...   \n",
       "0                                     BA only (5 min)   \n",
       "46                                     PA counselling   \n",
       "64  Smoking cessation—disadvantaged groups: client...   \n",
       "1   BA [5 min plus nicotine replacement therapy (N...   \n",
       "70    Smoking cessation—disadvantaged groups: NHS SSS   \n",
       "71  Smoking cessation—disadvantaged groups: pharma...   \n",
       "90            Screening and BA during GP consultation   \n",
       "19                               Life-skills training   \n",
       "74  Statins—disadvantaged groups: invitation for s...   \n",
       "72       Statins—general population: pharmacist based   \n",
       "86                       Individual stress management   \n",
       "87                                         Curricular   \n",
       "30                                        Urban trail   \n",
       "13                                  Brief counselling   \n",
       "11            Accelerated partner therapy—doxycycline   \n",
       "15        Information motivation and behaviour skills   \n",
       "12           Accelerated partner therapy—azithromycin   \n",
       "76                                    Advice about PA   \n",
       "16                               Enhanced counselling   \n",
       "\n",
       "                                           comparator     median  \\\n",
       "53   Background quit rate; no intervention or usua...  20.000000   \n",
       "4                                              Advice  12.987013   \n",
       "56    Background quit rate; no intervention or advice   3.846154   \n",
       "62                                         Usual care   3.311258   \n",
       "51                                Intervention no NRT   2.793296   \n",
       "2                                Background quit rate   2.702703   \n",
       "54   Usual care or intervention but no telephone c...   2.341920   \n",
       "58                                    No intervention   1.984127   \n",
       "61                                         Usual care   1.831502   \n",
       "0                                Background quit rate   1.366120   \n",
       "46                                    No intervention   1.157407   \n",
       "64                                    No intervention   0.639386   \n",
       "1                                Background quit rate   0.473934   \n",
       "70                                    No intervention   0.372301   \n",
       "71                                    No intervention   0.317360   \n",
       "90                                    No intervention   0.303030   \n",
       "19                                   Normal education   0.286369   \n",
       "74                      Usual care or no intervention   0.230097   \n",
       "72                      Usual care or no intervention   0.204415   \n",
       "86                                    No intervention   0.200080   \n",
       "87              No intervention or standard education   0.138889   \n",
       "30                                    No intervention   0.095740   \n",
       "13                                  Didactic messages   0.082008   \n",
       "11                                   Patient referral   0.071301   \n",
       "15                               Didactic information   0.070706   \n",
       "12                                   Patient referral   0.051480   \n",
       "76                                         Usual care   0.027855   \n",
       "16                                  Didactic messages   0.021927   \n",
       "\n",
       "    num_estimates     spread  \n",
       "53            8.0   2.288330  \n",
       "4             4.0   7.194245  \n",
       "56           15.0   0.074499  \n",
       "62            3.0  10.989011  \n",
       "51            2.0   1.597444  \n",
       "2             8.0   1.801802  \n",
       "54            9.0   0.683527  \n",
       "58            4.0   0.243902  \n",
       "61            2.0   4.608295  \n",
       "0             8.0   0.909091  \n",
       "46            2.0   1.353180  \n",
       "64            3.0   0.166889  \n",
       "1             8.0   0.315557  \n",
       "70            2.0   3.311258  \n",
       "71            2.0   0.235738  \n",
       "90            3.0   0.151515  \n",
       "19            3.0   0.180180  \n",
       "74            2.0   1.445087  \n",
       "72            4.0   0.151837  \n",
       "86            3.0   0.086498  \n",
       "87            4.0   0.093721  \n",
       "30            4.0   0.044425  \n",
       "13            2.0   4.385965  \n",
       "11            2.0   0.106952  \n",
       "15            2.0   0.129634  \n",
       "12            2.0   0.077220  \n",
       "76            2.0   0.051546  \n",
       "16            2.0   0.083243  "
      ]
     },
     "execution_count": 55,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "nice_df = pd.read_csv('./data/nice_data.csv', na_filter = False)\n",
    "\n",
    "nice_df = nice_df[(nice_df['range'] != 'NA') & \n",
    "                  (nice_df['range'] != 'N/A') &\n",
    "                  (nice_df['median'] != 'N/A')]\n",
    "\n",
    "nice_df['spread'] = nice_df['range'] \\\n",
    "    .str.split('–') \\\n",
    "    .apply(lambda x: abs(int(x[0]) - int(x[1])))\n",
    "\n",
    "nice_df = nice_df.apply(pd.to_numeric, errors='ignore')\n",
    "\n",
    "del nice_df['range']\n",
    "\n",
    "#Invert so large numbers are better, convert to QALY/1000£\n",
    "nice_df['spread'] = (1/nice_df['spread'])*1000\n",
    "nice_df['median'] = (1/nice_df['median'])*1000\n",
    "\n",
    "nice_df.sort_values(by='median', ascending=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>mean</th>\n",
       "      <th>std</th>\n",
       "      <th>downside_risk</th>\n",
       "      <th>intervention</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>41.418910</td>\n",
       "      <td>41.364215</td>\n",
       "      <td>1.438643</td>\n",
       "      <td>Iodine supplementation</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>12.039437</td>\n",
       "      <td>11.307934</td>\n",
       "      <td>3.733827</td>\n",
       "      <td>Deworm the World</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>9.064981</td>\n",
       "      <td>8.657475</td>\n",
       "      <td>4.589170</td>\n",
       "      <td>Schistosomiasis Control Initiative</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>4.894470</td>\n",
       "      <td>4.598517</td>\n",
       "      <td>6.279625</td>\n",
       "      <td>Sightsavers</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>4.519663</td>\n",
       "      <td>14.533890</td>\n",
       "      <td>9.365194</td>\n",
       "      <td>Household lead pipe replacement</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>3.572679</td>\n",
       "      <td>2.964297</td>\n",
       "      <td>6.958995</td>\n",
       "      <td>Against Malaria Foundation</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>3.222606</td>\n",
       "      <td>2.162316</td>\n",
       "      <td>7.082046</td>\n",
       "      <td>Malaria Consortium</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>1.060328</td>\n",
       "      <td>0.380961</td>\n",
       "      <td>8.921943</td>\n",
       "      <td>GiveDirectly</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "        mean        std  downside_risk                        intervention\n",
       "6  41.418910  41.364215       1.438643              Iodine supplementation\n",
       "0  12.039437  11.307934       3.733827                    Deworm the World\n",
       "1   9.064981   8.657475       4.589170  Schistosomiasis Control Initiative\n",
       "2   4.894470   4.598517       6.279625                         Sightsavers\n",
       "7   4.519663  14.533890       9.365194     Household lead pipe replacement\n",
       "4   3.572679   2.964297       6.958995          Against Malaria Foundation\n",
       "5   3.222606   2.162316       7.082046                  Malaria Consortium\n",
       "3   1.060328   0.380961       8.921943                        GiveDirectly"
      ]
     },
     "execution_count": 26,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "gw_df = pd.read_csv('./data/gw_data.csv')\n",
    "\n",
    "# Mean of the monte carlo intervention means:\n",
    "t = gw_df.agg('mean').mean()\n",
    "\n",
    "def downside_risk(series):\n",
    "    return np.sqrt((np.minimum(0.0, series - t)**2).sum()/series.size)\n",
    "\n",
    "gw_df = gw_df.agg(['mean', 'std', downside_risk]).T\n",
    "gw_df.reset_index(inplace=True)\n",
    "\n",
    "renames = {'iodine': 'Iodine supplementation', 'dtw':'Deworm the World', \n",
    "           'sci': 'Schistosomiasis Control Initiative', 'ss': 'Sightsavers',\n",
    "           'lead': 'Household lead pipe replacement', \n",
    "           'bednets': 'Against Malaria Foundation',\n",
    "           'smc': 'Malaria Consortium',\n",
    "           'cash': 'GiveDirectly'}\n",
    "\n",
    "gw_df['intervention'] = gw_df['index'].apply(lambda x: renames[x])\n",
    "del gw_df['index']\n",
    "\n",
    "gw_df.sort_values(by='mean', ascending=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {},
   "outputs": [],
   "source": [
    "# br_df = pd.read_csv('./data/biorisk.csv')\n",
    "# br_df['cost_effectiveness'] = (br_df['range_upper'] - br_df['range_lower'])/2 + br_df['range_lower']\n",
    "# br_df['cost_effectiveness'] = (1/br_df['cost_effectiveness'])*1000 #Convert to DALY/$1000\n",
    "# br_df['stdev'] = (br_df['range_upper'] - br_df['range_lower'])/2\n",
    "# br_df['stdev'] = (1/br_df['stdev'])*1000\n",
    "# br_df = br_df[['intervention', 'description', 'cost_effectiveness', 'stdev']]\n",
    "# br_df['source'] = 'BIORISK'\n",
    "# br_df"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# GHCEA Data "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>PubYear</th>\n",
       "      <th>InterventionPhrase</th>\n",
       "      <th>DisplayRatio</th>\n",
       "      <th>stdev</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>564</th>\n",
       "      <td>2010</td>\n",
       "      <td>Preventive treatment of malaria in pregnancy w...</td>\n",
       "      <td>1000.000000</td>\n",
       "      <td>334.566881</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>846</th>\n",
       "      <td>2011</td>\n",
       "      <td>Routine measles-containing vaccine followed by...</td>\n",
       "      <td>1000.000000</td>\n",
       "      <td>728.877849</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>413</th>\n",
       "      <td>2014</td>\n",
       "      <td>Aspirin alone (325 mg initial dose &amp; subsequen...</td>\n",
       "      <td>1000.000000</td>\n",
       "      <td>1645.853207</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>921</th>\n",
       "      <td>2014</td>\n",
       "      <td>New tuberculosis vaccine (40% efficacy)</td>\n",
       "      <td>1000.000000</td>\n",
       "      <td>944.841656</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>571</th>\n",
       "      <td>2010</td>\n",
       "      <td>Preventive treatment of malaria in pregnancy w...</td>\n",
       "      <td>1000.000000</td>\n",
       "      <td>13.391457</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>63</th>\n",
       "      <td>2003</td>\n",
       "      <td>Current treatment: all patients receiving anti...</td>\n",
       "      <td>0.005263</td>\n",
       "      <td>0.005875</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>369</th>\n",
       "      <td>2010</td>\n",
       "      <td>Creatinine test conducted at baseline (asympto...</td>\n",
       "      <td>0.005263</td>\n",
       "      <td>0.001583</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>44</th>\n",
       "      <td>2011</td>\n",
       "      <td>Orlistat treatment</td>\n",
       "      <td>0.004762</td>\n",
       "      <td>0.006003</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>875</th>\n",
       "      <td>2016</td>\n",
       "      <td>Cochlear implants</td>\n",
       "      <td>0.004167</td>\n",
       "      <td>0.034438</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>50</th>\n",
       "      <td>2009</td>\n",
       "      <td>Walking School Bus (WSB) program to increase t...</td>\n",
       "      <td>0.001852</td>\n",
       "      <td>0.000330</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>653 rows × 4 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "     PubYear                                 InterventionPhrase  DisplayRatio  \\\n",
       "564     2010  Preventive treatment of malaria in pregnancy w...   1000.000000   \n",
       "846     2011  Routine measles-containing vaccine followed by...   1000.000000   \n",
       "413     2014  Aspirin alone (325 mg initial dose & subsequen...   1000.000000   \n",
       "921     2014            New tuberculosis vaccine (40% efficacy)   1000.000000   \n",
       "571     2010  Preventive treatment of malaria in pregnancy w...   1000.000000   \n",
       "..       ...                                                ...           ...   \n",
       "63      2003  Current treatment: all patients receiving anti...      0.005263   \n",
       "369     2010  Creatinine test conducted at baseline (asympto...      0.005263   \n",
       "44      2011                                 Orlistat treatment      0.004762   \n",
       "875     2016                                  Cochlear implants      0.004167   \n",
       "50      2009  Walking School Bus (WSB) program to increase t...      0.001852   \n",
       "\n",
       "           stdev  \n",
       "564   334.566881  \n",
       "846   728.877849  \n",
       "413  1645.853207  \n",
       "921   944.841656  \n",
       "571    13.391457  \n",
       "..           ...  \n",
       "63      0.005875  \n",
       "369     0.001583  \n",
       "44      0.006003  \n",
       "875     0.034438  \n",
       "50      0.000330  \n",
       "\n",
       "[653 rows x 4 columns]"
      ]
     },
     "execution_count": 28,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "interval_df = pd.read_csv('./data/GHCEA_manualintervals.csv')\n",
    "\n",
    "#Remove non-integer rows\n",
    "interval_df  = interval_df[interval_df['DisplayRatio'].apply(lambda x: str(x).isdigit())]\n",
    "\n",
    "#Convert to floats\n",
    "interval_df['DisplayRatio'] = interval_df['DisplayRatio'].astype(float)\n",
    "\n",
    "#Eliminate non-usable CIs, from manual process\n",
    "interval_df = interval_df[interval_df['CI_Usable'] == 1]\n",
    "\n",
    "#Just use USD for now, because conversion ratio at time is unknown for others\n",
    "# Only 9 AUD, 1 EUR filtered out\n",
    "interval_df = interval_df[interval_df['CI_Currency'] == 'USD']\n",
    "\n",
    "# Remove any remaining nan intervals\n",
    "interval_df = interval_df[~interval_df['CI_Difference'].isnull()]\n",
    "\n",
    "#Convert to DALY/1000USD\n",
    "interval_df['DisplayRatio'] = (1/interval_df['DisplayRatio'])*1000\n",
    "interval_df['CI_Difference'] = (1/interval_df['CI_Difference'])*1000\n",
    "\n",
    "#Remove non standard CIs\n",
    "interval_df = interval_df[~interval_df['CI_Type'].isin(['INR', 'IQR'])]\n",
    "\n",
    "#Also remove studies with quality rating lower than 4.5 out of 7:\n",
    "interval_df = interval_df[interval_df['Rating'] >= 4.5] #4 \n",
    "\n",
    "# This is incorrect. Use the rough CI to standard deviation\n",
    "# conversions from Wolfram below instead\n",
    "# def handle_intervals(row):\n",
    "#     if row['CI_Type'] == 'range':\n",
    "#         return row['CI_Difference'] / 2\n",
    "#     elif row['CI_Type'] == '95':\n",
    "#         return (row['CI_Difference'] / 3.96)*np.sqrt(1000)\n",
    "#     elif row['CI_Type'] == '91':\n",
    "#         return (row['CI_Difference'] / 3.29)*np.sqrt(1000)\n",
    "#     elif row['CI_Type'] == '80':\n",
    "#         #Simple interpolation for denominator\n",
    "#         denom = 1.96 + ((3.29 - 1.96)/(90-68))*(80-68)\n",
    "#         return (row['CI_Difference'] / denom)*np.sqrt(1000)\n",
    "    \n",
    "# https://mathworld.wolfram.com/ConfidenceInterval.html\n",
    "# CI_Difference = [mean +- c*sigma], difference covers both sides\n",
    "# so multiply by 2\n",
    "def handle_intervals(row):\n",
    "    if row['CI_Type'] == 'range':\n",
    "        return row['CI_Difference'] / 2\n",
    "    elif row['CI_Type'] == '95':\n",
    "        return row['CI_Difference'] / 1.95996*2\n",
    "    elif row['CI_Type'] == '91':\n",
    "        return row['CI_Difference'] / 1.64485*2\n",
    "    elif row['CI_Type'] == '80':\n",
    "        return row['CI_Difference'] / 1.28155*2\n",
    "        \n",
    "\n",
    "interval_df['stdev'] = interval_df.apply(handle_intervals, axis=1)\n",
    "interval_df[\n",
    "    ['PubYear','InterventionPhrase', 'DisplayRatio', 'stdev']\n",
    "].sort_values(by='DisplayRatio', ascending=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "metadata": {},
   "outputs": [],
   "source": [
    "#interval_df[interval_df['InterventionPhrase'] == \"Policy intervention to reduce sodium consumption by 10%\"]\n",
    "#Ok, there are 183 of these. . . I guess if they tested all those interventions, why not include them?"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Putting It All Together\n",
    "\n",
    "Because both the GiveWell and Future of Humanity Institute (FHI) data share the same units, we can combine them to get a sense of the scale. Also, if we lazily assume that we can estimate the standard deviation of the Disease Control Priorities (DCP2) and National Institute for Health and Care Excellence (NICE) estimates by dividing the [range of the estimates by two](https://stats.stackexchange.com/questions/69575/relationship-between-the-range-and-the-standard-deviation), we can include those as well.  Note also that the NICE estimates are median results while Givewell and FHI are mean results, so this might need to be changed.\n",
    "\n",
    "One final thing to consider: the Givewell estimates are from shovel-ready charities accepting donations, while many of the others measure impact against a counterfactual using an [Incremental Cost Effectiveness Ratio](https://en.wikipedia.org/wiki/Incremental_cost-effectiveness_ratio) without a clear avenue for donors to make that change happen.  Instead, many of these interventions probably need to be implemented at the hospital, insurer, or federal policy level rather than through a charity. \n",
    "\n",
    "After the above wrangling, the GHCEA estimates have units that match the rest as well: standard deviations and mean impacts.  Below, I concatenate all the different sources and look at some histograms to get an idea of the distributions (mostly lognormal).  Next, I fit some curves, run the portfolio optimization, and visualize the results. "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 102,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>intervention</th>\n",
       "      <th>cost_effectiveness</th>\n",
       "      <th>stdev</th>\n",
       "      <th>source</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Research - Diarrhoeal diseases</td>\n",
       "      <td>3549.783221</td>\n",
       "      <td>80857.231707</td>\n",
       "      <td>FHI</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Research - Meningititis</td>\n",
       "      <td>1732.527683</td>\n",
       "      <td>41075.262076</td>\n",
       "      <td>FHI</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Research - Leishmaniasis</td>\n",
       "      <td>1703.723172</td>\n",
       "      <td>8363.477589</td>\n",
       "      <td>FHI</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Routine measles-containing vaccine followed by...</td>\n",
       "      <td>1000.000000</td>\n",
       "      <td>728.877849</td>\n",
       "      <td>GHCEA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Aspirin alone (325 mg initial dose &amp; subsequen...</td>\n",
       "      <td>1000.000000</td>\n",
       "      <td>1645.853207</td>\n",
       "      <td>GHCEA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Preventive treatment of malaria in pregnancy w...</td>\n",
       "      <td>1000.000000</td>\n",
       "      <td>13.391457</td>\n",
       "      <td>GHCEA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>Preventive treatment of malaria in pregnancy w...</td>\n",
       "      <td>1000.000000</td>\n",
       "      <td>334.566881</td>\n",
       "      <td>GHCEA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>New tuberculosis vaccine (40% efficacy)</td>\n",
       "      <td>1000.000000</td>\n",
       "      <td>944.841656</td>\n",
       "      <td>GHCEA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>Research - Leprosy</td>\n",
       "      <td>824.521890</td>\n",
       "      <td>71250.250787</td>\n",
       "      <td>FHI</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>Research - Trypanosomiasis</td>\n",
       "      <td>802.785665</td>\n",
       "      <td>110366.393439</td>\n",
       "      <td>FHI</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>Research - Malaria</td>\n",
       "      <td>801.655755</td>\n",
       "      <td>7066.975304</td>\n",
       "      <td>FHI</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>Research - Multiple salmonella infections</td>\n",
       "      <td>753.616047</td>\n",
       "      <td>16466.171159</td>\n",
       "      <td>FHI</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>Research - Typhoid and paratyphoid fever</td>\n",
       "      <td>709.092672</td>\n",
       "      <td>30713.464549</td>\n",
       "      <td>FHI</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>Research - Chagas disease</td>\n",
       "      <td>534.967344</td>\n",
       "      <td>6210.949437</td>\n",
       "      <td>FHI</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>Syphilis screening before third trimester + tr...</td>\n",
       "      <td>500.000000</td>\n",
       "      <td>303.979086</td>\n",
       "      <td>GHCEA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>Brief smoking cessation advice + Bupropion</td>\n",
       "      <td>333.333333</td>\n",
       "      <td>0.058923</td>\n",
       "      <td>GHCEA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>Syphilis screening before third trimester + tr...</td>\n",
       "      <td>333.333333</td>\n",
       "      <td>204.085798</td>\n",
       "      <td>GHCEA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>Intermittent preventive treatment in infants (...</td>\n",
       "      <td>333.333333</td>\n",
       "      <td>255.746614</td>\n",
       "      <td>GHCEA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>Syphilis screening before third trimester + tr...</td>\n",
       "      <td>333.333333</td>\n",
       "      <td>173.702335</td>\n",
       "      <td>GHCEA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>Intermittent preventive treatment in infants (...</td>\n",
       "      <td>333.333333</td>\n",
       "      <td>330.235919</td>\n",
       "      <td>GHCEA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>Research - HIV</td>\n",
       "      <td>303.678832</td>\n",
       "      <td>2132.474086</td>\n",
       "      <td>FHI</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>Research - Trichuriasis</td>\n",
       "      <td>251.336051</td>\n",
       "      <td>13978.148011</td>\n",
       "      <td>FHI</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>New tuberculosis vaccine (40% efficacy)</td>\n",
       "      <td>250.000000</td>\n",
       "      <td>132.695577</td>\n",
       "      <td>GHCEA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>Syphilis screening before third trimester + tr...</td>\n",
       "      <td>250.000000</td>\n",
       "      <td>127.553624</td>\n",
       "      <td>GHCEA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>Syphilis screening before third trimester + tr...</td>\n",
       "      <td>250.000000</td>\n",
       "      <td>151.989543</td>\n",
       "      <td>GHCEA</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                         intervention  cost_effectiveness  \\\n",
       "0                      Research - Diarrhoeal diseases         3549.783221   \n",
       "1                             Research - Meningititis         1732.527683   \n",
       "2                            Research - Leishmaniasis         1703.723172   \n",
       "3   Routine measles-containing vaccine followed by...         1000.000000   \n",
       "4   Aspirin alone (325 mg initial dose & subsequen...         1000.000000   \n",
       "5   Preventive treatment of malaria in pregnancy w...         1000.000000   \n",
       "6   Preventive treatment of malaria in pregnancy w...         1000.000000   \n",
       "7             New tuberculosis vaccine (40% efficacy)         1000.000000   \n",
       "8                                  Research - Leprosy          824.521890   \n",
       "9                          Research - Trypanosomiasis          802.785665   \n",
       "10                                 Research - Malaria          801.655755   \n",
       "11          Research - Multiple salmonella infections          753.616047   \n",
       "12           Research - Typhoid and paratyphoid fever          709.092672   \n",
       "13                          Research - Chagas disease          534.967344   \n",
       "14  Syphilis screening before third trimester + tr...          500.000000   \n",
       "15         Brief smoking cessation advice + Bupropion          333.333333   \n",
       "16  Syphilis screening before third trimester + tr...          333.333333   \n",
       "17  Intermittent preventive treatment in infants (...          333.333333   \n",
       "18  Syphilis screening before third trimester + tr...          333.333333   \n",
       "19  Intermittent preventive treatment in infants (...          333.333333   \n",
       "20                                     Research - HIV          303.678832   \n",
       "21                            Research - Trichuriasis          251.336051   \n",
       "22            New tuberculosis vaccine (40% efficacy)          250.000000   \n",
       "23  Syphilis screening before third trimester + tr...          250.000000   \n",
       "24  Syphilis screening before third trimester + tr...          250.000000   \n",
       "\n",
       "            stdev source  \n",
       "0    80857.231707    FHI  \n",
       "1    41075.262076    FHI  \n",
       "2     8363.477589    FHI  \n",
       "3      728.877849  GHCEA  \n",
       "4     1645.853207  GHCEA  \n",
       "5       13.391457  GHCEA  \n",
       "6      334.566881  GHCEA  \n",
       "7      944.841656  GHCEA  \n",
       "8    71250.250787    FHI  \n",
       "9   110366.393439    FHI  \n",
       "10    7066.975304    FHI  \n",
       "11   16466.171159    FHI  \n",
       "12   30713.464549    FHI  \n",
       "13    6210.949437    FHI  \n",
       "14     303.979086  GHCEA  \n",
       "15       0.058923  GHCEA  \n",
       "16     204.085798  GHCEA  \n",
       "17     255.746614  GHCEA  \n",
       "18     173.702335  GHCEA  \n",
       "19     330.235919  GHCEA  \n",
       "20    2132.474086    FHI  \n",
       "21   13978.148011    FHI  \n",
       "22     132.695577  GHCEA  \n",
       "23     127.553624  GHCEA  \n",
       "24     151.989543  GHCEA  "
      ]
     },
     "execution_count": 102,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "temp1_df = fhi_df[['disease','mean', 'stdev']].copy()\n",
    "temp1_df.rename(columns={'mean': 'cost_effectiveness', 'disease': 'intervention'}, inplace=True)\n",
    "temp1_df['intervention'] = 'Research - ' + temp1_df['intervention']\n",
    "temp1_df['source'] = 'FHI'\n",
    "\n",
    "temp2_df = gw_df[['intervention', 'mean', 'std']].copy() #.reset_index().copy()\n",
    "#'index': 'intervention',\n",
    "temp2_df.rename(columns={'mean': 'cost_effectiveness', 'std':'stdev'}, inplace=True)\n",
    "temp2_df['source'] = 'GW'\n",
    "\n",
    "# Is this the cost effectiveness here a mean or median?\n",
    "temp3_df = ph_df[['intervention', 'cost_effectiveness', 'spread']].copy()\n",
    "temp3_df['stdev'] = temp3_df['spread'] / 2\n",
    "del temp3_df['spread']\n",
    "temp3_df['source'] = 'DCP2'\n",
    "\n",
    "# The cost effectiveness here is a median, others above are means. . . \n",
    "temp4_df = nice_df[['guidance_topic', 'median', 'spread']].copy()\n",
    "temp4_df.rename(columns={'guidance_topic': 'intervention', \n",
    "    'median': 'cost_effectiveness'}, inplace=True)\n",
    "# Convert DALY/1000£ to DALY/1000USD, using 2012 dollars for now:\n",
    "# https://www.x-rates.com/average/?from=GBP&to=USD&amount=1&year=2012\n",
    "temp4_df['cost_effectiveness'] = temp4_df['cost_effectiveness']*1.6\n",
    "temp4_df['spread'] = temp4_df['spread']*1.6\n",
    "temp4_df['stdev'] = temp4_df['spread'] / 2\n",
    "del temp4_df['spread']\n",
    "temp4_df.rename(columns={'Intervention': 'intervention'}, inplace=True)\n",
    "temp4_df['source'] = 'NICE'\n",
    "  \n",
    "temp5_df = interval_df[['InterventionPhrase','DisplayRatio', 'stdev']].copy()\n",
    "temp5_df.rename(columns={'InterventionPhrase': 'intervention', \n",
    "    'DisplayRatio': 'cost_effectiveness'}, inplace=True)\n",
    "temp5_df['source'] = 'GHCEA'\n",
    "\n",
    "#temp6_df = br_df[['intervention', 'cost_effectiveness', 'stdev', 'source']]\n",
    "\n",
    "comb_df = pd.concat([temp1_df, temp2_df, temp3_df, temp4_df, temp5_df])\n",
    "comb_df.to_csv('./data/outputs/meta-returns.csv', index=False)\n",
    "comb_df = comb_df.sort_values(by='cost_effectiveness', ascending=False)\n",
    "comb_df.reset_index(drop=True, inplace=True)\n",
    "comb_df.head(25)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "metadata": {},
   "outputs": [],
   "source": [
    "# For some reason there are two null values. No more! \n",
    "# comb_df[comb_df.isnull().any(axis=1)]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 96,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 504x360 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "fig, ax = plt.subplots(figsize=(7,5))\n",
    "\n",
    "plt_df = comb_df[['source', 'cost_effectiveness']].copy()\n",
    "plt_df['cost_effectiveness'] = np.log(plt_df['cost_effectiveness'])\n",
    "plt_df.hist(column='cost_effectiveness', bins=50, color='#4682b4', ax=ax)\n",
    "\n",
    "ax.set_xlabel('log(cost_effectiveness) (DALY/1000USD)')\n",
    "ax.set_ylabel('Count')\n",
    "plt.savefig('./data/outputs/hist.png')\n",
    "\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 73,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 756x504 with 5 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "#col=\"time\",  col=\"year\", col_wrap=2, size=4 , sharex=False\n",
    "g = sns.FacetGrid(plt_df,  col=\"source\", col_wrap=3,  height=3.5, sharey=False)  \n",
    "g = g.map(plt.hist, \"cost_effectiveness\", bins=20, color='#4682b4')\n",
    "g.set_axis_labels(\"log(cost_effectiveness)\", \"Count\")\n",
    "g.savefig('./data/outputs/facet-hists.png')\n",
    "# g"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Fitting Some Curves\n",
    "\n",
    "I take two approaches to determine if there is evidence of a return to risk.  The first is to run a simple linear regression through the data to see if it has a positive slope. This technique isn't ideal though -- imagine if you calculated the cost effectiveness for every possible action including things like \"lighting $1000 on fire\".  This would result in many useless interventions that would pull down the slope of the linear regression.  \n",
    "\n",
    "![frontier.jpg](https://pstblog.com/images/metareturns/frontier.jpg)\n",
    "\n",
    "So my second approach is to see if the frontier that encloses the top estimates has a positive slope.  In Modern Portfolio Theory, this frontier is called the [efficient frontier](https://en.wikipedia.org/wiki/Efficient_frontier), which I've written about [before](https://github.com/psthomas/efficient-frontier).  I didn't have enough data to test out this theory in the past, but the combination of all these sources makes it possible to do so now. "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Aaron Clausen based power law package, only works for univariate test though\n",
    "# http://tuvalu.santafe.edu/~aaronc/powerlaws/\n",
    "#https://github.com/jeffalstott/powerlaw\n",
    "#https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0085777\n",
    "#https://stackoverflow.com/questions/24402834/fitting-power-law-function-with-pymc\n",
    "# import powerlaw\n",
    "# results = powerlaw.Fit(comb_df['cost_effectiveness'])\n",
    "# print(results.power_law.alpha)\n",
    "# print(results.power_law.xmin)\n",
    "# #R, p = results.distribution_compare('power_law', 'lognormal')\n",
    "# powerlaw.plot_pdf(comb_df['cost_effectiveness'], color='b')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 85,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Best power fit:  y = 17.230*x^0.406\n"
     ]
    }
   ],
   "source": [
    "# Fit a power law\n",
    "from scipy.optimize import curve_fit\n",
    "# Remove intercept? \n",
    "def pow_func(x, a, b):\n",
    "    return a*(x**b) #+ c\n",
    "\n",
    "popt, pcov = curve_fit(pow_func, comb_df['stdev'], comb_df['cost_effectiveness'])\n",
    "label = 'y = %5.3f*x^%5.3f' % tuple(popt)\n",
    "print('Best power fit: ', label)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 86,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 648x576 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "fig, ax = plt.subplots(figsize=(9,8))\n",
    "\n",
    "group_colors = {'GHCEA': 'lightslategray','GW':'red',\n",
    "    'FHI':'black', 'NICE': 'green', 'DCP2':'blue' } #'BIORISK':'yellow'\n",
    "\n",
    "for src in group_colors.keys():\n",
    "    x_vals = comb_df[(comb_df['source'] == src)].loc[:,'stdev']\n",
    "    y_vals = comb_df[(comb_df['source'] == src)].loc[:,'cost_effectiveness']\n",
    "    ax.scatter(x=x_vals, y=y_vals, color=group_colors[src], s=20, alpha=0.7, label=src) \n",
    "\n",
    "ax.set_xlabel('Standard Deviation (DALY/1000USD)')\n",
    "ax.set_ylabel('Cost Effectiveness (DALY/1000USD)')\n",
    "\n",
    "x = pd.DataFrame({\n",
    "    'stdev': np.linspace(comb_df['stdev'].min(), comb_df['stdev'].max(), 10000)\n",
    "})\n",
    "\n",
    "#Fit linear regression\n",
    "poly_51 = smf.ols(formula='cost_effectiveness ~ 1 + stdev',\n",
    "                 data=comb_df, missing='drop').fit()\n",
    "\n",
    "plt.plot(\n",
    "    x['stdev'],\n",
    "    poly_51.predict(x['stdev']),\n",
    "    'k-',\n",
    "    label='y={1:.6f}x+{2:.2f}, $R^2$={0:.2f}'.format(\n",
    "        poly_51.rsquared, poly_51.params.stdev, poly_51.params.Intercept\n",
    "    ),\n",
    "    alpha=0.6\n",
    ")    \n",
    "\n",
    "#Plot power law\n",
    "plt.plot(x['stdev'], pow_func(x['stdev'], *popt), 'b-', alpha=0.9, label=label)\n",
    "\n",
    "plt.legend()\n",
    "plt.savefig('./data/outputs/linear-returns.png')\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 87,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 648x576 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "fig, ax = plt.subplots(figsize=(9,8))\n",
    "\n",
    "for src in group_colors.keys():\n",
    "    x_vals = comb_df[(comb_df['source'] == src)].loc[:,'stdev']\n",
    "    y_vals = comb_df[(comb_df['source'] == src)].loc[:,'cost_effectiveness']\n",
    "    ax.scatter(x=x_vals, y=y_vals, color=group_colors[src], s=20, alpha=0.7, label=src) \n",
    "\n",
    "ax.set_xlabel('Standard Deviation (DALY/1000USD)')\n",
    "ax.set_ylabel('Cost Effectiveness (DALY/1000USD)')\n",
    "ax.set_yscale('log')\n",
    "ax.set_xscale('log')\n",
    "#ax.set_ylim(1e-2, 1e5)\n",
    "#ax.set_ylim(1e-3, 1e6)\n",
    "#ax.set_xlim(1e-2, 1e6)\n",
    "\n",
    "plt.plot(x['stdev'], poly_51.predict(x['stdev']), 'k-', label='y={1:.6f}x+{2:.2f}, $R^2$={0:.2f}' \\\n",
    "    .format(poly_51.rsquared, poly_51.params.stdev, poly_51.params.Intercept), \n",
    "    alpha=0.6)  \n",
    "\n",
    "plt.plot(x['stdev'], pow_func(x['stdev'], *popt), 'b-', alpha=0.6, label=label)\n",
    "\n",
    "plt.legend()\n",
    "plt.savefig('./data/outputs/lognormal-returns.png')\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# The Efficient Frontier\n",
    "\n",
    "Finally, I use a modified version of an algorithm [described on Quantopian](https://blog.quantopian.com/markowitz-portfolio-optimization-2/) to generate a frontier of interventions.  This code uses convex optimization to find the minimum variance portfolio at a variety of cost effectiveness values.  The covariance matrix I use as input is all zeros except for the diagonal of variances (although this could be changed if you have some reason to think intervention outcomes are correlated in some way).  \n",
    "\n",
    "Note that the plot below is interactive with scroll-to-zoom enabled.  "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 92,
   "metadata": {},
   "outputs": [],
   "source": [
    "#Code for finding the efficient frontier.\n",
    "def efficient_frontier(variances, mean_returns):\n",
    "    '''\n",
    "    Returns an optimal portfolio, frontier, and portfolio \n",
    "    weights given a covariance matrix and matrix of mean returns. \n",
    "    Modified from source: \n",
    "    https://blog.quantopian.com/markowitz-portfolio-optimization-2/\n",
    "    '''\n",
    "    # Turn off progress printing \n",
    "    solvers.options['show_progress'] = False\n",
    "    \n",
    "    n = len(mean_returns)\n",
    "    N = 100\n",
    "    # Mus are the desired returns\n",
    "    mus = [10**(5.0 * t/N - 1.0) for t in range(N)] \n",
    "    # Sample more at low, high ends for better curve\n",
    "    mus += [(5000/50)*t for t in range(50)]  \n",
    "    mus += [(0.01 + (1/100)*t) for t in range(100)]\n",
    "    mus += [0.001]\n",
    "    mus = sorted(mus)\n",
    "    \n",
    "    #mus = np.linspace(0.001, 100000, 100)\n",
    "    #variances = np.nonzero(covariances)\n",
    "#     lower_bound = np.amin(variances)\n",
    "#     upper_bound = np.amax(variances)\n",
    "#     mus = list(np.linspace(lower_bound, upper_bound, num=N))\n",
    "#     print(lower_bound, upper_bound, mus)\n",
    "    \n",
    "    dim = len(comb_df.index)\n",
    "    covariances = np.zeros((dim, dim), float) #Create covariance matrix\n",
    "    np.fill_diagonal(covariances, variances) #Only diagonal of variances for now\n",
    "\n",
    "    S = opt.matrix(covariances)  # convert array to matrix  \n",
    "    pbar = opt.matrix(mean_returns)  # convert array to matrix\n",
    "\n",
    "    # Create constraint matrices\n",
    "    G = -opt.matrix(np.eye(n))   # negative n x n identity matrix\n",
    "    h = opt.matrix(0.0, (n ,1))\n",
    "    A = opt.matrix(1.0, (1, n))\n",
    "    b = opt.matrix(1.0)\n",
    "    \n",
    "    #print(mus, S, pbar, G, h, A, b)\n",
    "    \n",
    "    # Calculate efficient frontier weights using quadratic programming\n",
    "    portfolios = [solvers.qp(mu*S, -pbar, G, h, A, b)['x'] \n",
    "                  for mu in mus]\n",
    "    \n",
    "    ## CALCULATE RISKS AND RETURNS FOR FRONTIER\n",
    "    frontier_returns = [blas.dot(pbar, x) for x in portfolios] \n",
    "    #np.sqrt returns the stdev, not variance\n",
    "    frontier_risks = [np.sqrt(blas.dot(x, S*x)) for x in portfolios] \n",
    "    \n",
    "    ## CALCULATE THE 2ND DEGREE POLYNOMIAL OF THE FRONTIER CURVE\n",
    "    m1 = np.polyfit(frontier_returns, frontier_risks, 2)\n",
    "    x1 = np.sqrt(m1[2] / m1[0])\n",
    "    \n",
    "    # CALCULATE THE OPTIMAL PORTFOLIO\n",
    "    wt = solvers.qp(opt.matrix(x1 * S), -pbar, G, h, A, b)['x'] \n",
    "    \n",
    "    result = {'optimal_portfolio': np.asarray(wt),'returns': frontier_returns, \n",
    "        'risks': frontier_risks, 'portfolios': portfolios}\n",
    "\n",
    "    return result"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 93,
   "metadata": {},
   "outputs": [],
   "source": [
    "#Find the frontier\n",
    "# dim = len(comb_df.index)\n",
    "# covariances = np.zeros((dim, dim), float) #Create covariance matrix\n",
    "# np.fill_diagonal(covariances, comb_df['stdev']**2) #Only diagonal of variances for now\n",
    "variances = comb_df['stdev']**2\n",
    "returns = comb_df['cost_effectiveness']\n",
    "frontier = efficient_frontier(variances, returns)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 95,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "\n",
       "<div id=\"altair-viz-9663cc867b4545748b1bcc220334f64f\"></div>\n",
       "<script type=\"text/javascript\">\n",
       "  (function(spec, embedOpt){\n",
       "    let outputDiv = document.currentScript.previousElementSibling;\n",
       "    if (outputDiv.id !== \"altair-viz-9663cc867b4545748b1bcc220334f64f\") {\n",
       "      outputDiv = document.getElementById(\"altair-viz-9663cc867b4545748b1bcc220334f64f\");\n",
       "    }\n",
       "    const paths = {\n",
       "      \"vega\": \"https://cdn.jsdelivr.net/npm//vega@5?noext\",\n",
       "      \"vega-lib\": \"https://cdn.jsdelivr.net/npm//vega-lib?noext\",\n",
       "      \"vega-lite\": \"https://cdn.jsdelivr.net/npm//vega-lite@4.8.1?noext\",\n",
       "      \"vega-embed\": \"https://cdn.jsdelivr.net/npm//vega-embed@6?noext\",\n",
       "    };\n",
       "\n",
       "    function loadScript(lib) {\n",
       "      return new Promise(function(resolve, reject) {\n",
       "        var s = document.createElement('script');\n",
       "        s.src = paths[lib];\n",
       "        s.async = true;\n",
       "        s.onload = () => resolve(paths[lib]);\n",
       "        s.onerror = () => reject(`Error loading script: ${paths[lib]}`);\n",
       "        document.getElementsByTagName(\"head\")[0].appendChild(s);\n",
       "      });\n",
       "    }\n",
       "\n",
       "    function showError(err) {\n",
       "      outputDiv.innerHTML = `<div class=\"error\" style=\"color:red;\">${err}</div>`;\n",
       "      throw err;\n",
       "    }\n",
       "\n",
       "    function displayChart(vegaEmbed) {\n",
       "      vegaEmbed(outputDiv, spec, embedOpt)\n",
       "        .catch(err => showError(`Javascript Error: ${err.message}<br>This usually means there's a typo in your chart specification. See the javascript console for the full traceback.`));\n",
       "    }\n",
       "\n",
       "    if(typeof define === \"function\" && define.amd) {\n",
       "      requirejs.config({paths});\n",
       "      require([\"vega-embed\"], displayChart, err => showError(`Error loading script: ${err.message}`));\n",
       "    } else if (typeof vegaEmbed === \"function\") {\n",
       "      displayChart(vegaEmbed);\n",
       "    } else {\n",
       "      loadScript(\"vega\")\n",
       "        .then(() => loadScript(\"vega-lite\"))\n",
       "        .then(() => loadScript(\"vega-embed\"))\n",
       "        .catch(showError)\n",
       "        .then(() => displayChart(vegaEmbed));\n",
       "    }\n",
       "  })({\"config\": {\"view\": {\"continuousWidth\": 400, \"continuousHeight\": 300}}, \"layer\": [{\"data\": {\"name\": \"data-2bdb44c16e010c2db41978a8e13877ca\"}, \"mark\": \"circle\", \"encoding\": {\"color\": {\"type\": \"nominal\", \"field\": \"source\"}, \"opacity\": {\"value\": 0.9}, \"tooltip\": [{\"type\": \"nominal\", \"field\": \"source\"}, {\"type\": \"nominal\", \"field\": \"intervention\"}, {\"type\": \"quantitative\", \"field\": \"stdev\"}, {\"type\": \"quantitative\", \"field\": \"cost_effectiveness\"}], \"x\": {\"type\": \"quantitative\", \"axis\": {\"title\": \"Standard Deviation (DALY/1000USD)\"}, \"field\": \"stdev\", \"scale\": {\"type\": \"log\"}}, \"y\": {\"type\": \"quantitative\", \"axis\": {\"title\": \"Cost Effectiveness (DALY/1000USD)\"}, \"field\": \"cost_effectiveness\", \"scale\": {\"type\": \"log\"}}}, \"height\": 450, \"selection\": {\"selector007\": {\"type\": \"interval\", \"bind\": \"scales\", \"encodings\": [\"x\", \"y\"]}}, \"width\": 700}, {\"data\": {\"name\": \"data-e1437c5e7a8ba73216d18c14637b03bb\"}, \"mark\": \"line\", \"encoding\": {\"color\": {\"type\": \"nominal\", \"field\": \"fit_type\"}, \"x\": {\"type\": \"quantitative\", \"field\": \"stdev\"}, \"y\": {\"type\": \"quantitative\", \"field\": \"yfit\"}}}], \"$schema\": \"https://vega.github.io/schema/vega-lite/v4.8.1.json\", \"datasets\": {\"data-2bdb44c16e010c2db41978a8e13877ca\": [{\"intervention\": \"Research - HIV\", \"cost_effectiveness\": 303.6788, \"stdev\": 2132.4741, \"source\": \"FHI\"}, {\"intervention\": \"Research - Malaria\", \"cost_effectiveness\": 801.6558, \"stdev\": 7066.9753, \"source\": \"FHI\"}, {\"intervention\": \"Research - TB\", \"cost_effectiveness\": 116.9226, \"stdev\": 5881.6193, \"source\": \"FHI\"}, {\"intervention\": \"Research - Diarrhoeal diseases\", \"cost_effectiveness\": 3549.7832, \"stdev\": 80857.2317, \"source\": \"FHI\"}, {\"intervention\": \"Research - Hookworm\", \"cost_effectiveness\": 120.5266, \"stdev\": 937.0801, \"source\": \"FHI\"}, {\"intervention\": \"Research - Ascariasis\", \"cost_effectiveness\": 187.7758, \"stdev\": 1946.7857, \"source\": \"FHI\"}, {\"intervention\": \"Research - Trichuriasis\", \"cost_effectiveness\": 251.3361, \"stdev\": 13978.148, \"source\": \"FHI\"}, {\"intervention\": \"Research - Lymphatic filariasis\", \"cost_effectiveness\": 59.9131, \"stdev\": 988.92, \"source\": \"FHI\"}, {\"intervention\": \"Research - Schistosomiasis\", \"cost_effectiveness\": 38.4771, \"stdev\": 511.8974, \"source\": \"FHI\"}, {\"intervention\": \"Research - Onchocerciasis\", \"cost_effectiveness\": 18.3657, \"stdev\": 271.1584, \"source\": \"FHI\"}, {\"intervention\": \"Research - Dengue\", \"cost_effectiveness\": 0.3735, \"stdev\": 2.1905, \"source\": \"FHI\"}, {\"intervention\": \"Research - Leishmaniasis\", \"cost_effectiveness\": 1703.7232, \"stdev\": 8363.4776, \"source\": \"FHI\"}, {\"intervention\": \"Research - Chagas disease\", \"cost_effectiveness\": 534.9673, \"stdev\": 6210.9494, \"source\": \"FHI\"}, {\"intervention\": \"Research - Trypanosomiasis\", \"cost_effectiveness\": 802.7857, \"stdev\": 110366.3934, \"source\": \"FHI\"}, {\"intervention\": \"Research - Meningititis\", \"cost_effectiveness\": 1732.5277, \"stdev\": 41075.2621, \"source\": \"FHI\"}, {\"intervention\": \"Research - Typhoid and paratyphoid fever\", \"cost_effectiveness\": 709.0927, \"stdev\": 30713.4645, \"source\": \"FHI\"}, {\"intervention\": \"Research - Multiple salmonella infections\", \"cost_effectiveness\": 753.616, \"stdev\": 16466.1712, \"source\": \"FHI\"}, {\"intervention\": \"Research - Leprosy\", \"cost_effectiveness\": 824.5219, \"stdev\": 71250.2508, \"source\": \"FHI\"}, {\"intervention\": \"Research - Trachoma\", \"cost_effectiveness\": 17.0663, \"stdev\": 252.7737, \"source\": \"FHI\"}, {\"intervention\": \"Deworm the World\", \"cost_effectiveness\": 12.0394, \"stdev\": 11.3079, \"source\": \"GW\"}, {\"intervention\": \"Schistosomiasis Control Initiative\", \"cost_effectiveness\": 9.065, \"stdev\": 8.6575, \"source\": \"GW\"}, {\"intervention\": \"Sightsavers\", \"cost_effectiveness\": 4.8945, \"stdev\": 4.5985, \"source\": \"GW\"}, {\"intervention\": \"GiveDirectly\", \"cost_effectiveness\": 1.0603, \"stdev\": 0.381, \"source\": \"GW\"}, {\"intervention\": \"Against Malaria Foundation\", \"cost_effectiveness\": 3.5727, \"stdev\": 2.9643, \"source\": \"GW\"}, {\"intervention\": \"Malaria Consortium\", \"cost_effectiveness\": 3.2226, \"stdev\": 2.1623, \"source\": \"GW\"}, {\"intervention\": \"Iodine supplementation\", \"cost_effectiveness\": 41.4189, \"stdev\": 41.3642, \"source\": \"GW\"}, {\"intervention\": \"Household lead pipe replacement\", \"cost_effectiveness\": 4.5197, \"stdev\": 14.5339, \"source\": \"GW\"}, {\"intervention\": \"ACE inhibitor and beta-blocker, with diuretics\", \"cost_effectiveness\": 6.6667, \"stdev\": 2.0243, \"source\": \"DCP2\"}, {\"intervention\": \"Advertising ban and reduced access to beverage retail\", \"cost_effectiveness\": 2.4752, \"stdev\": 6.7568, \"source\": \"DCP2\"}, {\"intervention\": \"Annual mass drug administration\", \"cost_effectiveness\": 66.6667, \"stdev\": 21.7391, \"source\": \"DCP2\"}, {\"intervention\": \"Antipsychotic drugs with optional psychosocial treatment, communitybased\", \"cost_effectiveness\": 0.1017, \"stdev\": 0.034, \"source\": \"DCP2\"}, {\"intervention\": \"Antipsychotic drugs with optional psychosocial treatment, hospitalbased\", \"cost_effectiveness\": 0.0839, \"stdev\": 0.032, \"source\": \"DCP2\"}, {\"intervention\": \"Antiretroviral therapy\", \"cost_effectiveness\": 1.0846, \"stdev\": 0.4371, \"source\": \"DCP2\"}, {\"intervention\": \"Aspirin and dipyridamole\", \"cost_effectiveness\": 12.3457, \"stdev\": 21.7391, \"source\": \"DCP2\"}, {\"intervention\": \"Aspirin, betablocker, and optional ACE inhibitor\", \"cost_effectiveness\": 1.4535, \"stdev\": 1.0526, \"source\": \"DCP2\"}, {\"intervention\": \"Ayurvedic treatment and levodopa or carbidopa\", \"cost_effectiveness\": 0.8834, \"stdev\": 0.6579, \"source\": \"DCP2\"}, {\"intervention\": \"BCG vaccine\", \"cost_effectiveness\": 14.7059, \"stdev\": 18.5185, \"source\": \"DCP2\"}, {\"intervention\": \"Blood and needle safety\", \"cost_effectiveness\": 11.9048, \"stdev\": 9.2593, \"source\": \"DCP2\"}, {\"intervention\": \"Case management at community or facility level\", \"cost_effectiveness\": 7.7519, \"stdev\": 3.1646, \"source\": \"DCP2\"}, {\"intervention\": \"Case management at hospital level\", \"cost_effectiveness\": 0.2208, \"stdev\": 0.1549, \"source\": \"DCP2\"}, {\"intervention\": \"Cholera or rotavirus immunization\", \"cost_effectiveness\": 0.3687, \"stdev\": 1.0917, \"source\": \"DCP2\"}, {\"intervention\": \"Condom promotion and distribution\", \"cost_effectiveness\": 12.1951, \"stdev\": 8.3333, \"source\": \"DCP2\"}, {\"intervention\": \"Construction and promotion of basic sanitation where facilities are limited\", \"cost_effectiveness\": 7.0922, \"stdev\": 1.9305, \"source\": \"DCP2\"}, {\"intervention\": \"Diethyl carbamazine salt\", \"cost_effectiveness\": 45.4545, \"stdev\": 11.9048, \"source\": \"DCP2\"}, {\"intervention\": \"Directly observed short-course chemotherapy\", \"cost_effectiveness\": 3.3223, \"stdev\": 1.0707, \"source\": \"DCP2\"}, {\"intervention\": \"Directly observed short-course chemotherapy\", \"cost_effectiveness\": 9.8039, \"stdev\": 2.8736, \"source\": \"DCP2\"}, {\"intervention\": \"Drugs with optional episodic or maintenance psychosocial treatment\", \"cost_effectiveness\": 0.5886, \"stdev\": 0.2399, \"source\": \"DCP2\"}, {\"intervention\": \"Drugs with optional psychosocial treatment\", \"cost_effectiveness\": 1.3624, \"stdev\": 0.7143, \"source\": \"DCP2\"}, {\"intervention\": \"Enforcement of seatbelt laws, promotion of child restraints and random driver breath testing\", \"cost_effectiveness\": 0.4083, \"stdev\": 0.1724, \"source\": \"DCP2\"}, {\"intervention\": \"Excise tax\", \"cost_effectiveness\": 0.7262, \"stdev\": 1.9608, \"source\": \"DCP2\"}, {\"intervention\": \"Excise tax, advertising ban, with brief advice\", \"cost_effectiveness\": 1.5848, \"stdev\": 8.3333, \"source\": \"DCP2\"}, {\"intervention\": \"Family, community, or clinical neonatal package\", \"cost_effectiveness\": 2.8986, \"stdev\": 38.4615, \"source\": \"DCP2\"}, {\"intervention\": \"Heparin and recombinant tissue plasminogen activator\", \"cost_effectiveness\": 0.5058, \"stdev\": 0.3579, \"source\": \"DCP2\"}, {\"intervention\": \"Improved water and sanitation at current coverage of amenities and other interventions\", \"cost_effectiveness\": 0.2389, \"stdev\": 0.1132, \"source\": \"DCP2\"}, {\"intervention\": \"Increased speeding penalties, enforcement, media campaigns, and speed bumps\", \"cost_effectiveness\": 47.619, \"stdev\": 14.2857, \"source\": \"DCP2\"}, {\"intervention\": \"Insecticidetreated bednets\", \"cost_effectiveness\": 90.9091, \"stdev\": 41.6667, \"source\": \"DCP2\"}, {\"intervention\": \"Intermittent preventive treatment in pregnancy with drug other than sulfadoxinepyrimethamine\", \"cost_effectiveness\": 142.8571, \"stdev\": 55.5556, \"source\": \"DCP2\"}, {\"intervention\": \"Intermittent preventive treatment in pregnancy with sulfadoxinepyrimethamine\", \"cost_effectiveness\": 52.6316, \"stdev\": 45.4545, \"source\": \"DCP2\"}, {\"intervention\": \"Isoniazid treatment\", \"cost_effectiveness\": 0.076, \"stdev\": 0.0674, \"source\": \"DCP2\"}, {\"intervention\": \"Isoniazid treatment\", \"cost_effectiveness\": 5.0761, \"stdev\": 1.6502, \"source\": \"DCP2\"}, {\"intervention\": \"Legislation substituting 2% of trans fat with polyunsaturated fat at $6 per adult\", \"cost_effectiveness\": 1.1933, \"stdev\": 0.3909, \"source\": \"DCP2\"}, {\"intervention\": \"Lithium, valproate, with optional psy-chosocial treatment, community-based\", \"cost_effectiveness\": 0.3212, \"stdev\": 0.4065, \"source\": \"DCP2\"}, {\"intervention\": \"Lithium, valproate, with optional psychosocial treatment, hospital-based\", \"cost_effectiveness\": 0.2264, \"stdev\": 0.3023, \"source\": \"DCP2\"}, {\"intervention\": \"Management of drug resistance\", \"cost_effectiveness\": 3.1447, \"stdev\": 2.2624, \"source\": \"DCP2\"}, {\"intervention\": \"Management of drug resistance\", \"cost_effectiveness\": 4.8309, \"stdev\": 45.4545, \"source\": \"DCP2\"}, {\"intervention\": \"Mother-to-child transmission prevention\", \"cost_effectiveness\": 5.2083, \"stdev\": 1.3514, \"source\": \"DCP2\"}, {\"intervention\": \"Peer and education programs for high-risk groups\", \"cost_effectiveness\": 27.027, \"stdev\": 8.0645, \"source\": \"DCP2\"}, {\"intervention\": \"Polypill by absolute risk approach\", \"cost_effectiveness\": 0.4699, \"stdev\": 0.1845, \"source\": \"DCP2\"}, {\"intervention\": \"Residual household spraying\", \"cost_effectiveness\": 58.8235, \"stdev\": 33.3333, \"source\": \"DCP2\"}, {\"intervention\": \"Second-line treatment with phenobarbital and lamotrigine or surgery\", \"cost_effectiveness\": 0.3304, \"stdev\": 7.5758, \"source\": \"DCP2\"}, {\"intervention\": \"Staffed community ambulance\", \"cost_effectiveness\": 8.3333, \"stdev\": 4.2017, \"source\": \"DCP2\"}, {\"intervention\": \"Statin, with aspirin and betablocker with ACE inhibitor\", \"cost_effectiveness\": 0.4931, \"stdev\": 1.5198, \"source\": \"DCP2\"}, {\"intervention\": \"Surgical ward or services in district hospital or community clinic\", \"cost_effectiveness\": 7.3529, \"stdev\": 3.0675, \"source\": \"DCP2\"}, {\"intervention\": \"Tetracycline or azithromycin\", \"cost_effectiveness\": 0.1595, \"stdev\": 0.0993, \"source\": \"DCP2\"}, {\"intervention\": \"Treatment of Kaposi's sarcoma\", \"cost_effectiveness\": 0.0191, \"stdev\": 0.0143, \"source\": \"DCP2\"}, {\"intervention\": \"Treatment of opportunistic infections\", \"cost_effectiveness\": 6.4103, \"stdev\": 1.6287, \"source\": \"DCP2\"}, {\"intervention\": \"Tuberculosis coinfection prevention and treatment\", \"cost_effectiveness\": 8.2645, \"stdev\": 17.2414, \"source\": \"DCP2\"}, {\"intervention\": \"Vector control\", \"cost_effectiveness\": 0.3897, \"stdev\": 0.4359, \"source\": \"DCP2\"}, {\"intervention\": \"Vector control\", \"cost_effectiveness\": 6.25, \"stdev\": 2.1368, \"source\": \"DCP2\"}, {\"intervention\": \"Voluntary counseling and testing\", \"cost_effectiveness\": 21.2766, \"stdev\": 6.6667, \"source\": \"DCP2\"}, {\"intervention\": \"BA only (5 min)\", \"cost_effectiveness\": 2.1858, \"stdev\": 0.7273, \"source\": \"NICE\"}, {\"intervention\": \"BA [5 min plus nicotine replacement therapy (NRT)]\", \"cost_effectiveness\": 0.7583, \"stdev\": 0.2524, \"source\": \"NICE\"}, {\"intervention\": \"BA (5 min plus self-help)\", \"cost_effectiveness\": 4.3243, \"stdev\": 1.4414, \"source\": \"NICE\"}, {\"intervention\": \"Exercise prescriptions\", \"cost_effectiveness\": 20.7792, \"stdev\": 5.7554, \"source\": \"NICE\"}, {\"intervention\": \"Accelerated partner therapy\\u2014doxycycline\", \"cost_effectiveness\": 0.1141, \"stdev\": 0.0856, \"source\": \"NICE\"}, {\"intervention\": \"Accelerated partner therapy\\u2014azithromycin\", \"cost_effectiveness\": 0.0824, \"stdev\": 0.0618, \"source\": \"NICE\"}, {\"intervention\": \"Brief counselling\", \"cost_effectiveness\": 0.1312, \"stdev\": 3.5088, \"source\": \"NICE\"}, {\"intervention\": \"Information motivation and behaviour skills\", \"cost_effectiveness\": 0.1131, \"stdev\": 0.1037, \"source\": \"NICE\"}, {\"intervention\": \"Enhanced counselling\", \"cost_effectiveness\": 0.0351, \"stdev\": 0.0666, \"source\": \"NICE\"}, {\"intervention\": \"Life-skills training\", \"cost_effectiveness\": 0.4582, \"stdev\": 0.1441, \"source\": \"NICE\"}, {\"intervention\": \"Urban trail\", \"cost_effectiveness\": 0.1532, \"stdev\": 0.0355, \"source\": \"NICE\"}, {\"intervention\": \"PA counselling\", \"cost_effectiveness\": 1.8519, \"stdev\": 1.0825, \"source\": \"NICE\"}, {\"intervention\": \"Smoking cessation\\u2014general population: incentive schemes NRT\", \"cost_effectiveness\": 4.4693, \"stdev\": 1.278, \"source\": \"NICE\"}, {\"intervention\": \"Smoking cessation\\u2014general population: client centred\", \"cost_effectiveness\": 32.0, \"stdev\": 1.8307, \"source\": \"NICE\"}, {\"intervention\": \"Smoking cessation\\u2014general population: proactive telephone counselling\", \"cost_effectiveness\": 3.7471, \"stdev\": 0.5468, \"source\": \"NICE\"}, {\"intervention\": \"Smoking cessation\\u2014general population: recruitment to quit and win\", \"cost_effectiveness\": 6.1538, \"stdev\": 0.0596, \"source\": \"NICE\"}, {\"intervention\": \"Smoking cessation\\u2014general population: identify smokers through other means\", \"cost_effectiveness\": 3.1746, \"stdev\": 0.1951, \"source\": \"NICE\"}, {\"intervention\": \"Smoking cessation\\u2014general population: pharmacist based\", \"cost_effectiveness\": 2.9304, \"stdev\": 3.6866, \"source\": \"NICE\"}, {\"intervention\": \"Smoking cessation \\u2014general population: dentist based\", \"cost_effectiveness\": 5.298, \"stdev\": 8.7912, \"source\": \"NICE\"}, {\"intervention\": \"Smoking cessation\\u2014disadvantaged groups: client-centred social marketing\", \"cost_effectiveness\": 1.023, \"stdev\": 0.1335, \"source\": \"NICE\"}, {\"intervention\": \"Smoking cessation\\u2014disadvantaged groups: NHS SSS\", \"cost_effectiveness\": 0.5957, \"stdev\": 2.649, \"source\": \"NICE\"}, {\"intervention\": \"Smoking cessation\\u2014disadvantaged groups: pharmacist based\", \"cost_effectiveness\": 0.5078, \"stdev\": 0.1886, \"source\": \"NICE\"}, {\"intervention\": \"Statins\\u2014general population: pharmacist based\", \"cost_effectiveness\": 0.3271, \"stdev\": 0.1215, \"source\": \"NICE\"}, {\"intervention\": \"Statins\\u2014disadvantaged groups: invitation for screening by GP\", \"cost_effectiveness\": 0.3682, \"stdev\": 1.1561, \"source\": \"NICE\"}, {\"intervention\": \"Advice about PA\", \"cost_effectiveness\": 0.0446, \"stdev\": 0.0412, \"source\": \"NICE\"}, {\"intervention\": \"Individual stress management\", \"cost_effectiveness\": 0.3201, \"stdev\": 0.0692, \"source\": \"NICE\"}, {\"intervention\": \"Curricular\", \"cost_effectiveness\": 0.2222, \"stdev\": 0.075, \"source\": \"NICE\"}, {\"intervention\": \"Screening and BA during GP consultation\", \"cost_effectiveness\": 0.4848, \"stdev\": 0.1212, \"source\": \"NICE\"}, {\"intervention\": \"Intralesional and intramuscular administration of the pentavalent antimonial drug sodium stibogluconate\", \"cost_effectiveness\": 0.625, \"stdev\": 0.957, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 26.3158, \"stdev\": 30.9408, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 2.9412, \"stdev\": 3.7333, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 10.3093, \"stdev\": 12.5669, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 0.0357, \"stdev\": 0.044, \"source\": \"GHCEA\"}, {\"intervention\": \"Syphilis screening before third trimester + treat with three injections of benzathine penicillin if positive\", \"cost_effectiveness\": 200.0, \"stdev\": 121.5916, \"source\": \"GHCEA\"}, {\"intervention\": \"Sickle cell disease screening using isoelectric focusing (IEF)\", \"cost_effectiveness\": 5.2632, \"stdev\": 1.715, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 4.5455, \"stdev\": 5.1129, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 0.0588, \"stdev\": 0.0681, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 8.3333, \"stdev\": 10.5394, \"source\": \"GHCEA\"}, {\"intervention\": \"Mass media campaign to promote tobacco cessation\", \"cost_effectiveness\": 0.2632, \"stdev\": 3.255, \"source\": \"GHCEA\"}, {\"intervention\": \"Pharmacological therapy for high blood pressure\", \"cost_effectiveness\": 0.2941, \"stdev\": 7.5214, \"source\": \"GHCEA\"}, {\"intervention\": \"Pharmacological therapy of high cholesterol\", \"cost_effectiveness\": 0.0588, \"stdev\": 1.3933, \"source\": \"GHCEA\"}, {\"intervention\": \"Rotarix vaccine\", \"cost_effectiveness\": 0.1389, \"stdev\": 0.1899, \"source\": \"GHCEA\"}, {\"intervention\": \"Therapy with Bupropion for Tobacco Cessation\", \"cost_effectiveness\": 0.0143, \"stdev\": 0.3305, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 6.25, \"stdev\": 8.5249, \"source\": \"GHCEA\"}, {\"intervention\": \"Risperidone (5 mg/day)\", \"cost_effectiveness\": 0.025, \"stdev\": 12.2943, \"source\": \"GHCEA\"}, {\"intervention\": \"Methylphenidate\", \"cost_effectiveness\": 0.0833, \"stdev\": 0.0791, \"source\": \"GHCEA\"}, {\"intervention\": \"SunSmart program (skin cancer prevention program) in a well-resourced state\", \"cost_effectiveness\": 0.0714, \"stdev\": 0.102, \"source\": \"GHCEA\"}, {\"intervention\": \"Cognitive behavioral therapy with private psychiatrists\", \"cost_effectiveness\": 0.0526, \"stdev\": 0.0444, \"source\": \"GHCEA\"}, {\"intervention\": \"Pre-diabetes screen screen plus diet and exercise to prevent or slow the onset of diabetes\", \"cost_effectiveness\": 0.05, \"stdev\": 0.0638, \"source\": \"GHCEA\"}, {\"intervention\": \"Multiple family groups:  Family engagement sessions and psychoeducation\", \"cost_effectiveness\": 0.0667, \"stdev\": 0.0237, \"source\": \"GHCEA\"}, {\"intervention\": \"Active After-school Communities Program (AASC)--physical activity co-ordinators develop and deliver physical activity program specific to each school\", \"cost_effectiveness\": 0.0169, \"stdev\": 0.0082, \"source\": \"GHCEA\"}, {\"intervention\": \"Residential treatment + naltrexone\", \"cost_effectiveness\": 0.01, \"stdev\": 0.0119, \"source\": \"GHCEA\"}, {\"intervention\": \"Group-based psychological intervention following opportunistic screening  to prevent depression\", \"cost_effectiveness\": 0.0588, \"stdev\": 0.0189, \"source\": \"GHCEA\"}, {\"intervention\": \"Angiotensin-converting enzyme (ACE) inhibitors via mainstream general practitioner to prevent cardiovascular disease\", \"cost_effectiveness\": 0.037, \"stdev\": 0.0269, \"source\": \"GHCEA\"}, {\"intervention\": \"Selective serotonin reuptake inhibitors as second line treatment\", \"cost_effectiveness\": 0.0526, \"stdev\": 0.0249, \"source\": \"GHCEA\"}, {\"intervention\": \"Tricyclic antidepressants - imipramine\", \"cost_effectiveness\": 0.0714, \"stdev\": 0.0316, \"source\": \"GHCEA\"}, {\"intervention\": \"Knee replacement surgery\", \"cost_effectiveness\": 0.1, \"stdev\": 0.2041, \"source\": \"GHCEA\"}, {\"intervention\": \"Laparoscopic adjustable gastric banding plus standard care\", \"cost_effectiveness\": 0.3226, \"stdev\": 0.3169, \"source\": \"GHCEA\"}, {\"intervention\": \"HMG-CoA reductase inhibitors (statins) via mainstream general practitioner to prevent cardiovascular disease\", \"cost_effectiveness\": 0.0196, \"stdev\": 0.0464, \"source\": \"GHCEA\"}, {\"intervention\": \"Cognitive behavioral therapy\", \"cost_effectiveness\": 0.3448, \"stdev\": 0.3292, \"source\": \"GHCEA\"}, {\"intervention\": \"Looma Healthy Lifestyle- community based intervention to reduce morbidity from diabetes and cardiovascular disease including heath education, exercise\", \"cost_effectiveness\": 0.0056, \"stdev\": 0.0049, \"source\": \"GHCEA\"}, {\"intervention\": \"Orlistat treatment\", \"cost_effectiveness\": 0.0048, \"stdev\": 0.006, \"source\": \"GHCEA\"}, {\"intervention\": \"Nicotine replacement therapy for 6-12 weeks\", \"cost_effectiveness\": 0.0625, \"stdev\": 0.0537, \"source\": \"GHCEA\"}, {\"intervention\": \"Maintenance treatment with tricyclic antidepressants\", \"cost_effectiveness\": 0.2703, \"stdev\": 1.2755, \"source\": \"GHCEA\"}, {\"intervention\": \"Brief alcohol intervention + telemarketing + support\", \"cost_effectiveness\": 0.1149, \"stdev\": 0.0564, \"source\": \"GHCEA\"}, {\"intervention\": \"Screening of children in preschool for depression and anxiety\", \"cost_effectiveness\": 0.122, \"stdev\": 0.0529, \"source\": \"GHCEA\"}, {\"intervention\": \"Walking School Bus (WSB) program to increase the number of children of primary school age walking to school (accompanied by volunteer adults)\", \"cost_effectiveness\": 0.0019, \"stdev\": 0.0003, \"source\": \"GHCEA\"}, {\"intervention\": \"Cognitive behavioral therapy-public psychiatrists\", \"cost_effectiveness\": 0.0526, \"stdev\": 0.0425, \"source\": \"GHCEA\"}, {\"intervention\": \"Maintenance treatment with selective serotonin re-uptake inhibitors\", \"cost_effectiveness\": 0.0667, \"stdev\": 0.3401, \"source\": \"GHCEA\"}, {\"intervention\": \"Drug treatment with selective serotonin re-uptake inhibitors SSRIs for acute episodes and 6 months continuation\", \"cost_effectiveness\": 0.0833, \"stdev\": 0.1458, \"source\": \"GHCEA\"}, {\"intervention\": \"Residential treatment - alcohol\", \"cost_effectiveness\": 0.0059, \"stdev\": 0.0075, \"source\": \"GHCEA\"}, {\"intervention\": \"Pre-diabetes screen plus Metformin, diet and exercise to prevent or slow the onset of diabetes\", \"cost_effectiveness\": 0.0143, \"stdev\": 0.0088, \"source\": \"GHCEA\"}, {\"intervention\": \"Clozapine (400 mg/day)\", \"cost_effectiveness\": 0.0286, \"stdev\": 0.0329, \"source\": \"GHCEA\"}, {\"intervention\": \"Current treatment: all patients receiving antipsychotic medication (haloperidol or other typical antipsychotic, atypical antipsychotic, clozapine) and smaller proportion receiving psychosocial intervention\", \"cost_effectiveness\": 0.0053, \"stdev\": 0.0059, \"source\": \"GHCEA\"}, {\"intervention\": \"Olanzapine (15 mg/day)\", \"cost_effectiveness\": 0.0323, \"stdev\": 0.0464, \"source\": \"GHCEA\"}, {\"intervention\": \"Cognitive behavioral therapy with private psychiatrist\", \"cost_effectiveness\": 0.0357, \"stdev\": 0.0155, \"source\": \"GHCEA\"}, {\"intervention\": \"Drink driving mass media\", \"cost_effectiveness\": 0.0625, \"stdev\": 0.0026, \"source\": \"GHCEA\"}, {\"intervention\": \"Trauma focused cognitive behavioral therapy 8-12 individual weekly sessions\", \"cost_effectiveness\": 0.1136, \"stdev\": 0.05, \"source\": \"GHCEA\"}, {\"intervention\": \"Hip replacement surgery\", \"cost_effectiveness\": 0.2326, \"stdev\": 0.5102, \"source\": \"GHCEA\"}, {\"intervention\": \"Clozapine (400 mg/day)\", \"cost_effectiveness\": 0.0526, \"stdev\": 0.034, \"source\": \"GHCEA\"}, {\"intervention\": \"Behavioral family management\", \"cost_effectiveness\": 0.05, \"stdev\": 0.02, \"source\": \"GHCEA\"}, {\"intervention\": \"Pre-diabetes screen plus Orlistat to prevent or slow the onset of diabetes\", \"cost_effectiveness\": 0.0115, \"stdev\": 0.0283, \"source\": \"GHCEA\"}, {\"intervention\": \"Education to improve decision making relating to prostate specific antigen testing\", \"cost_effectiveness\": 0.1, \"stdev\": 0.055, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 1.1236, \"stdev\": 1.4183, \"source\": \"GHCEA\"}, {\"intervention\": \"Cognitive behavioral therapy-public psychologist\", \"cost_effectiveness\": 0.1754, \"stdev\": 0.1276, \"source\": \"GHCEA\"}, {\"intervention\": \"Serotonin reuptake inhibitors - paroxetine\", \"cost_effectiveness\": 0.0323, \"stdev\": 0.0165, \"source\": \"GHCEA\"}, {\"intervention\": \"Treatment with bupropion for a period of 7 weeks\", \"cost_effectiveness\": 0.1299, \"stdev\": 0.2551, \"source\": \"GHCEA\"}, {\"intervention\": \"Olanzapine (15 mg/day)\", \"cost_effectiveness\": 0.0132, \"stdev\": 0.0087, \"source\": \"GHCEA\"}, {\"intervention\": \"Indicated psychological interventions\", \"cost_effectiveness\": 0.05, \"stdev\": 0.019, \"source\": \"GHCEA\"}, {\"intervention\": \"Trauma focused cognitive behavioral therapy 8-12 individual weekly sessions\", \"cost_effectiveness\": 0.0556, \"stdev\": 0.0928, \"source\": \"GHCEA\"}, {\"intervention\": \"Tricyclic antidepressants TCAs for acute major depressive episodes plus a 6-month continuation phase after remission of symptoms\", \"cost_effectiveness\": 0.2174, \"stdev\": 0.3401, \"source\": \"GHCEA\"}, {\"intervention\": \"Sibutramine treatment\", \"cost_effectiveness\": 0.0083, \"stdev\": 0.0113, \"source\": \"GHCEA\"}, {\"intervention\": \"Pre-diabetes screen plus Acarbose to prevent or slow the onset of diabetes\", \"cost_effectiveness\": 0.0312, \"stdev\": 0.0094, \"source\": \"GHCEA\"}, {\"intervention\": \"Cognitive behavioral therapy-public psychiatrist\", \"cost_effectiveness\": 0.0476, \"stdev\": 0.0276, \"source\": \"GHCEA\"}, {\"intervention\": \"Cognitive behavioral therapy with public psychologist\", \"cost_effectiveness\": 0.2083, \"stdev\": 0.0919, \"source\": \"GHCEA\"}, {\"intervention\": \"Pre-diabetes screen plus exercise to prevent or slow the onset of diabetes\", \"cost_effectiveness\": 0.0385, \"stdev\": 0.0155, \"source\": \"GHCEA\"}, {\"intervention\": \"Pre-diabetes screen plus diet to prevent or slow the onset of diabetes\", \"cost_effectiveness\": 0.0303, \"stdev\": 0.0082, \"source\": \"GHCEA\"}, {\"intervention\": \"Risperidone (5 mg/day)\", \"cost_effectiveness\": 0.0588, \"stdev\": 85.0357, \"source\": \"GHCEA\"}, {\"intervention\": \"Low dose diuretics to prevent cardiovascular disease\", \"cost_effectiveness\": 0.1042, \"stdev\": 0.044, \"source\": \"GHCEA\"}, {\"intervention\": \"Cognitive dissonance \\u2013 school based bulimia and anorexia preventative intervention\", \"cost_effectiveness\": 0.0091, \"stdev\": 0.0108, \"source\": \"GHCEA\"}, {\"intervention\": \"Cognitive behavioral therapy with public psychiatrist\", \"cost_effectiveness\": 0.0385, \"stdev\": 0.0157, \"source\": \"GHCEA\"}, {\"intervention\": \"Optimal treatment with antipsychotic medication (haloperidol or other typical antipsychotic, atypical antipsychotic, clozapine) and psychosocial intervention based on severity groups\", \"cost_effectiveness\": 0.01, \"stdev\": 0.007, \"source\": \"GHCEA\"}, {\"intervention\": \"Serotonin and noradrenaline reuptake inhibitors - venlafaxine\", \"cost_effectiveness\": 0.0526, \"stdev\": 0.0425, \"source\": \"GHCEA\"}, {\"intervention\": \"Cognitive behavioral therapy individual sessions plus two parent/family sessions + general practitioner (GP) visit for diagnosis and referral\", \"cost_effectiveness\": 0.0435, \"stdev\": 0.0179, \"source\": \"GHCEA\"}, {\"intervention\": \"Cognitive behavioral therapy-public psychologist\", \"cost_effectiveness\": 0.0526, \"stdev\": 0.034, \"source\": \"GHCEA\"}, {\"intervention\": \"Pre-diabetes screen plus Metformin to prevent or slow the onset of diabetes\", \"cost_effectiveness\": 0.0526, \"stdev\": 0.0537, \"source\": \"GHCEA\"}, {\"intervention\": \"Selective serotonin reuptake inhibitors as first-line treatment\", \"cost_effectiveness\": 0.0526, \"stdev\": 0.0255, \"source\": \"GHCEA\"}, {\"intervention\": \"Behavioral intervention in families\", \"cost_effectiveness\": 0.1852, \"stdev\": 0.0729, \"source\": \"GHCEA\"}, {\"intervention\": \"Cognitive behavioral therapy-private psychologist\", \"cost_effectiveness\": 0.0588, \"stdev\": 0.0486, \"source\": \"GHCEA\"}, {\"intervention\": \"General practitioner referral to exercise physiologist\", \"cost_effectiveness\": 0.0154, \"stdev\": 0.009, \"source\": \"GHCEA\"}, {\"intervention\": \"Brief alcohol intervention\", \"cost_effectiveness\": 0.1695, \"stdev\": 0.2041, \"source\": \"GHCEA\"}, {\"intervention\": \"Cognitive behavioral therapy-private psychiatrist\", \"cost_effectiveness\": 0.0455, \"stdev\": 0.0352, \"source\": \"GHCEA\"}, {\"intervention\": \"Cognitive behavioral therapy with public psychologist\", \"cost_effectiveness\": 0.1351, \"stdev\": 0.0508, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 1.6129, \"stdev\": 2.0364, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 2.1739, \"stdev\": 2.9428, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 0.1299, \"stdev\": 0.1519, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 0.2128, \"stdev\": 0.2804, \"source\": \"GHCEA\"}, {\"intervention\": \"Community health workerss received training to implement the community case management of severe acute malnutrition\", \"cost_effectiveness\": 34.4828, \"stdev\": 102.0429, \"source\": \"GHCEA\"}, {\"intervention\": \"Neonatal care package- 2 antenatal home visits by community health workers followed by 3 postnatal home visits\", \"cost_effectiveness\": 8.3333, \"stdev\": 5.0654, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 5.2632, \"stdev\": 6.2745, \"source\": \"GHCEA\"}, {\"intervention\": \"Community-based interventions for maternal and newborn health (e.g. pregnancy surveillance, birth preparedness, essential newborn care training, referral and/or home treatment for sepsis)\", \"cost_effectiveness\": 8.3333, \"stdev\": 5.0654, \"source\": \"GHCEA\"}, {\"intervention\": \"Inpatient treatment for severe acute malnutrition\", \"cost_effectiveness\": 4.1667, \"stdev\": 2.975, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 0.1961, \"stdev\": 0.2502, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 7.6923, \"stdev\": 30.6804, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 1.2821, \"stdev\": 1.6754, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 0.1282, \"stdev\": 0.1491, \"source\": \"GHCEA\"}, {\"intervention\": \"Antivenom for snakebite\", \"cost_effectiveness\": 11.6279, \"stdev\": 5.01, \"source\": \"GHCEA\"}, {\"intervention\": \"Quadrivalent conjugate meningococcal vaccine\", \"cost_effectiveness\": 1.4925, \"stdev\": 1.2917, \"source\": \"GHCEA\"}, {\"intervention\": \"Sickle cell disease screening using isoelectric focusing (IEF)\", \"cost_effectiveness\": 6.25, \"stdev\": 3.7794, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 6.6667, \"stdev\": 7.7159, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 1.4493, \"stdev\": 1.7597, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 3.8462, \"stdev\": 4.6822, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 1.5385, \"stdev\": 1.9795, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 1.1111, \"stdev\": 1.1375, \"source\": \"GHCEA\"}, {\"intervention\": \"Xpert MTB/RIF automated DNA test to detect tuberculosis and rifampicin (RIF) resistance\", \"cost_effectiveness\": 0.7143, \"stdev\": 0.6762, \"source\": \"GHCEA\"}, {\"intervention\": \"Syphilis screening before third trimester + treat with three injections of benzathine penicillin if positive\", \"cost_effectiveness\": 19.2308, \"stdev\": 1.1214, \"source\": \"GHCEA\"}, {\"intervention\": \"Sickle cell disease screening using isoelectric focusing (IEF)\", \"cost_effectiveness\": 0.1087, \"stdev\": 0.0537, \"source\": \"GHCEA\"}, {\"intervention\": \"Cochlear implant\", \"cost_effectiveness\": 0.0238, \"stdev\": 0.0284, \"source\": \"GHCEA\"}, {\"intervention\": \"Tuberculosis culture using the solid media, 24 patients/week\", \"cost_effectiveness\": 2.0, \"stdev\": 1.0821, \"source\": \"GHCEA\"}, {\"intervention\": \"Rotarix vaccine\", \"cost_effectiveness\": 0.5, \"stdev\": 0.8726, \"source\": \"GHCEA\"}, {\"intervention\": \"Tuberculosis culture using the solid media, 8 patients/week\", \"cost_effectiveness\": 0.8333, \"stdev\": 0.4696, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 8.3333, \"stdev\": 10.9055, \"source\": \"GHCEA\"}, {\"intervention\": \"Tuberculin skin test (TST) followed by isoniazid preventive therapy (IPT) for positive TST (no evidence of active tuberculosis)\", \"cost_effectiveness\": 0.3448, \"stdev\": 0.7525, \"source\": \"GHCEA\"}, {\"intervention\": \"Visit the health center three times weekly during the first 2 months (of tuberculosis treatment) of intensive treatment and twice weekly thereafter for supervised medication intake\", \"cost_effectiveness\": 9.0909, \"stdev\": 39.2473, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 0.0909, \"stdev\": 0.1155, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 5.5556, \"stdev\": 7.1942, \"source\": \"GHCEA\"}, {\"intervention\": \"Antivenom for snakebite\", \"cost_effectiveness\": 10.0, \"stdev\": 3.0279, \"source\": \"GHCEA\"}, {\"intervention\": \"Sickle cell disease screening using isoelectric focusing (IEF)\", \"cost_effectiveness\": 3.4483, \"stdev\": 3.4014, \"source\": \"GHCEA\"}, {\"intervention\": \"Syphilis screening before third trimester + treat with three injections of benzathine penicillin if positive\", \"cost_effectiveness\": 50.0, \"stdev\": 6.6444, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 10.0, \"stdev\": 11.2135, \"source\": \"GHCEA\"}, {\"intervention\": \"Quadrivalent conjugate meningococcal vaccine\", \"cost_effectiveness\": 1.3889, \"stdev\": 1.2551, \"source\": \"GHCEA\"}, {\"intervention\": \"Syphilis screening before third trimester + treat with three injections of benzathine penicillin if positive\", \"cost_effectiveness\": 142.8571, \"stdev\": 71.5245, \"source\": \"GHCEA\"}, {\"intervention\": \"Quadrivalent conjugate meningococcal vaccine\", \"cost_effectiveness\": 1.2987, \"stdev\": 1.0563, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 5.0, \"stdev\": 3.4854, \"source\": \"GHCEA\"}, {\"intervention\": \"Sickle cell disease screening using isoelectric focusing (IEF)\", \"cost_effectiveness\": 2.7778, \"stdev\": 2.7881, \"source\": \"GHCEA\"}, {\"intervention\": \"Syphilis screening before third trimester + treat with three injections of benzathine penicillin if positive\", \"cost_effectiveness\": 71.4286, \"stdev\": 17.622, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 0.625, \"stdev\": 0.7413, \"source\": \"GHCEA\"}, {\"intervention\": \"Sickle cell disease screening using isoelectric focusing (IEF)\", \"cost_effectiveness\": 1.6129, \"stdev\": 0.5495, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 18.8679, \"stdev\": 25.5427, \"source\": \"GHCEA\"}, {\"intervention\": \"Antivenom for snakebite\", \"cost_effectiveness\": 11.1111, \"stdev\": 5.0521, \"source\": \"GHCEA\"}, {\"intervention\": \"Syphilis screening before third trimester + treat with three injections of benzathine penicillin if positive\", \"cost_effectiveness\": 43.4783, \"stdev\": 15.0113, \"source\": \"GHCEA\"}, {\"intervention\": \"Quadrivalent conjugate meningococcal vaccine\", \"cost_effectiveness\": 1.3699, \"stdev\": 1.1893, \"source\": \"GHCEA\"}, {\"intervention\": \"Sickle cell disease screening using isoelectric focusing (IEF)\", \"cost_effectiveness\": 5.2632, \"stdev\": 1.4433, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 4.1667, \"stdev\": 4.1819, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 1.9231, \"stdev\": 2.4617, \"source\": \"GHCEA\"}, {\"intervention\": \"Quadrivalent conjugate meningococcal vaccine\", \"cost_effectiveness\": 1.2346, \"stdev\": 1.1313, \"source\": \"GHCEA\"}, {\"intervention\": \"Sickle cell disease screening using isoelectric focusing (IEF)\", \"cost_effectiveness\": 4.0, \"stdev\": 2.4296, \"source\": \"GHCEA\"}, {\"intervention\": \"Syphilis screening before third trimester + treat with three injections of benzathine penicillin if positive\", \"cost_effectiveness\": 125.0, \"stdev\": 86.8512, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 10.5263, \"stdev\": 12.855, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 5.8824, \"stdev\": 6.5703, \"source\": \"GHCEA\"}, {\"intervention\": \"Sickle cell disease screening using isoelectric focusing (IEF)\", \"cost_effectiveness\": 3.2258, \"stdev\": 2.5384, \"source\": \"GHCEA\"}, {\"intervention\": \"Syphilis screening before third trimester + treat with three injections of benzathine penicillin if positive\", \"cost_effectiveness\": 200.0, \"stdev\": 121.5916, \"source\": \"GHCEA\"}, {\"intervention\": \"Antivenom for snakebite\", \"cost_effectiveness\": 7.1429, \"stdev\": 1.5617, \"source\": \"GHCEA\"}, {\"intervention\": \"Quadrivalent conjugate meningococcal vaccine\", \"cost_effectiveness\": 1.2658, \"stdev\": 1.1543, \"source\": \"GHCEA\"}, {\"intervention\": \"Fortification of wheat flour with folic acid to prevent spina bifida\", \"cost_effectiveness\": 8.3333, \"stdev\": 46.3831, \"source\": \"GHCEA\"}, {\"intervention\": \"Rotarix vaccine\", \"cost_effectiveness\": 0.0714, \"stdev\": 0.1694, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 2.5, \"stdev\": 3.0086, \"source\": \"GHCEA\"}, {\"intervention\": \"Human papilloma virus (HPV) vaccine; 70% coverage\", \"cost_effectiveness\": 0.0062, \"stdev\": 0.0081, \"source\": \"GHCEA\"}, {\"intervention\": \"Pap smear screening every 5 years\", \"cost_effectiveness\": 0.0312, \"stdev\": 0.1013, \"source\": \"GHCEA\"}, {\"intervention\": \"Hybrid Benefit-based tailored treatment and Treat-to-target strategy to reduce cardiovascular disease\", \"cost_effectiveness\": 2.2222, \"stdev\": 12.9332, \"source\": \"GHCEA\"}, {\"intervention\": \"Universal hearing screening using otoacoustic emission (OAE)\", \"cost_effectiveness\": 0.0312, \"stdev\": 0.0378, \"source\": \"GHCEA\"}, {\"intervention\": \"Targeted hearing screening using otoacoustic emission (OAE) and automated auditory brainstem response (AABR)\", \"cost_effectiveness\": 0.0455, \"stdev\": 0.0729, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 8.3333, \"stdev\": 12.6714, \"source\": \"GHCEA\"}, {\"intervention\": \"Clinical assessment\", \"cost_effectiveness\": 0.1282, \"stdev\": 0.1624, \"source\": \"GHCEA\"}, {\"intervention\": \"Benefit-based tailored treatment\", \"cost_effectiveness\": 0.1351, \"stdev\": 21.992, \"source\": \"GHCEA\"}, {\"intervention\": \"Comprehensive programme included screening of all patients with sputum-smear-positive pulmonary tuberculosis, rapid diagnosis, standardized care and financial protection against catastrophic health expenditure\", \"cost_effectiveness\": 16.6667, \"stdev\": 0.8433, \"source\": \"GHCEA\"}, {\"intervention\": \"Target-to-treat\", \"cost_effectiveness\": 0.0909, \"stdev\": 6.3302, \"source\": \"GHCEA\"}, {\"intervention\": \"Universal hearing screening using otoacoustic emission (OAE) and automated auditory brainstem response (AABR)\", \"cost_effectiveness\": 0.0244, \"stdev\": 0.0237, \"source\": \"GHCEA\"}, {\"intervention\": \"Pulse oximetry + clinical assessment\", \"cost_effectiveness\": 0.0169, \"stdev\": 0.0584, \"source\": \"GHCEA\"}, {\"intervention\": \"Colonoscopy screening every 10 years\", \"cost_effectiveness\": 0.013, \"stdev\": 0.1232, \"source\": \"GHCEA\"}, {\"intervention\": \"Hybrid Benefit-based tailored treatment and Treat-to-target intensive strategy to reduce cardiovascular disease\", \"cost_effectiveness\": 2.2222, \"stdev\": 4.2359, \"source\": \"GHCEA\"}, {\"intervention\": \"Treat-to-target Intensive strategy to reduce cardiovascular disease\", \"cost_effectiveness\": 2.2222, \"stdev\": 13.9023, \"source\": \"GHCEA\"}, {\"intervention\": \"Benefit-based tailored treatment Intensive Strategy to reduce cardiovascular disease\", \"cost_effectiveness\": 3.5714, \"stdev\": 9.111, \"source\": \"GHCEA\"}, {\"intervention\": \"Benefit-based tailored treatment to reduce incidence of cardiovascular disease\", \"cost_effectiveness\": 3.4483, \"stdev\": 14.2121, \"source\": \"GHCEA\"}, {\"intervention\": \"Health X project for national tuberculosis control\", \"cost_effectiveness\": 6.25, \"stdev\": 5.6068, \"source\": \"GHCEA\"}, {\"intervention\": \"Targeted hearing screening using otoacoustic emission (OAE)\", \"cost_effectiveness\": 0.0667, \"stdev\": 0.1134, \"source\": \"GHCEA\"}, {\"intervention\": \"Treat-to-target strategy to reduce incidence of cardiovascular disease\", \"cost_effectiveness\": 2.2222, \"stdev\": 11.2879, \"source\": \"GHCEA\"}, {\"intervention\": \"Pentavalent antimony\", \"cost_effectiveness\": 0.05, \"stdev\": 0.1097, \"source\": \"GHCEA\"}, {\"intervention\": \"Cochlear implant\", \"cost_effectiveness\": 0.01, \"stdev\": 0.0465, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 6.25, \"stdev\": 8.8841, \"source\": \"GHCEA\"}, {\"intervention\": \"Syphilis screening before third trimester + treat with three injections of benzathine penicillin if positive\", \"cost_effectiveness\": 142.8571, \"stdev\": 86.8512, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 0.3571, \"stdev\": 0.2655, \"source\": \"GHCEA\"}, {\"intervention\": \"Sickle cell disease screening using isoelectric focusing (IEF)\", \"cost_effectiveness\": 1.0101, \"stdev\": 0.0855, \"source\": \"GHCEA\"}, {\"intervention\": \"Quadrivalent conjugate meningococcal vaccine\", \"cost_effectiveness\": 1.2658, \"stdev\": 1.1251, \"source\": \"GHCEA\"}, {\"intervention\": \"Syphilis screening before third trimester + treat with three injections of benzathine penicillin if positive\", \"cost_effectiveness\": 142.8571, \"stdev\": 86.8512, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 3.5714, \"stdev\": 3.3333, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 12.1951, \"stdev\": 12.8745, \"source\": \"GHCEA\"}, {\"intervention\": \"Sickle cell disease screening using isoelectric focusing (IEF)\", \"cost_effectiveness\": 6.25, \"stdev\": 5.2872, \"source\": \"GHCEA\"}, {\"intervention\": \"Long-lasting insecticide-treated bed nets (ITNs) + information on correct use and malaria transmission\", \"cost_effectiveness\": 45.4545, \"stdev\": 1.2397, \"source\": \"GHCEA\"}, {\"intervention\": \"Sickle cell disease screening using isoelectric focusing (IEF)\", \"cost_effectiveness\": 5.5556, \"stdev\": 1.7747, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 1.2821, \"stdev\": 1.5482, \"source\": \"GHCEA\"}, {\"intervention\": \"Syphilis screening before third trimester + treat with three injections of benzathine penicillin if positive\", \"cost_effectiveness\": 38.4615, \"stdev\": 121.5916, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 11.3636, \"stdev\": 12.4793, \"source\": \"GHCEA\"}, {\"intervention\": \"Sickle cell disease screening using isoelectric focusing (IEF)\", \"cost_effectiveness\": 3.3333, \"stdev\": 1.3883, \"source\": \"GHCEA\"}, {\"intervention\": \"Antivenom for snakebite\", \"cost_effectiveness\": 7.6923, \"stdev\": 2.4862, \"source\": \"GHCEA\"}, {\"intervention\": \"Quadrivalent conjugate meningococcal vaccine\", \"cost_effectiveness\": 1.3333, \"stdev\": 1.2134, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 3.7037, \"stdev\": 4.5716, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 4.3478, \"stdev\": 5.078, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 0.3226, \"stdev\": 0.4261, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 4.1667, \"stdev\": 5.5801, \"source\": \"GHCEA\"}, {\"intervention\": \"Increased minimum legal drinking age to reduce alcohol consumption\", \"cost_effectiveness\": 0.1111, \"stdev\": 0.7394, \"source\": \"GHCEA\"}, {\"intervention\": \"Longer individual intervention by telephone for alcohol misuse/abuse\", \"cost_effectiveness\": 0.01, \"stdev\": 0.0401, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 1.1111, \"stdev\": 1.4261, \"source\": \"GHCEA\"}, {\"intervention\": \"Syphilis screening before third trimester + treat with three injections of benzathine penicillin if positive\", \"cost_effectiveness\": 66.6667, \"stdev\": 121.5916, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 1.0, \"stdev\": 0.9914, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 0.0667, \"stdev\": 0.0767, \"source\": \"GHCEA\"}, {\"intervention\": \"Rotarix vaccine\", \"cost_effectiveness\": 1.6667, \"stdev\": 2.3364, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 4.7619, \"stdev\": 5.2445, \"source\": \"GHCEA\"}, {\"intervention\": \"Enhanced regulatory system was established based on governmental policies requiring condom use between sex workers and clients, for which violations could result in fines and closures of sex establishments\", \"cost_effectiveness\": 1.7544, \"stdev\": 0.8767, \"source\": \"GHCEA\"}, {\"intervention\": \"Cochlear implant\", \"cost_effectiveness\": 0.0056, \"stdev\": 0.0426, \"source\": \"GHCEA\"}, {\"intervention\": \"Tension-free inguinal hernia repair surgery with mosquito net meesh\", \"cost_effectiveness\": 9.0909, \"stdev\": 81.3739, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 3.125, \"stdev\": 3.5237, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 17.5439, \"stdev\": 21.7947, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 2.2727, \"stdev\": 2.5945, \"source\": \"GHCEA\"}, {\"intervention\": \"Syphilis screening before third trimester + treat with three injections of benzathine penicillin if positive\", \"cost_effectiveness\": 250.0, \"stdev\": 173.7023, \"source\": \"GHCEA\"}, {\"intervention\": \"Sickle cell disease screening using isoelectric focusing (IEF)\", \"cost_effectiveness\": 6.6667, \"stdev\": 4.5352, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 0.1961, \"stdev\": 0.1868, \"source\": \"GHCEA\"}, {\"intervention\": \"Sickle cell disease screening using isoelectric focusing (IEF)\", \"cost_effectiveness\": 0.0769, \"stdev\": 8.3642, \"source\": \"GHCEA\"}, {\"intervention\": \"Quadrivalent conjugate meningococcal vaccine\", \"cost_effectiveness\": 1.6667, \"stdev\": 1.3116, \"source\": \"GHCEA\"}, {\"intervention\": \"Syphilis screening before third trimester + treat with three injections of benzathine penicillin if positive\", \"cost_effectiveness\": 90.9091, \"stdev\": 19.3003, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 4.5455, \"stdev\": 4.677, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 0.625, \"stdev\": 0.8202, \"source\": \"GHCEA\"}, {\"intervention\": \"Multidrug-resistant treatment as per WHO guidelines\", \"cost_effectiveness\": 1.2987, \"stdev\": 1.6867, \"source\": \"GHCEA\"}, {\"intervention\": \"Syphilis screening before third trimester + treat with three injections of benzathine penicillin if positive\", \"cost_effectiveness\": 111.1111, \"stdev\": 41.9281, \"source\": \"GHCEA\"}, {\"intervention\": \"Sickle cell disease screening using isoelectric focusing (IEF)\", \"cost_effectiveness\": 0.0833, \"stdev\": 9.2766, \"source\": \"GHCEA\"}, {\"intervention\": \"Quadrivalent conjugate meningococcal vaccine\", \"cost_effectiveness\": 1.4925, \"stdev\": 1.249, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 8.3333, \"stdev\": 8.5192, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 2.2727, \"stdev\": 2.4024, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 1.4706, \"stdev\": 1.9633, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 1.9231, \"stdev\": 2.5153, \"source\": \"GHCEA\"}, {\"intervention\": \"Syphilis screening before third trimester + treat with three injections of benzathine penicillin if positive\", \"cost_effectiveness\": 200.0, \"stdev\": 121.5916, \"source\": \"GHCEA\"}, {\"intervention\": \"Intermittent preventive treatment in infants (IPTi) using sulfadoxine pyrimethamine (SP) against clinical malaria; at 2, 3, and 9 months.\", \"cost_effectiveness\": 20.0, \"stdev\": 2.5971, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 0.7692, \"stdev\": 0.6239, \"source\": \"GHCEA\"}, {\"intervention\": \"Sickle cell disease screening using isoelectric focusing (IEF)\", \"cost_effectiveness\": 6.25, \"stdev\": 1.1517, \"source\": \"GHCEA\"}, {\"intervention\": \"Community-based screening and early treatment with antiviral therapy for hepatitis B virus\", \"cost_effectiveness\": 1.7544, \"stdev\": 60.7398, \"source\": \"GHCEA\"}, {\"intervention\": \"Antivenom for snakebite\", \"cost_effectiveness\": 6.25, \"stdev\": 4.3737, \"source\": \"GHCEA\"}, {\"intervention\": \"Quadrivalent conjugate meningococcal vaccine\", \"cost_effectiveness\": 1.5625, \"stdev\": 1.3016, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 2.5, \"stdev\": 2.8802, \"source\": \"GHCEA\"}, {\"intervention\": \"Sickle cell disease screening using isoelectric focusing (IEF)\", \"cost_effectiveness\": 4.0, \"stdev\": 1.6728, \"source\": \"GHCEA\"}, {\"intervention\": \"Syphilis screening before third trimester + treat with three injections of benzathine penicillin if positive\", \"cost_effectiveness\": 250.0, \"stdev\": 151.9895, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 15.625, \"stdev\": 22.1063, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 3.125, \"stdev\": 3.9025, \"source\": \"GHCEA\"}, {\"intervention\": \"Quadrivalent conjugate meningococcal vaccine\", \"cost_effectiveness\": 1.7544, \"stdev\": 1.4875, \"source\": \"GHCEA\"}, {\"intervention\": \"Sickle cell disease screening using isoelectric focusing (IEF)\", \"cost_effectiveness\": 4.5455, \"stdev\": 2.0783, \"source\": \"GHCEA\"}, {\"intervention\": \"Intermittent preventive treatment in infants (IPTi) using sulfadoxine pyrimethamine (SP) against clinical malaria; at 3, 9, and 15 months.\", \"cost_effectiveness\": 250.0, \"stdev\": 228.2839, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 9.0909, \"stdev\": 9.1085, \"source\": \"GHCEA\"}, {\"intervention\": \"Individual donation Nucleic acid amplification testing (ID-NAT) to the HIV antibody screening for HIV screenig of blood donations\", \"cost_effectiveness\": 0.2174, \"stdev\": 0.5957, \"source\": \"GHCEA\"}, {\"intervention\": \"Mini pool nucleic acid amplification testing (MPNAT) for HIV screenig of blood donations\", \"cost_effectiveness\": 0.3448, \"stdev\": 0.6683, \"source\": \"GHCEA\"}, {\"intervention\": \"Intermittent preventive treatment in infants (IPTi) using sulfadoxine pyrimethamine (SP) against clinical malaria; at 3, 9, and 15 months.\", \"cost_effectiveness\": 333.3333, \"stdev\": 255.7466, \"source\": \"GHCEA\"}, {\"intervention\": \"Low-dose, high-frequency (LDHF) training for basic emergency obstetric and newborn care\", \"cost_effectiveness\": 18.1818, \"stdev\": 12.3554, \"source\": \"GHCEA\"}, {\"intervention\": \"Syphilis screening before third trimester + treat with three injections of benzathine penicillin if positive\", \"cost_effectiveness\": 142.8571, \"stdev\": 86.8512, \"source\": \"GHCEA\"}, {\"intervention\": \"Adding p24 antigen for HIV screening of blood donations\", \"cost_effectiveness\": 0.625, \"stdev\": 0.2606, \"source\": \"GHCEA\"}, {\"intervention\": \"Quality improvement program to reduce maternal and fetal mortality\", \"cost_effectiveness\": 6.25, \"stdev\": 15.461, \"source\": \"GHCEA\"}, {\"intervention\": \"Target-to-treat\", \"cost_effectiveness\": 0.0588, \"stdev\": 1.3304, \"source\": \"GHCEA\"}, {\"intervention\": \"Benefit-based tailored treatment\", \"cost_effectiveness\": 0.0833, \"stdev\": 7.9721, \"source\": \"GHCEA\"}, {\"intervention\": \"Intermittent preventive treatment in infants (IPTi) using sulfadoxine pyrimethamine (SP) against clinical malaria; at 3, 4, 9 and 12 months.\", \"cost_effectiveness\": 250.0, \"stdev\": 271.3907, \"source\": \"GHCEA\"}, {\"intervention\": \"Antivenom for snakebite\", \"cost_effectiveness\": 9.0909, \"stdev\": 3.0845, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 2.6316, \"stdev\": 3.27, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 0.1, \"stdev\": 0.1092, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 2.6316, \"stdev\": 3.0115, \"source\": \"GHCEA\"}, {\"intervention\": \"Cochlear implant\", \"cost_effectiveness\": 0.0062, \"stdev\": 0.0319, \"source\": \"GHCEA\"}, {\"intervention\": \"Sickle cell disease screening using isoelectric focusing (IEF)\", \"cost_effectiveness\": 6.6667, \"stdev\": 4.6383, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 7.6923, \"stdev\": 8.6683, \"source\": \"GHCEA\"}, {\"intervention\": \"Quadrivalent conjugate meningococcal vaccine\", \"cost_effectiveness\": 1.4085, \"stdev\": 1.1556, \"source\": \"GHCEA\"}, {\"intervention\": \"Antivenom for snakebite\", \"cost_effectiveness\": 11.6279, \"stdev\": 5.1083, \"source\": \"GHCEA\"}, {\"intervention\": \"Syphilis screening before third trimester + treat with three injections of benzathine penicillin if positive\", \"cost_effectiveness\": 200.0, \"stdev\": 102.0429, \"source\": \"GHCEA\"}, {\"intervention\": \"Sickle cell disease screening using isoelectric focusing (IEF)\", \"cost_effectiveness\": 2.5, \"stdev\": 1.1189, \"source\": \"GHCEA\"}, {\"intervention\": \"Syphilis screening before third trimester + treat with three injections of benzathine penicillin if positive\", \"cost_effectiveness\": 47.619, \"stdev\": 1.9699, \"source\": \"GHCEA\"}, {\"intervention\": \"Quadrivalent conjugate meningococcal vaccine\", \"cost_effectiveness\": 1.3514, \"stdev\": 1.1214, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 5.0, \"stdev\": 5.3715, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 1.6949, \"stdev\": 1.7669, \"source\": \"GHCEA\"}, {\"intervention\": \"SGOT/SGPT (serum glutamic oxaloacetic transaminase/serum glutamic pyruvic transaminase) test conducted at baseline (asymptomatic)\", \"cost_effectiveness\": 0.05, \"stdev\": 0.015, \"source\": \"GHCEA\"}, {\"intervention\": \"Creatinine test conducted at baseline (asymptomatic)\", \"cost_effectiveness\": 0.0053, \"stdev\": 0.0016, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 11.236, \"stdev\": 12.868, \"source\": \"GHCEA\"}, {\"intervention\": \"Complete blood count (CBC - hemoglobin, neutrophils, and platelets) test conducted at baseline (asymptomatic)\", \"cost_effectiveness\": 0.6667, \"stdev\": 1.0123, \"source\": \"GHCEA\"}, {\"intervention\": \"Rotarix vaccine\", \"cost_effectiveness\": 2.7778, \"stdev\": 3.7313, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 4.0, \"stdev\": 4.655, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 2.2727, \"stdev\": 3.1192, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 0.0909, \"stdev\": 0.3667, \"source\": \"GHCEA\"}, {\"intervention\": \"Composite programs for HIV prevention\", \"cost_effectiveness\": 6.25, \"stdev\": 0.0546, \"source\": \"GHCEA\"}, {\"intervention\": \"Aspirin + beta blockers + angiotensin-converting enzyme inhibitors (ACEI) for prevention of acute myocardial infarction\", \"cost_effectiveness\": 0.3226, \"stdev\": 0.1157, \"source\": \"GHCEA\"}, {\"intervention\": \"Avahan HIV prevention programme- peer-led outreach, education and condom distribution, free treatment of sexually transmitted infections (STIs), free commodity supplies (condoms, STI drugs), and facilitation of community mobilization\", \"cost_effectiveness\": 20.0, \"stdev\": 53.7068, \"source\": \"GHCEA\"}, {\"intervention\": \"Avahan HIV prevention programme- peer-led outreach, education and condom distribution, free treatment of sexually transmitted infections (STIs), free commodity supplies (condoms, STI drugs), and facilitation of community mobilization\", \"cost_effectiveness\": 1.9608, \"stdev\": 0.3122, \"source\": \"GHCEA\"}, {\"intervention\": \"Migrant Labourer Program for HIV prevention\", \"cost_effectiveness\": 10.0, \"stdev\": 0.144, \"source\": \"GHCEA\"}, {\"intervention\": \"Rotavirus vaccination\", \"cost_effectiveness\": 3.2258, \"stdev\": 2.1127, \"source\": \"GHCEA\"}, {\"intervention\": \"Avahan HIV prevention programme- peer-led outreach, education and condom distribution, free treatment of sexually transmitted infections (STIs), free commodity supplies (condoms, STI drugs), and facilitation of community mobilization\", \"cost_effectiveness\": 21.2766, \"stdev\": 20.0084, \"source\": \"GHCEA\"}, {\"intervention\": \"Rotavirus vaccination\", \"cost_effectiveness\": 9.0909, \"stdev\": 6.8485, \"source\": \"GHCEA\"}, {\"intervention\": \"Increase in rotavirus immunization coverage to 90% through targeted increases in rural and urban regions\", \"cost_effectiveness\": 25.641, \"stdev\": 17.5906, \"source\": \"GHCEA\"}, {\"intervention\": \"Aspirin + beta blockers + angiotensin-converting enzyme inhibitors (ACEI) + statin for prevention of acute myocardial infarction\", \"cost_effectiveness\": 0.137, \"stdev\": 0.0659, \"source\": \"GHCEA\"}, {\"intervention\": \"Avahan HIV prevention programme- peer-led outreach, education and condom distribution, free treatment of sexually transmitted infections (STIs), free commodity supplies (condoms, STI drugs), and facilitation of community mobilization\", \"cost_effectiveness\": 10.0, \"stdev\": 8.3642, \"source\": \"GHCEA\"}, {\"intervention\": \"Rotavirus vaccination\", \"cost_effectiveness\": 8.3333, \"stdev\": 6.1472, \"source\": \"GHCEA\"}, {\"intervention\": \"Program to increase coverage of tertiary treatment of cardiovascular disease with increased access to tertiary treatment\", \"cost_effectiveness\": 0.4348, \"stdev\": 0.6758, \"source\": \"GHCEA\"}, {\"intervention\": \"Aspirin + injection streptokinase (1 dose at 1.5 mU)\", \"cost_effectiveness\": 1.4493, \"stdev\": 1.1865, \"source\": \"GHCEA\"}, {\"intervention\": \"Hybrid Benefit-based tailored treatment and Treat-to-target strategy to reduce cardiovascular disease (CVD)\", \"cost_effectiveness\": 2.7027, \"stdev\": 16.4056, \"source\": \"GHCEA\"}, {\"intervention\": \"Avahan HIV prevention programme- peer-led outreach, education and condom distribution, free treatment of sexually transmitted infections (STIs), free commodity supplies (condoms, STI drugs), and facilitation of community mobilization\", \"cost_effectiveness\": 52.6316, \"stdev\": 32.9171, \"source\": \"GHCEA\"}, {\"intervention\": \"Aspirin + beta blockers for prevention of acute myocardial infarction\", \"cost_effectiveness\": 0.5, \"stdev\": 0.3088, \"source\": \"GHCEA\"}, {\"intervention\": \"Aspirin alone for prevention of acute myocardial infarction\", \"cost_effectiveness\": 3.3333, \"stdev\": 2.3898, \"source\": \"GHCEA\"}, {\"intervention\": \"Isoniazid preventive therapy therapy for all HIV+ pregnant women regardless of CD4 count\", \"cost_effectiveness\": 5.5556, \"stdev\": 0.7935, \"source\": \"GHCEA\"}, {\"intervention\": \"Target-to-treat\", \"cost_effectiveness\": 0.0667, \"stdev\": 1.7449, \"source\": \"GHCEA\"}, {\"intervention\": \"Avahan HIV prevention programme- peer-led outreach, education and condom distribution, free treatment of sexually transmitted infections (STIs), free commodity supplies (condoms, STI drugs), and facilitation of community mobilization\", \"cost_effectiveness\": 10.4167, \"stdev\": 5.6377, \"source\": \"GHCEA\"}, {\"intervention\": \"Avahan HIV prevention programme- peer-led outreach, education and condom distribution, free treatment of sexually transmitted infections (STIs), free commodity supplies (condoms, STI drugs), and facilitation of community mobilization\", \"cost_effectiveness\": 31.25, \"stdev\": 15.6989, \"source\": \"GHCEA\"}, {\"intervention\": \"Avahan HIV prevention programme- peer-led outreach, education and condom distribution, free treatment of sexually transmitted infections (STIs), free commodity supplies (condoms, STI drugs), and facilitation of community mobilization\", \"cost_effectiveness\": 18.8679, \"stdev\": 28.3452, \"source\": \"GHCEA\"}, {\"intervention\": \"Avahan HIV prevention programme- peer-led outreach, education and condom distribution, free treatment of sexually transmitted infections (STIs), free commodity supplies (condoms, STI drugs), and facilitation of community mobilization\", \"cost_effectiveness\": 50.0, \"stdev\": 40.8172, \"source\": \"GHCEA\"}, {\"intervention\": \"Avahan HIV prevention programme- peer-led outreach, education and condom distribution, free treatment of sexually transmitted infections (STIs), free commodity supplies (condoms, STI drugs), and facilitation of community mobilization\", \"cost_effectiveness\": 34.4828, \"stdev\": 36.4439, \"source\": \"GHCEA\"}, {\"intervention\": \"Genetically modified (GM) fortification of mustard oil with genetically modified mustard seed\", \"cost_effectiveness\": 1.9608, \"stdev\": 35.1872, \"source\": \"GHCEA\"}, {\"intervention\": \"Avahan HIV prevention programme- peer-led outreach, education and condom distribution, free treatment of sexually transmitted infections (STIs), free commodity supplies (condoms, STI drugs), and facilitation of community mobilization\", \"cost_effectiveness\": 41.6667, \"stdev\": 20.4086, \"source\": \"GHCEA\"}, {\"intervention\": \"Aspirin alone (325 mg initial dose & subsequently 75 mg doses once daily\", \"cost_effectiveness\": 1000.0, \"stdev\": 1645.8532, \"source\": \"GHCEA\"}, {\"intervention\": \"Benefit-based tailored treatment to reduce cardiovascular disease\", \"cost_effectiveness\": 4.5455, \"stdev\": 18.486, \"source\": \"GHCEA\"}, {\"intervention\": \"Rotavirus vaccination\", \"cost_effectiveness\": 10.0, \"stdev\": 6.6695, \"source\": \"GHCEA\"}, {\"intervention\": \"Rotavirus vaccination\", \"cost_effectiveness\": 10.0, \"stdev\": 7.4484, \"source\": \"GHCEA\"}, {\"intervention\": \"High-dose vitamin A supplementation\", \"cost_effectiveness\": 34.4828, \"stdev\": 510.2145, \"source\": \"GHCEA\"}, {\"intervention\": \"Rotavirus vaccination\", \"cost_effectiveness\": 5.8824, \"stdev\": 3.3678, \"source\": \"GHCEA\"}, {\"intervention\": \"Gestational diabetes mellitus screening using oral glucose tolerance test (OGTT)\", \"cost_effectiveness\": 0.5556, \"stdev\": 0.2989, \"source\": \"GHCEA\"}, {\"intervention\": \"Program to increase coverage of primary prevention of cardiovascular disease with increased access to treatment\", \"cost_effectiveness\": 2.0408, \"stdev\": 3.8507, \"source\": \"GHCEA\"}, {\"intervention\": \"Rotavirus vaccine introduced at the current DPT3 (diphtheria, pertussis, tetanus) immunization coverage level\", \"cost_effectiveness\": 13.3333, \"stdev\": 54.3649, \"source\": \"GHCEA\"}, {\"intervention\": \"Rotavirus vaccination\", \"cost_effectiveness\": 6.6667, \"stdev\": 4.3795, \"source\": \"GHCEA\"}, {\"intervention\": \"Program to increase coverage of primary prevention and tertiary treatment of cardiovascular disease with increased access to primary prevention and tertiary treatment\", \"cost_effectiveness\": 0.4348, \"stdev\": 170.0715, \"source\": \"GHCEA\"}, {\"intervention\": \"Benefit-based tailored treatment\", \"cost_effectiveness\": 0.0909, \"stdev\": 9.0785, \"source\": \"GHCEA\"}, {\"intervention\": \"Supplementary immunization activity (SIA) for measles\", \"cost_effectiveness\": 83.3333, \"stdev\": 5.0021, \"source\": \"GHCEA\"}, {\"intervention\": \"Avahan HIV prevention programme- peer-led outreach, education and condom distribution, free treatment of sexually transmitted infections (STIs), free commodity supplies (condoms, STI drugs), and facilitation of community mobilization\", \"cost_effectiveness\": 16.3934, \"stdev\": 12.005, \"source\": \"GHCEA\"}, {\"intervention\": \"Avahan HIV prevention programme- peer-led outreach, education and condom distribution, free treatment of sexually transmitted infections (STIs), free commodity supplies (condoms, STI drugs), and facilitation of community mobilization\", \"cost_effectiveness\": 30.303, \"stdev\": 15.0063, \"source\": \"GHCEA\"}, {\"intervention\": \"Benefit-based tailored treatment and treat-to-target intensive strategy combined to reduce cardiovascular disease\", \"cost_effectiveness\": 2.7027, \"stdev\": 1.8493, \"source\": \"GHCEA\"}, {\"intervention\": \"Avahan HIV prevention programme- peer-led outreach, education and condom distribution, free treatment of sexually transmitted infections (STIs), free commodity supplies (condoms, STI drugs), and facilitation of community mobilization\", \"cost_effectiveness\": 52.6316, \"stdev\": 26.8534, \"source\": \"GHCEA\"}, {\"intervention\": \"Polypill (combining aspirin, beta blockers, angiotensin-converting enzyme inhibitors and statins) for prevention of acute myocardial infarction\", \"cost_effectiveness\": 0.5263, \"stdev\": 0.3197, \"source\": \"GHCEA\"}, {\"intervention\": \"Treat-to-target Intensive strategy to reduce cardiovascular disease\", \"cost_effectiveness\": 2.381, \"stdev\": 4.6404, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 9.0909, \"stdev\": 11.725, \"source\": \"GHCEA\"}, {\"intervention\": \"Treat-to-target strategy to reduce cardiovascular disease\", \"cost_effectiveness\": 2.439, \"stdev\": 10.9137, \"source\": \"GHCEA\"}, {\"intervention\": \"Program to increase coverage of primary and secondary prevention of cardiovascular disease with increased access to primary and secondary treatment\", \"cost_effectiveness\": 0.4, \"stdev\": 68.0286, \"source\": \"GHCEA\"}, {\"intervention\": \"Isoniazid preventive therapy therapy for all HIV+ pregnant women with CD4 count <= 200 cells/ul\", \"cost_effectiveness\": 4.7619, \"stdev\": 5.7327, \"source\": \"GHCEA\"}, {\"intervention\": \"Avahan HIV prevention programme- peer-led outreach, education and condom distribution, free treatment of sexually transmitted infections (STIs), free commodity supplies (condoms, STI drugs), and facilitation of community mobilization\", \"cost_effectiveness\": 9.0909, \"stdev\": 1.2134, \"source\": \"GHCEA\"}, {\"intervention\": \"Program to increase coverage of primary, secondary and tertiary treatment of cardiovascular disease with increased access to secondary and tertiary treatment\", \"cost_effectiveness\": 0.1724, \"stdev\": 0.2353, \"source\": \"GHCEA\"}, {\"intervention\": \"Avahan HIV prevention programme- peer-led outreach, education and condom distribution, free treatment of sexually transmitted infections (STIs), free commodity supplies (condoms, STI drugs), and facilitation of community mobilization\", \"cost_effectiveness\": 14.2857, \"stdev\": 18.2219, \"source\": \"GHCEA\"}, {\"intervention\": \"Avahan HIV prevention programme- peer-led outreach, education and condom distribution, free treatment of sexually transmitted infections (STIs), free commodity supplies (condoms, STI drugs), and facilitation of community mobilization\", \"cost_effectiveness\": 2.5641, \"stdev\": 0.9663, \"source\": \"GHCEA\"}, {\"intervention\": \"Coverage of 3 doses of rotavirus with DPT (diphtheria, pertussis, tetanus) and 1 dose of the measles vaccine\", \"cost_effectiveness\": 31.25, \"stdev\": 14.6529, \"source\": \"GHCEA\"}, {\"intervention\": \"Avahan HIV prevention programme- peer-led outreach, education and condom distribution, free treatment of sexually transmitted infections (STIs), free commodity supplies (condoms, STI drugs), and facilitation of community mobilization\", \"cost_effectiveness\": 10.6383, \"stdev\": 7.6724, \"source\": \"GHCEA\"}, {\"intervention\": \"Avahan HIV prevention programme- peer-led outreach, education and condom distribution, free treatment of sexually transmitted infections (STIs), free commodity supplies (condoms, STI drugs), and facilitation of community mobilization\", \"cost_effectiveness\": 50.0, \"stdev\": 68.0286, \"source\": \"GHCEA\"}, {\"intervention\": \"Program to increase coverage of secondary prevention of cardiovascular disease with increased access to secondary treatment\", \"cost_effectiveness\": 0.4, \"stdev\": 1.6811, \"source\": \"GHCEA\"}, {\"intervention\": \"Avahan HIV prevention programme- peer-led outreach, education and condom distribution, free treatment of sexually transmitted infections (STIs), free commodity supplies (condoms, STI drugs), and facilitation of community mobilization\", \"cost_effectiveness\": 2.3256, \"stdev\": 0.4241, \"source\": \"GHCEA\"}, {\"intervention\": \"Rotavirus vaccination\", \"cost_effectiveness\": 7.6923, \"stdev\": 5.7327, \"source\": \"GHCEA\"}, {\"intervention\": \"Men who have sex with men (MSM) programs for HIV prevention\", \"cost_effectiveness\": 83.3333, \"stdev\": 1.7809, \"source\": \"GHCEA\"}, {\"intervention\": \"Avahan HIV prevention programme- peer-led outreach, education and condom distribution, free treatment of sexually transmitted infections (STIs), free commodity supplies (condoms, STI drugs), and facilitation of community mobilization\", \"cost_effectiveness\": 14.2857, \"stdev\": 9.7184, \"source\": \"GHCEA\"}, {\"intervention\": \"Avahan HIV prevention programme- peer-led outreach, education and condom distribution, free treatment of sexually transmitted infections (STIs), free commodity supplies (condoms, STI drugs), and facilitation of community mobilization\", \"cost_effectiveness\": 29.4118, \"stdev\": 20.0084, \"source\": \"GHCEA\"}, {\"intervention\": \"Benefit-based tailored treatment Intensive Strategy to reduce cardiovascular disease\", \"cost_effectiveness\": 5.0, \"stdev\": 17.5633, \"source\": \"GHCEA\"}, {\"intervention\": \"Rotavirus vaccination\", \"cost_effectiveness\": 8.3333, \"stdev\": 7.1861, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 13.5135, \"stdev\": 17.2808, \"source\": \"GHCEA\"}, {\"intervention\": \"Haemophilus influenzae type B (Hib) vaccine\", \"cost_effectiveness\": 11.9048, \"stdev\": 48.5919, \"source\": \"GHCEA\"}, {\"intervention\": \"Yaws eradication program\", \"cost_effectiveness\": 2.439, \"stdev\": 1.1478, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 11.7647, \"stdev\": 14.5153, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 7.1429, \"stdev\": 9.3326, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 1.0, \"stdev\": 1.24, \"source\": \"GHCEA\"}, {\"intervention\": \"Gestational diabetes mellitus screening using oral glucose tolerance test (OGTT)\", \"cost_effectiveness\": 0.5, \"stdev\": 0.1507, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 0.9091, \"stdev\": 1.0968, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 3.5714, \"stdev\": 4.5949, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 1.0, \"stdev\": 1.0518, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 3.4483, \"stdev\": 5.0258, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 3.4483, \"stdev\": 4.4603, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 7.1429, \"stdev\": 10.8776, \"source\": \"GHCEA\"}, {\"intervention\": \"Post exposure prophylaxis (PEP) for prevention of Rabies infection\", \"cost_effectiveness\": 0.8333, \"stdev\": 0.4985, \"source\": \"GHCEA\"}, {\"intervention\": \"Assisted partner services intervention for HIV testing\", \"cost_effectiveness\": 1.1628, \"stdev\": 1.7121, \"source\": \"GHCEA\"}, {\"intervention\": \"Pneumococcal vaccination (PCV10)\", \"cost_effectiveness\": 15.1515, \"stdev\": 13.2523, \"source\": \"GHCEA\"}, {\"intervention\": \"Assisted partner services intervention for HIV testing\", \"cost_effectiveness\": 0.9091, \"stdev\": 1.2819, \"source\": \"GHCEA\"}, {\"intervention\": \"Cochlear implants\", \"cost_effectiveness\": 0.1075, \"stdev\": 0.3932, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 0.5263, \"stdev\": 0.3629, \"source\": \"GHCEA\"}, {\"intervention\": \"Quadrivalent conjugate meningococcal vaccine\", \"cost_effectiveness\": 1.4706, \"stdev\": 1.2076, \"source\": \"GHCEA\"}, {\"intervention\": \"Providing long-lasting insecticide-treated nets (LLINs) and point-of-use water filters to delay HIV-1 progression\", \"cost_effectiveness\": 9.0909, \"stdev\": 4.7684, \"source\": \"GHCEA\"}, {\"intervention\": \"Syphilis screening before third trimester + treat with three injections of benzathine penicillin if positive\", \"cost_effectiveness\": 100.0, \"stdev\": 39.2231, \"source\": \"GHCEA\"}, {\"intervention\": \"Intermittent preventive treatment in infants (IPTi) using 3 days of amodiaquine-artesunate (AQ3-AS3) against clinical malaria; at 2, 3, and 9 months.\", \"cost_effectiveness\": 111.1111, \"stdev\": 67.938, \"source\": \"GHCEA\"}, {\"intervention\": \"Sickle cell disease screening using isoelectric focusing (IEF)\", \"cost_effectiveness\": 2.6316, \"stdev\": 2.0247, \"source\": \"GHCEA\"}, {\"intervention\": \"Haemophilus influenzae type b (Hib) vaccine\", \"cost_effectiveness\": 20.4082, \"stdev\": 27.5792, \"source\": \"GHCEA\"}, {\"intervention\": \"Intermittent preventive treatment in infants (IPTi) using sulfadoxine pyrimethamine plus 3 days of artesunate (SP-AS3) against clinical malaria; at 2, 3, and 9 months.\", \"cost_effectiveness\": 71.4286, \"stdev\": 33.8226, \"source\": \"GHCEA\"}, {\"intervention\": \"Pneumococcal vaccination (PCV13)\", \"cost_effectiveness\": 18.8679, \"stdev\": 16.1973, \"source\": \"GHCEA\"}, {\"intervention\": \"Intermittent preventive treatment in infants (IPTi) using 3 days of chlorproguanil-dapsone (CD3) against clinical malaria; at 2, 3, and 9 months.\", \"cost_effectiveness\": 12.5, \"stdev\": 1.4357, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 0.0909, \"stdev\": 0.0893, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 27.027, \"stdev\": 33.789, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 4.5455, \"stdev\": 6.5783, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 0.3226, \"stdev\": 0.361, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 21.2766, \"stdev\": 29.4411, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 13.1579, \"stdev\": 16.7834, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 1.6393, \"stdev\": 2.1504, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 1.8519, \"stdev\": 2.335, \"source\": \"GHCEA\"}, {\"intervention\": \"Syphilis screening before third trimester + treat with three injections of benzathine penicillin if positive\", \"cost_effectiveness\": 71.4286, \"stdev\": 22.9418, \"source\": \"GHCEA\"}, {\"intervention\": \"Xpert MTB/RIF automated DNA test to detect tuberculosis and rifampicin (RIF) resistance\", \"cost_effectiveness\": 0.9091, \"stdev\": 0.5306, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 5.2632, \"stdev\": 5.5422, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 5.8824, \"stdev\": 6.1695, \"source\": \"GHCEA\"}, {\"intervention\": \"Syphilis screening before third trimester + treat with three injections of benzathine penicillin if positive\", \"cost_effectiveness\": 500.0, \"stdev\": 303.9791, \"source\": \"GHCEA\"}, {\"intervention\": \"Antivenom for snakebite\", \"cost_effectiveness\": 3.7037, \"stdev\": 3.7792, \"source\": \"GHCEA\"}, {\"intervention\": \"Sickle cell disease screening using isoelectric focusing (IEF)\", \"cost_effectiveness\": 2.7778, \"stdev\": 1.295, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 3.4483, \"stdev\": 4.0897, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 1.0, \"stdev\": 1.246, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 0.1333, \"stdev\": 0.1812, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 5.5556, \"stdev\": 7.5587, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 10.6383, \"stdev\": 10.2556, \"source\": \"GHCEA\"}, {\"intervention\": \"Sickle cell disease screening using isoelectric focusing (IEF)\", \"cost_effectiveness\": 3.7037, \"stdev\": 3.019, \"source\": \"GHCEA\"}, {\"intervention\": \"Syphilis screening before third trimester + treat with three injections of benzathine penicillin if positive\", \"cost_effectiveness\": 333.3333, \"stdev\": 173.7023, \"source\": \"GHCEA\"}, {\"intervention\": \"Sickle cell disease screening using isoelectric focusing (IEF)\", \"cost_effectiveness\": 2.2222, \"stdev\": 0.9728, \"source\": \"GHCEA\"}, {\"intervention\": \"Cochlear implant\", \"cost_effectiveness\": 0.1299, \"stdev\": 0.5017, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 2.7027, \"stdev\": 2.1619, \"source\": \"GHCEA\"}, {\"intervention\": \"Syphilis screening before third trimester + treat with three injections of benzathine penicillin if positive\", \"cost_effectiveness\": 142.8571, \"stdev\": 27.0204, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 6.25, \"stdev\": 8.033, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 0.1724, \"stdev\": 0.2096, \"source\": \"GHCEA\"}, {\"intervention\": \"Antivenom for snakebite\", \"cost_effectiveness\": 5.8824, \"stdev\": 4.5429, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 9.0909, \"stdev\": 9.5608, \"source\": \"GHCEA\"}, {\"intervention\": \"Sickle cell disease screening using isoelectric focusing (IEF)\", \"cost_effectiveness\": 3.4483, \"stdev\": 2.3954, \"source\": \"GHCEA\"}, {\"intervention\": \"Syphilis screening before third trimester + treat with three injections of benzathine penicillin if positive\", \"cost_effectiveness\": 100.0, \"stdev\": 121.5916, \"source\": \"GHCEA\"}, {\"intervention\": \"Quadrivalent conjugate meningococcal vaccine\", \"cost_effectiveness\": 1.3889, \"stdev\": 1.1879, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 0.2703, \"stdev\": 0.3572, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 0.0625, \"stdev\": 0.0661, \"source\": \"GHCEA\"}, {\"intervention\": \"Quadrivalent conjugate meningococcal vaccine\", \"cost_effectiveness\": 1.6129, \"stdev\": 1.2983, \"source\": \"GHCEA\"}, {\"intervention\": \"Sickle cell disease screening using isoelectric focusing (IEF)\", \"cost_effectiveness\": 3.125, \"stdev\": 0.9672, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 5.0, \"stdev\": 5.9172, \"source\": \"GHCEA\"}, {\"intervention\": \"Syphilis screening before third trimester + treat with three injections of benzathine penicillin if positive\", \"cost_effectiveness\": 142.8571, \"stdev\": 81.0611, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 3.8462, \"stdev\": 6.5758, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 3.125, \"stdev\": 3.747, \"source\": \"GHCEA\"}, {\"intervention\": \"Rotarix vaccine\", \"cost_effectiveness\": 0.3571, \"stdev\": 1.0083, \"source\": \"GHCEA\"}, {\"intervention\": \"Benefit-based tailored treatment\", \"cost_effectiveness\": 0.1235, \"stdev\": 8.3029, \"source\": \"GHCEA\"}, {\"intervention\": \"Target-to-treat\", \"cost_effectiveness\": 0.0909, \"stdev\": 6.1844, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 0.1562, \"stdev\": 0.1749, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 10.8696, \"stdev\": 14.224, \"source\": \"GHCEA\"}, {\"intervention\": \"Mass vaccination of livestock against brucellosis\", \"cost_effectiveness\": 37.037, \"stdev\": 2.1193, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 15.873, \"stdev\": 20.8421, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 0.3846, \"stdev\": 0.5064, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 9.0909, \"stdev\": 12.7331, \"source\": \"GHCEA\"}, {\"intervention\": \"Preventive treatment of malaria in pregnancy with sulphadoxine-pyrimethamine (IPTp-SP) combined with insectiside treated mosquito nets on neonatal survival\", \"cost_effectiveness\": 1000.0, \"stdev\": 334.5669, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 5.5556, \"stdev\": 5.592, \"source\": \"GHCEA\"}, {\"intervention\": \"Preventive treatment of malaria in pregnancy with sulphadoxine-pyrimethamine (IPTp-SP) combined with insectiside treated mosquito nets on clinical malaria\", \"cost_effectiveness\": 20.4082, \"stdev\": 13.3915, \"source\": \"GHCEA\"}, {\"intervention\": \"Intermittent preventive treatment in infants (IPTi) using sulfadoxine pyrimethamine (SP) against clinical malaria; at 3, 4, and 9 months.\", \"cost_effectiveness\": 125.0, \"stdev\": 60.8848, \"source\": \"GHCEA\"}, {\"intervention\": \"Sickle cell disease screening using isoelectric focusing (IEF)\", \"cost_effectiveness\": 1.5625, \"stdev\": 0.6529, \"source\": \"GHCEA\"}, {\"intervention\": \"Preventive treatment of malaria in pregnancy with sulphadoxine-pyrimethamine (IPTp-SP) combined with insectiside treated mosquito nets on combined clinical malaria and neonatal mortality\", \"cost_effectiveness\": 1000.0, \"stdev\": 13.3915, \"source\": \"GHCEA\"}, {\"intervention\": \"Syphilis screening before third trimester + treat with three injections of benzathine penicillin if positive\", \"cost_effectiveness\": 250.0, \"stdev\": 127.5536, \"source\": \"GHCEA\"}, {\"intervention\": \"RTS,S/AS01 malaria vaccine\", \"cost_effectiveness\": 5.0, \"stdev\": 0.0456, \"source\": \"GHCEA\"}, {\"intervention\": \"Oral rehydration salts and zinc treatment included in social franchising program\", \"cost_effectiveness\": 4.1667, \"stdev\": 6.3777, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 29.4118, \"stdev\": 40.2377, \"source\": \"GHCEA\"}, {\"intervention\": \"Pre-erythrocytic RTS, S malaria vaccination\", \"cost_effectiveness\": 13.8889, \"stdev\": 5.5609, \"source\": \"GHCEA\"}, {\"intervention\": \"Increasing coverage of valve surgery (VS) by refering for surgery abroad\", \"cost_effectiveness\": 0.2326, \"stdev\": 0.6707, \"source\": \"GHCEA\"}, {\"intervention\": \"Increasing coverage of valve surgery (VS) by building surgical center\", \"cost_effectiveness\": 0.037, \"stdev\": 0.1899, \"source\": \"GHCEA\"}, {\"intervention\": \"Orthopaedic Trauma Care Specialist (OTCS) program\", \"cost_effectiveness\": 6.6667, \"stdev\": 14.6994, \"source\": \"GHCEA\"}, {\"intervention\": \"Preventive chemotherapy treatment of Lymphatic Filariasis\", \"cost_effectiveness\": 15.1515, \"stdev\": 15.461, \"source\": \"GHCEA\"}, {\"intervention\": \"Scaling up secondary prevention (SP) services: creating and maintaining a registry of individuals with a history of acute rheumatic fever (ARF) or Rheumatic heart disease (RHD) who then receive prophylactic penicillin on a regular basis.\", \"cost_effectiveness\": 1.1765, \"stdev\": 0.0483, \"source\": \"GHCEA\"}, {\"intervention\": \"Prereferral rectal artesunate, low intervention uptake (25%), low referral compliance (25%)\", \"cost_effectiveness\": 1.0, \"stdev\": 4.1313, \"source\": \"GHCEA\"}, {\"intervention\": \"Scaling up primary prevention (PP) services: improving treatment of pharyngitis in primary care settings.\", \"cost_effectiveness\": 0.3448, \"stdev\": 1.0753, \"source\": \"GHCEA\"}, {\"intervention\": \"Sickle cell disease screening using isoelectric focusing (IEF)\", \"cost_effectiveness\": 0.5, \"stdev\": 0.0902, \"source\": \"GHCEA\"}, {\"intervention\": \"Xpert MTB/RIF automated DNA test to detect tuberculosis and rifampicin (RIF) resistance\", \"cost_effectiveness\": 1.0417, \"stdev\": 1.0073, \"source\": \"GHCEA\"}, {\"intervention\": \"Syphilis screening before third trimester + treat with three injections of benzathine penicillin if positive\", \"cost_effectiveness\": 38.4615, \"stdev\": 7.3692, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 3.0303, \"stdev\": 3.4434, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 11.4943, \"stdev\": 14.0749, \"source\": \"GHCEA\"}, {\"intervention\": \"Magnesium sulfate + calcium\", \"cost_effectiveness\": 55.5556, \"stdev\": 400.1682, \"source\": \"GHCEA\"}, {\"intervention\": \"Magnesium sulfate + calcium during antenatal care for pre-eclampsia/eclampsia\", \"cost_effectiveness\": 38.4615, \"stdev\": 238.418, \"source\": \"GHCEA\"}, {\"intervention\": \"Magnesium sulfate\", \"cost_effectiveness\": 250.0, \"stdev\": 728.8778, \"source\": \"GHCEA\"}, {\"intervention\": \"Bacille Calmette Guerin (BCG) vaccination against tuberculosis, in current extended group\", \"cost_effectiveness\": 0.1163, \"stdev\": 0.0807, \"source\": \"GHCEA\"}, {\"intervention\": \"School gruiten intervention that focused on free fruit and vegetable provisions and encouraged nutrition curriculum. Included neither family nor computer feedback tools.\", \"cost_effectiveness\": 0.0625, \"stdev\": 0.0086, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 1.3889, \"stdev\": 1.7995, \"source\": \"GHCEA\"}, {\"intervention\": \"Bacille Calmette Guerin (BCG) vaccination against tuberculosis, in current target group\", \"cost_effectiveness\": 0.1429, \"stdev\": 0.0088, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 1.0, \"stdev\": 1.2413, \"source\": \"GHCEA\"}, {\"intervention\": \"Rotavirus vaccination\", \"cost_effectiveness\": 14.0845, \"stdev\": 22.1832, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 3.5714, \"stdev\": 4.4255, \"source\": \"GHCEA\"}, {\"intervention\": \"Antivenom for snakebite\", \"cost_effectiveness\": 10.0, \"stdev\": 3.5409, \"source\": \"GHCEA\"}, {\"intervention\": \"Syphilis screening before third trimester + treat with three injections of benzathine penicillin if positive\", \"cost_effectiveness\": 50.0, \"stdev\": 8.3856, \"source\": \"GHCEA\"}, {\"intervention\": \"Quadrivalent conjugate meningococcal vaccine\", \"cost_effectiveness\": 1.4085, \"stdev\": 1.249, \"source\": \"GHCEA\"}, {\"intervention\": \"Sickle cell disease screening using isoelectric focusing (IEF)\", \"cost_effectiveness\": 4.7619, \"stdev\": 1.6923, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 8.3333, \"stdev\": 8.6477, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 6.25, \"stdev\": 7.1065, \"source\": \"GHCEA\"}, {\"intervention\": \"Quadrivalent conjugate meningococcal vaccine\", \"cost_effectiveness\": 1.3333, \"stdev\": 1.2119, \"source\": \"GHCEA\"}, {\"intervention\": \"Antivenom for snakebite\", \"cost_effectiveness\": 10.4167, \"stdev\": 5.0426, \"source\": \"GHCEA\"}, {\"intervention\": \"State-wide health insurance program includes comprehensive health care, increase to antenatal care (ANC), delivery care, essential obstetric care (EOC) to reduce maternal mortality\", \"cost_effectiveness\": 20.0, \"stdev\": 7.8254, \"source\": \"GHCEA\"}, {\"intervention\": \"Syphilis screening before third trimester + treat with three injections of benzathine penicillin if positive\", \"cost_effectiveness\": 90.9091, \"stdev\": 46.766, \"source\": \"GHCEA\"}, {\"intervention\": \"Cochlear implant\", \"cost_effectiveness\": 0.0833, \"stdev\": 0.2981, \"source\": \"GHCEA\"}, {\"intervention\": \"Burns management\", \"cost_effectiveness\": 1.8519, \"stdev\": 3.4365, \"source\": \"GHCEA\"}, {\"intervention\": \"Sickle cell disease screening using isoelectric focusing (IEF)\", \"cost_effectiveness\": 6.25, \"stdev\": 1.993, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 0.8333, \"stdev\": 1.0347, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 0.4762, \"stdev\": 0.5403, \"source\": \"GHCEA\"}, {\"intervention\": \"National rotavirus vaccination\", \"cost_effectiveness\": 6.25, \"stdev\": 4.535, \"source\": \"GHCEA\"}, {\"intervention\": \"Children given DTP (diphtheria, tetanus, and pertussis) Vaccine at 6, 10, and 14 weeks; pregnant women receive tetanus shot at first contact with health system and 2nd dose 4 weeks after\", \"cost_effectiveness\": 200.0, \"stdev\": 257.6841, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 7.1429, \"stdev\": 8.6572, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 2.0833, \"stdev\": 2.63, \"source\": \"GHCEA\"}, {\"intervention\": \"Rotarix vaccine\", \"cost_effectiveness\": 0.5882, \"stdev\": 1.4725, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 4.3478, \"stdev\": 4.0981, \"source\": \"GHCEA\"}, {\"intervention\": \"Cochlear implant\", \"cost_effectiveness\": 0.0083, \"stdev\": 0.0233, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 5.8824, \"stdev\": 8.2666, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 2.8571, \"stdev\": 3.3814, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 15.1515, \"stdev\": 20.0556, \"source\": \"GHCEA\"}, {\"intervention\": \"DOTS-Plus project- chronic cases of MDR-TB referred from public or private facilities and cases with a diagnosis of MDR-TB during treatment with the first-line retreatment regimen\", \"cost_effectiveness\": 4.7619, \"stdev\": 2.9925, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 2.2727, \"stdev\": 3.0733, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 3.0303, \"stdev\": 4.1484, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 0.0667, \"stdev\": 0.0765, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 6.6667, \"stdev\": 8.8464, \"source\": \"GHCEA\"}, {\"intervention\": \"Haemophilus influenzae type b (Hib) vaccine included in routine childhood immunization services\", \"cost_effectiveness\": 0.0667, \"stdev\": 0.1765, \"source\": \"GHCEA\"}, {\"intervention\": \"Multidrug-resistant treatment as per WHO guidelines\", \"cost_effectiveness\": 1.7544, \"stdev\": 4.1821, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 8.3333, \"stdev\": 10.6383, \"source\": \"GHCEA\"}, {\"intervention\": \"Quadrivalent conjugate meningococcal vaccine\", \"cost_effectiveness\": 1.5152, \"stdev\": 1.2536, \"source\": \"GHCEA\"}, {\"intervention\": \"Syphilis screening before third trimester + treat with three injections of benzathine penicillin if positive\", \"cost_effectiveness\": 58.8235, \"stdev\": 8.6235, \"source\": \"GHCEA\"}, {\"intervention\": \"Sickle cell disease screening using isoelectric focusing (IEF)\", \"cost_effectiveness\": 1.4286, \"stdev\": 0.2789, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 1.5625, \"stdev\": 0.9608, \"source\": \"GHCEA\"}, {\"intervention\": \"Cochlear implant\", \"cost_effectiveness\": 0.1351, \"stdev\": 0.5002, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 0.0833, \"stdev\": 0.0812, \"source\": \"GHCEA\"}, {\"intervention\": \"Sickle cell disease screening using isoelectric focusing (IEF)\", \"cost_effectiveness\": 4.7619, \"stdev\": 0.2144, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 1.6667, \"stdev\": 1.8908, \"source\": \"GHCEA\"}, {\"intervention\": \"Quadrivalent conjugate meningococcal vaccine\", \"cost_effectiveness\": 1.7241, \"stdev\": 1.4017, \"source\": \"GHCEA\"}, {\"intervention\": \"Syphilis screening before third trimester + treat with three injections of benzathine penicillin if positive\", \"cost_effectiveness\": 25.0, \"stdev\": 1.2963, \"source\": \"GHCEA\"}, {\"intervention\": \"Sickle cell disease screening using isoelectric focusing (IEF)\", \"cost_effectiveness\": 4.0, \"stdev\": 1.1326, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 4.1667, \"stdev\": 4.8113, \"source\": \"GHCEA\"}, {\"intervention\": \"Antivenom therapy for snakebite\", \"cost_effectiveness\": 6.6667, \"stdev\": 4.0749, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 2.2727, \"stdev\": 2.9926, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 0.1587, \"stdev\": 0.2378, \"source\": \"GHCEA\"}, {\"intervention\": \"Antivenom therapy for snakebite\", \"cost_effectiveness\": 3.4483, \"stdev\": 3.4223, \"source\": \"GHCEA\"}, {\"intervention\": \"Syphilis screening before third trimester + treat with three injections of benzathine penicillin if positive\", \"cost_effectiveness\": 71.4286, \"stdev\": 9.2818, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 5.5556, \"stdev\": 5.9969, \"source\": \"GHCEA\"}, {\"intervention\": \"Sickle cell disease screening using isoelectric focusing (IEF)\", \"cost_effectiveness\": 6.25, \"stdev\": 1.9969, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 0.9091, \"stdev\": 1.2751, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 0.8333, \"stdev\": 1.0733, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 1.087, \"stdev\": 1.444, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 0.6667, \"stdev\": 0.6719, \"source\": \"GHCEA\"}, {\"intervention\": \"Sickle cell disease screening using isoelectric focusing (IEF)\", \"cost_effectiveness\": 0.0294, \"stdev\": 6.038, \"source\": \"GHCEA\"}, {\"intervention\": \"Home HIV counseling and testing\", \"cost_effectiveness\": 0.7143, \"stdev\": 1.5006, \"source\": \"GHCEA\"}, {\"intervention\": \"Lateral-flow immunochromatographic assay (TB-LAM Alere) for tuberculosis diagnosis\", \"cost_effectiveness\": 2.5, \"stdev\": 1.0531, \"source\": \"GHCEA\"}, {\"intervention\": \"Benefit-based tailored treatment\", \"cost_effectiveness\": 0.0909, \"stdev\": 3.877, \"source\": \"GHCEA\"}, {\"intervention\": \"Sickle cell disease screening using isoelectric focusing (IEF)\", \"cost_effectiveness\": 0.0833, \"stdev\": 11.8655, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 5.5556, \"stdev\": 5.9951, \"source\": \"GHCEA\"}, {\"intervention\": \"Xpert MTB/RIF automated DNA test to detect tuberculosis and rifampicin (RIF) resistance\", \"cost_effectiveness\": 1.0, \"stdev\": 1.0276, \"source\": \"GHCEA\"}, {\"intervention\": \"Cochlear implant\", \"cost_effectiveness\": 0.0769, \"stdev\": 0.4746, \"source\": \"GHCEA\"}, {\"intervention\": \"Community health workers (CHW) visit patients twice yearly to increase hypertension adherence by monitoring blood pressure, teaching them about healthy lifestyle choices and encouraging follow-up visits\", \"cost_effectiveness\": 2.9412, \"stdev\": 2.5447, \"source\": \"GHCEA\"}, {\"intervention\": \"Syphilis screening before third trimester + treat with three injections of benzathine penicillin if positive\", \"cost_effectiveness\": 29.4118, \"stdev\": 7.6957, \"source\": \"GHCEA\"}, {\"intervention\": \"STI services in mobile clinic\", \"cost_effectiveness\": 9.0909, \"stdev\": 15.0063, \"source\": \"GHCEA\"}, {\"intervention\": \"Target-to-treat\", \"cost_effectiveness\": 0.0588, \"stdev\": 1.8228, \"source\": \"GHCEA\"}, {\"intervention\": \"Quadrivalent conjugate meningococcal vaccine\", \"cost_effectiveness\": 1.3514, \"stdev\": 1.1453, \"source\": \"GHCEA\"}, {\"intervention\": \"Pneumococcal conjugate vaccine - 1 dose\", \"cost_effectiveness\": 6.25, \"stdev\": 0.1165, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 2.6316, \"stdev\": 3.4965, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 10.5263, \"stdev\": 14.0536, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 0.1429, \"stdev\": 0.1737, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 0.1205, \"stdev\": 0.1384, \"source\": \"GHCEA\"}, {\"intervention\": \"Syphilis screening before third trimester + treat with three injections of benzathine penicillin if positive\", \"cost_effectiveness\": 71.4286, \"stdev\": 23.383, \"source\": \"GHCEA\"}, {\"intervention\": \"Sickle cell disease screening using isoelectric focusing (IEF)\", \"cost_effectiveness\": 2.7778, \"stdev\": 0.7598, \"source\": \"GHCEA\"}, {\"intervention\": \"Haemophilus influenzae type b (Hib)-containing and pneumococcal conjugate vaccine - 2 doses each\", \"cost_effectiveness\": 4.5455, \"stdev\": 10.4125, \"source\": \"GHCEA\"}, {\"intervention\": \"Haemophilus influenzae type b (Hib) - 1 dose\", \"cost_effectiveness\": 4.5455, \"stdev\": 0.1206, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 5.0, \"stdev\": 5.0619, \"source\": \"GHCEA\"}, {\"intervention\": \"Haemophilus influenzae type b (Hib)-containing and pneumococcal conjugate vaccine - 1 dose each\", \"cost_effectiveness\": 7.6923, \"stdev\": 0.1594, \"source\": \"GHCEA\"}, {\"intervention\": \"Quadrivalent conjugate meningococcal vaccine\", \"cost_effectiveness\": 1.5385, \"stdev\": 1.2724, \"source\": \"GHCEA\"}, {\"intervention\": \"Pneumococcal conjugate vaccine - 2 dose\", \"cost_effectiveness\": 4.5455, \"stdev\": 8.7216, \"source\": \"GHCEA\"}, {\"intervention\": \"Haemophilus influenzae type b (Hib) - 2 doses\", \"cost_effectiveness\": 2.7027, \"stdev\": 1.2354, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 0.6667, \"stdev\": 0.7756, \"source\": \"GHCEA\"}, {\"intervention\": \"Xpert MTB/RIF automated DNA test to detect tuberculosis and rifampicin (RIF) resistance\", \"cost_effectiveness\": 1.0, \"stdev\": 1.1977, \"source\": \"GHCEA\"}, {\"intervention\": \"Xpert MTB/RIF automated DNA test to detect tuberculosis and rifampicin (RIF) resistance\", \"cost_effectiveness\": 1.1628, \"stdev\": 1.1977, \"source\": \"GHCEA\"}, {\"intervention\": \"Sickle cell disease screening using isoelectric focusing (IEF)\", \"cost_effectiveness\": 0.1053, \"stdev\": 1.3827, \"source\": \"GHCEA\"}, {\"intervention\": \"Syphilis screening before third trimester + treat with three injections of benzathine penicillin if positive\", \"cost_effectiveness\": 250.0, \"stdev\": 151.9895, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 1.7857, \"stdev\": 1.7821, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 1.7544, \"stdev\": 2.1852, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 1.2195, \"stdev\": 1.5047, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 11.1111, \"stdev\": 13.049, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 19.2308, \"stdev\": 27.0241, \"source\": \"GHCEA\"}, {\"intervention\": \"Sickle cell disease screening using isoelectric focusing (IEF)\", \"cost_effectiveness\": 4.1667, \"stdev\": 1.5796, \"source\": \"GHCEA\"}, {\"intervention\": \"Tuberculosis diagnosis using LED fluorescence microscopy\", \"cost_effectiveness\": 32.2581, \"stdev\": 19.2534, \"source\": \"GHCEA\"}, {\"intervention\": \"Intermittent preventive treatment in infants (IPTi) using sulfadoxine pyrimethamine (SP) against clinical malaria; at 2, 3, and 9 months.\", \"cost_effectiveness\": 333.3333, \"stdev\": 330.2359, \"source\": \"GHCEA\"}, {\"intervention\": \"Tuberculosis diagnosis using Xpert for known HIV-positive cases\", \"cost_effectiveness\": 5.8824, \"stdev\": 6.8948, \"source\": \"GHCEA\"}, {\"intervention\": \"Intermittent preventive treatment in infants (IPTi) using mefloquine (MQ) against clinical malaria; at 2, 3, and 9 months.\", \"cost_effectiveness\": 25.641, \"stdev\": 17.4462, \"source\": \"GHCEA\"}, {\"intervention\": \"Malaria intermittent preventive treatment in infants (IPTi) using sulfadoxine-pyrimethamine (SP) through Expanded Programme on Immunization (EPI) in Ifakara\", \"cost_effectiveness\": 250.0, \"stdev\": 96.2669, \"source\": \"GHCEA\"}, {\"intervention\": \"Tuberculosis diagnosis using Xpert for smear negative and known HIV-positive cases\", \"cost_effectiveness\": 4.5455, \"stdev\": 3.9861, \"source\": \"GHCEA\"}, {\"intervention\": \"Intermittent preventive treatment in pregnancy- with mefloquine in addition to cotrimoxazole prophylaxis\", \"cost_effectiveness\": 142.8571, \"stdev\": 186.2097, \"source\": \"GHCEA\"}, {\"intervention\": \"Tuberculosis diagnosis using Xpert for smear negative and known HIV-positive cases with additional HIV testing\", \"cost_effectiveness\": 4.5455, \"stdev\": 2.7284, \"source\": \"GHCEA\"}, {\"intervention\": \"Urban Malaria Control Program\", \"cost_effectiveness\": 21.7391, \"stdev\": 6.1472, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 6.6667, \"stdev\": 7.5103, \"source\": \"GHCEA\"}, {\"intervention\": \"Tuberculosis diagnosis using same-day LED fluorescence microscopy\", \"cost_effectiveness\": 24.3902, \"stdev\": 24.2959, \"source\": \"GHCEA\"}, {\"intervention\": \"Xpert MTB/RIF (mycobacterium tuberculosis/rifampicin) tuberculosis diagnostic test scale up\", \"cost_effectiveness\": 8.3333, \"stdev\": 14.1726, \"source\": \"GHCEA\"}, {\"intervention\": \"Tuberculosis diagnosis using Xpert for known HIV-positive cases with additional HIV testing\", \"cost_effectiveness\": 6.6667, \"stdev\": 10.2043, \"source\": \"GHCEA\"}, {\"intervention\": \"Intermittent preventive treatment in infants (IPTi) using 3 days of chlorproguanil-dapsone (CD3) against clinical malaria; at 2, 3, and 9 months.\", \"cost_effectiveness\": 2.2222, \"stdev\": 0.5875, \"source\": \"GHCEA\"}, {\"intervention\": \"Syphilis screening before third trimester + treat with three injections of benzathine penicillin if positive\", \"cost_effectiveness\": 111.1111, \"stdev\": 50.6632, \"source\": \"GHCEA\"}, {\"intervention\": \"Intermittent preventive treatment in pregnancy- with mefloquine\", \"cost_effectiveness\": 6.6667, \"stdev\": 104.4451, \"source\": \"GHCEA\"}, {\"intervention\": \"Quadrivalent conjugate meningococcal vaccine\", \"cost_effectiveness\": 1.4925, \"stdev\": 1.3133, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 17.8571, \"stdev\": 26.0513, \"source\": \"GHCEA\"}, {\"intervention\": \"Maintenance drug treatment for major depression\", \"cost_effectiveness\": 0.8333, \"stdev\": 0.0567, \"source\": \"GHCEA\"}, {\"intervention\": \"HIV vaccine given to grade 1 students. Infected individuals given highly active antiretroviral treatment (HAART).\", \"cost_effectiveness\": 2.6316, \"stdev\": 11.4655, \"source\": \"GHCEA\"}, {\"intervention\": \"Continuation drug treatment\", \"cost_effectiveness\": 1.0, \"stdev\": 0.0567, \"source\": \"GHCEA\"}, {\"intervention\": \"Infected individuals given highly active antiretroviral treatment (HAART).\", \"cost_effectiveness\": 1.1494, \"stdev\": 2.6165, \"source\": \"GHCEA\"}, {\"intervention\": \"Episodic drug treatment for major depression\", \"cost_effectiveness\": 0.7692, \"stdev\": 0.0408, \"source\": \"GHCEA\"}, {\"intervention\": \"Scaling up of testing and treatment of HIV with universal antiretroviral treatment (ART), HIV testing services, conventional peer-educator outreach, mobile point-of-care night clinics\", \"cost_effectiveness\": 2.2222, \"stdev\": 6.2603, \"source\": \"GHCEA\"}, {\"intervention\": \"HIV vaccine given to grade 1 students\", \"cost_effectiveness\": 9.0909, \"stdev\": 22.1832, \"source\": \"GHCEA\"}, {\"intervention\": \"Maintenance cognitive behavioral therapy:CBT is a nonpharmacological intervention that is effective in the treatment of depression alone or combined with drug therapy.\", \"cost_effectiveness\": 2.9412, \"stdev\": 0.1701, \"source\": \"GHCEA\"}, {\"intervention\": \"Episodal cognitive behavioral therapy in the treatment of depression alone or combined with drug therapy.\", \"cost_effectiveness\": 1.3889, \"stdev\": 0.0392, \"source\": \"GHCEA\"}, {\"intervention\": \"Rotavirus vaccination\", \"cost_effectiveness\": 14.9254, \"stdev\": 22.6762, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 1.2987, \"stdev\": 1.7917, \"source\": \"GHCEA\"}, {\"intervention\": \"Quadrivalent conjugate meningococcal vaccine\", \"cost_effectiveness\": 1.4286, \"stdev\": 1.266, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 6.6667, \"stdev\": 6.8892, \"source\": \"GHCEA\"}, {\"intervention\": \"Sickle cell disease screening using isoelectric focusing (IEF)\", \"cost_effectiveness\": 5.5556, \"stdev\": 2.1898, \"source\": \"GHCEA\"}, {\"intervention\": \"Syphilis screening before third trimester + treat with three injections of benzathine penicillin if positive\", \"cost_effectiveness\": 50.0, \"stdev\": 3.3567, \"source\": \"GHCEA\"}, {\"intervention\": \"Antivenom therapy for snakebite\", \"cost_effectiveness\": 8.3333, \"stdev\": 2.5046, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 0.0833, \"stdev\": 0.094, \"source\": \"GHCEA\"}, {\"intervention\": \"Cochlear implants\", \"cost_effectiveness\": 0.0294, \"stdev\": 0.0216, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 0.9091, \"stdev\": 1.0689, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 9.0909, \"stdev\": 11.609, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 5.0, \"stdev\": 6.594, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 4.7619, \"stdev\": 6.3412, \"source\": \"GHCEA\"}, {\"intervention\": \"An automated molecular assay for detection of tuberculosis and rifampin resistance from sputum samples\", \"cost_effectiveness\": 16.3934, \"stdev\": 4.0817, \"source\": \"GHCEA\"}, {\"intervention\": \"Smear-microscopy plus LF-LAM testing for rapid diagnosis of tuberculosis (LF-LAM is a low-cost urinary lateral flow assay for lipoarabinomannan (LAM))\", \"cost_effectiveness\": 28.5714, \"stdev\": 6.7578, \"source\": \"GHCEA\"}, {\"intervention\": \"Sickle cell disease screening using isoelectric focusing (IEF)\", \"cost_effectiveness\": 4.7619, \"stdev\": 1.8553, \"source\": \"GHCEA\"}, {\"intervention\": \"Routine measles-containing vaccine followed by supplementary immunization\", \"cost_effectiveness\": 1000.0, \"stdev\": 728.8778, \"source\": \"GHCEA\"}, {\"intervention\": \"Syphilis screening before third trimester + treat with three injections of benzathine penicillin if positive\", \"cost_effectiveness\": 125.0, \"stdev\": 53.7068, \"source\": \"GHCEA\"}, {\"intervention\": \"Quadrivalent conjugate meningococcal vaccine\", \"cost_effectiveness\": 1.3333, \"stdev\": 1.1128, \"source\": \"GHCEA\"}, {\"intervention\": \"Lateral-flow immunochromatographic assay (TB-LAM Alere) for tuberculosis diagnosis\", \"cost_effectiveness\": 10.3093, \"stdev\": 5.3707, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 6.25, \"stdev\": 5.689, \"source\": \"GHCEA\"}, {\"intervention\": \"Xpert as replacement for smear-microscopy plus LF-LAM testing for rapid diagnosis of tuberculosis (Xpert is an automated molecular assay for detection of tuberculosis and rifampin resistance from sputum samples) (LF-LAM is a low-cost urinary lateral flow assay for lipoarabinomannan (LAM))\", \"cost_effectiveness\": 16.6667, \"stdev\": 4.5352, \"source\": \"GHCEA\"}, {\"intervention\": \"Typhoid vaccination-single dose\", \"cost_effectiveness\": 2.3256, \"stdev\": 1.225, \"source\": \"GHCEA\"}, {\"intervention\": \"Cochlear implants\", \"cost_effectiveness\": 0.1266, \"stdev\": 0.4485, \"source\": \"GHCEA\"}, {\"intervention\": \"Xpert as replacement for smear-microscopy plus LF-LAM testing for rapid diagnosis of tuberculosis (Xpert is an automated molecular assay for detection of tuberculosis and rifampin resistance from sputum samples) (LF-LAM is a low-cost urinary lateral flow assay for lipoarabinomannan (LAM))\", \"cost_effectiveness\": 18.1818, \"stdev\": 6.2603, \"source\": \"GHCEA\"}, {\"intervention\": \"Second generation antipsychotic Olanzapine\", \"cost_effectiveness\": 0.1587, \"stdev\": 0.0197, \"source\": \"GHCEA\"}, {\"intervention\": \"Home based highly active anti-retroviral therapy (HAART) added to a package of home based care (HBAC) and cotrimoxazole prophylaxis\", \"cost_effectiveness\": 1.2987, \"stdev\": 6.3183, \"source\": \"GHCEA\"}, {\"intervention\": \"Prenatal community distribution of misoprostol to pregnant mothers\", \"cost_effectiveness\": 14.7059, \"stdev\": 2.9837, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 19.6078, \"stdev\": 25.0781, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 0.7692, \"stdev\": 0.7144, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 2.0833, \"stdev\": 2.57, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 2.9412, \"stdev\": 3.8651, \"source\": \"GHCEA\"}, {\"intervention\": \"New tuberculosis vaccine (40% efficacy)\", \"cost_effectiveness\": 17.2414, \"stdev\": 4.509, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 2.7778, \"stdev\": 3.2336, \"source\": \"GHCEA\"}, {\"intervention\": \"Rotavirus vaccination\", \"cost_effectiveness\": 7.6923, \"stdev\": 9.1931, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 37.037, \"stdev\": 53.8769, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 0.303, \"stdev\": 0.299, \"source\": \"GHCEA\"}, {\"intervention\": \"Cochlear implants\", \"cost_effectiveness\": 0.0042, \"stdev\": 0.0344, \"source\": \"GHCEA\"}, {\"intervention\": \"Rotarix vaccine\", \"cost_effectiveness\": 0.625, \"stdev\": 0.8278, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 5.5556, \"stdev\": 7.1269, \"source\": \"GHCEA\"}, {\"intervention\": \"Vitamin K prophylaxis\", \"cost_effectiveness\": 9.0909, \"stdev\": 17.0071, \"source\": \"GHCEA\"}, {\"intervention\": \"Condom promotion programme for female sex workers for HIV prevention\", \"cost_effectiveness\": 3.125, \"stdev\": 4.7462, \"source\": \"GHCEA\"}, {\"intervention\": \"Brief smoking cessation advice + Nicotine replacement therapy (gum)\", \"cost_effectiveness\": 200.0, \"stdev\": 0.0368, \"source\": \"GHCEA\"}, {\"intervention\": \"Brief smoking cessation advice + Varenicline\", \"cost_effectiveness\": 200.0, \"stdev\": 0.0353, \"source\": \"GHCEA\"}, {\"intervention\": \"Bupropion for smoking cessation\", \"cost_effectiveness\": 142.8571, \"stdev\": 0.0298, \"source\": \"GHCEA\"}, {\"intervention\": \"Varenicline for smoking cessation\", \"cost_effectiveness\": 111.1111, \"stdev\": 0.0191, \"source\": \"GHCEA\"}, {\"intervention\": \"Condom promotion programme for men who have sex with men for HIV prevention\", \"cost_effectiveness\": 9.0909, \"stdev\": 3.7934, \"source\": \"GHCEA\"}, {\"intervention\": \"Rotavirus vaccination\", \"cost_effectiveness\": 8.3333, \"stdev\": 24.8885, \"source\": \"GHCEA\"}, {\"intervention\": \"Brief smoking cessation advice + Bupropion\", \"cost_effectiveness\": 333.3333, \"stdev\": 0.0589, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 15.625, \"stdev\": 22.1736, \"source\": \"GHCEA\"}, {\"intervention\": \"Nicotine replacement therapy (gum) for smoking cessation\", \"cost_effectiveness\": 76.9231, \"stdev\": 0.0149, \"source\": \"GHCEA\"}, {\"intervention\": \"Needle and syringe programme for HIV prevention\", \"cost_effectiveness\": 0.625, \"stdev\": 0.5613, \"source\": \"GHCEA\"}, {\"intervention\": \"30% of people receiving ART for HIV 2015-2030 Viral Load scenario 7: Every 2 years, switching criteria of  confirmed VL >1000 copies/mL, with resistance test\", \"cost_effectiveness\": 0.1887, \"stdev\": 0.1752, \"source\": \"GHCEA\"}, {\"intervention\": \"30% of people receiving ART for HIV 2015-2030 Viral Load scenario 3: Every year, switching criteria of confirmed VL >1000 copies/mL, with resistance test\", \"cost_effectiveness\": 0.1754, \"stdev\": 0.2128, \"source\": \"GHCEA\"}, {\"intervention\": \"Needle and syringe program, methadone maintenance program, condom promotion for female sex workers and men who have sex with men, antiretroviral therapy program\", \"cost_effectiveness\": 3.8462, \"stdev\": 8.6477, \"source\": \"GHCEA\"}, {\"intervention\": \"30% of people receiving ART for HIV 2015-2030 Viral Load scenario 8: Every 2 years, switching criteria of  confirmed VL >400 copies/mL, with resistance test\", \"cost_effectiveness\": 0.1887, \"stdev\": 0.1916, \"source\": \"GHCEA\"}, {\"intervention\": \"Brief smoking cessation advice\", \"cost_effectiveness\": 10.5263, \"stdev\": 0.6438, \"source\": \"GHCEA\"}, {\"intervention\": \"30% of people receiving ART for HIV 2015-2030 Viral Load scenario 5: Every 2 years, switching criteria of  confirmed VL >1000 copies/mL, no resistance test\", \"cost_effectiveness\": 0.1961, \"stdev\": 0.2002, \"source\": \"GHCEA\"}, {\"intervention\": \"3 doses of combined diphtheria-tetanus-pertussis-hepatitis B-Hib and 3 doses of Hep B vaccines\", \"cost_effectiveness\": 0.7692, \"stdev\": 0.4243, \"source\": \"GHCEA\"}, {\"intervention\": \"Antiretroviral therapy programme (including prevention of mother-to-child transmission of HIV)\", \"cost_effectiveness\": 5.8824, \"stdev\": 13.6057, \"source\": \"GHCEA\"}, {\"intervention\": \"Brief smoking cessation advice + Nicotine replacement therapy (patch)\", \"cost_effectiveness\": 62.5, \"stdev\": 0.0126, \"source\": \"GHCEA\"}, {\"intervention\": \"30% of people receiving ART for HIV 2015-2030 Viral Load scenario 4: Every year, switching criteria of  confirmed VL >400 copies/mL, with resistance test\", \"cost_effectiveness\": 0.1667, \"stdev\": 0.2197, \"source\": \"GHCEA\"}, {\"intervention\": \"Rotavirus vaccination\", \"cost_effectiveness\": 3.8462, \"stdev\": 3.7794, \"source\": \"GHCEA\"}, {\"intervention\": \"Clozapine\", \"cost_effectiveness\": 0.9091, \"stdev\": 13.0824, \"source\": \"GHCEA\"}, {\"intervention\": \"30% of people receiving ART for HIV 2015-2030 Viral Load scenario 2: Every year, switching criteria of confirmed VL >400 copies/mL, no resistance test\", \"cost_effectiveness\": 0.2, \"stdev\": 0.2166, \"source\": \"GHCEA\"}, {\"intervention\": \"30% of people receiving ART for HIV 2015-2030 Viral Load scenario 6: Every 2 years, switching criteria of  confirmed VL >400 copies/mL, no resistance test\", \"cost_effectiveness\": 0.2, \"stdev\": 0.2055, \"source\": \"GHCEA\"}, {\"intervention\": \"Nicotine replacement therapy (patch) for smoking cessation\", \"cost_effectiveness\": 29.4118, \"stdev\": 0.0062, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 9.0909, \"stdev\": 10.5318, \"source\": \"GHCEA\"}, {\"intervention\": \"Rotavirus vaccination\", \"cost_effectiveness\": 29.4118, \"stdev\": 46.3831, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 5.0, \"stdev\": 5.0654, \"source\": \"GHCEA\"}, {\"intervention\": \"New tuberculosis vaccine (40% efficacy)\", \"cost_effectiveness\": 28.5714, \"stdev\": 12.5391, \"source\": \"GHCEA\"}, {\"intervention\": \"Syphilis screening before third trimester + treat with three injections of benzathine penicillin if positive\", \"cost_effectiveness\": 333.3333, \"stdev\": 204.0858, \"source\": \"GHCEA\"}, {\"intervention\": \"Community-based therapeutic care, ready to use therapeutic food, a nutrient-dense food with a nutrient content/100 kcal that is similar to F100 milk\", \"cost_effectiveness\": 16.6667, \"stdev\": 3.5432, \"source\": \"GHCEA\"}, {\"intervention\": \"Sickle cell disease screening using isoelectric focusing (IEF)\", \"cost_effectiveness\": 5.2632, \"stdev\": 1.832, \"source\": \"GHCEA\"}, {\"intervention\": \"New tuberculosis vaccine (40% efficacy)\", \"cost_effectiveness\": 250.0, \"stdev\": 132.6956, \"source\": \"GHCEA\"}, {\"intervention\": \"Dihydroartemisinin piperaquine for first line treatment of plasmodium falciparum malaria\", \"cost_effectiveness\": 142.8571, \"stdev\": 3.7516, \"source\": \"GHCEA\"}, {\"intervention\": \"New tuberculosis vaccine (40% efficacy)\", \"cost_effectiveness\": 1000.0, \"stdev\": 944.8417, \"source\": \"GHCEA\"}, {\"intervention\": \"Policy intervention to reduce sodium consumption by 10%\", \"cost_effectiveness\": 3.7037, \"stdev\": 4.3373, \"source\": \"GHCEA\"}, {\"intervention\": \"Rotavirus vaccination\", \"cost_effectiveness\": 21.2766, \"stdev\": 30.9221, \"source\": \"GHCEA\"}, {\"intervention\": \"Rotavirus vaccination\", \"cost_effectiveness\": 23.2558, \"stdev\": 35.1872, \"source\": \"GHCEA\"}, {\"intervention\": \"Sickle cell disease screening using isoelectric focusing (IEF)\", \"cost_effectiveness\": 1.1905, \"stdev\": 0.1923, \"source\": \"GHCEA\"}, {\"intervention\": \"Syphilis screening before third trimester + treat with three injections of benzathine penicillin if positive\", \"cost_effectiveness\": 111.1111, \"stdev\": 14.1726, \"source\": \"GHCEA\"}, {\"intervention\": \"Pneumococcal conjugate vaccination\", \"cost_effectiveness\": 7.1429, \"stdev\": 7.9721, \"source\": \"GHCEA\"}, {\"intervention\": \"Syphilis screening before third trimester + treat with three injections of benzathine penicillin if positive\", \"cost_effectiveness\": 83.3333, \"stdev\": 30.9221, \"source\": \"GHCEA\"}, {\"intervention\": \"New tuberculosis vaccine (40% efficacy)\", \"cost_effectiveness\": 200.0, \"stdev\": 92.8507, \"source\": \"GHCEA\"}], \"data-e1437c5e7a8ba73216d18c14637b03bb\": [{\"stdev\": 80857.23197237821, \"yfit\": 3549.7832481973414, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 92.58171424000642, \"yfit\": 1008.3943163582869, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 16.213046729450305, \"yfit\": 1000.841171392662, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 14.139199431711091, \"yfit\": 1000.4215629991048, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.720947531173763, \"yfit\": 1000.2816506558054, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.571371807396666, \"yfit\": 1000.2117317771736, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.501596917290938, \"yfit\": 1000.1697782889314, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.463548625087508, \"yfit\": 1000.1418082456715, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.440556682924283, \"yfit\": 1000.1218291170801, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.425613439784149, \"yfit\": 1000.1068458956081, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.415359174943896, \"yfit\": 1000.0951947244163, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.408020266661916, \"yfit\": 1000.0858639137153, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.408020266661914, \"yfit\": 1000.0858639137153, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.402587481121907, \"yfit\": 1000.0782348560178, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.401581842755702, \"yfit\": 1000.0767378089413, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.398453935329579, \"yfit\": 1000.0718777177021, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.396465432643847, \"yfit\": 1000.0686046050774, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.395236193619207, \"yfit\": 1000.0664985492468, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.392682470618128, \"yfit\": 1000.0618878273146, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.392399948124504, \"yfit\": 1000.0613558099268, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.39062190609099, \"yfit\": 1000.0578918578383, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.389169748679572, \"yfit\": 1000.0548952925107, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.38893525133713, \"yfit\": 1000.0543953783737, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.387550646887469, \"yfit\": 1000.0511091471873, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.386614661240701, \"yfit\": 1000.0489506312177, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.386376357757658, \"yfit\": 1000.0483849048966, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.38538266475002, \"yfit\": 1000.0459468709721, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.38457167693342, \"yfit\": 1000.0438511908195, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.384534343575934, \"yfit\": 1000.0437521670981, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.383804357281422, \"yfit\": 1000.0417660811248, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.38317167466271, \"yfit\": 1000.0399602066691, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.382949167008608, \"yfit\": 1000.0393041978717, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.382619737759734, \"yfit\": 1000.0383110715273, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.382135366843388, \"yfit\": 1000.0367991101436, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.381707965809413, \"yfit\": 1000.0354078830022, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.38166052997889, \"yfit\": 1000.0352498677817, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.381328937369993, \"yfit\": 1000.0341234761853, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.380991247050916, \"yfit\": 1000.0329340342744, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.380689094245756, \"yfit\": 1000.0318293932578, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.380637021239126, \"yfit\": 1000.0316348409053, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.380417660350485, \"yfit\": 1000.0308006976833, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.380172917939513, \"yfit\": 1000.0298404194428, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.379951478594421, \"yfit\": 1000.0289419751298, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.379824061150966, \"yfit\": 1000.0284111010866, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.379750474787054, \"yfit\": 1000.0280995722459, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.37956746688826, \"yfit\": 1000.0273081197056, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.37940036876276, \"yfit\": 1000.0265631247925, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.379247388033463, \"yfit\": 1000.0258606077604, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.379178321056823, \"yfit\": 1000.0255365443903, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.37910697780051, \"yfit\": 1000.025197030653, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.378977797371341, \"yfit\": 1000.0245692376367, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.378858680130637, \"yfit\": 1000.0239744048001, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.37874860710326, \"yfit\": 1000.0234099976547, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.378665389516902, \"yfit\": 1000.0229731790532, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.378646685084727, \"yfit\": 1000.0228737349181, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.378552128460715, \"yfit\": 1000.0223635576413, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.378464244020803, \"yfit\": 1000.0218776027637, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.37838241821944, \"yfit\": 1000.0214141806315, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.378306106431465, \"yfit\": 1000.0209717549204, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.378257934356187, \"yfit\": 1000.020687062445, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.378234823867484, \"yfit\": 1000.0205489257584, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.378168137854658, \"yfit\": 1000.020144414907, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.37810566125468, \"yfit\": 1000.0197570528155, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.378047046831858, \"yfit\": 1000.0193857673218, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.37799198241708, \"yfit\": 1000.0190295736991, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.377940186742492, \"yfit\": 1000.0186875659376, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.377934242288182, \"yfit\": 1000.018647863848, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.377891405841748, \"yfit\": 1000.0183589090144, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.377845409930481, \"yfit\": 1000.0180428320812, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.37780199069461, \"yfit\": 1000.0177386224025, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.377760958927075, \"yfit\": 1000.0174456199844, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.377722142462458, \"yfit\": 1000.0171632127785, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.377685384367481, \"yfit\": 1000.016890832401, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.377677059806969, \"yfit\": 1000.0168284502852, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.37765054135174, \"yfit\": 1000.0166279503048, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.377617482368612, \"yfit\": 1000.0163740743433, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.37758608738072, \"yfit\": 1000.016128745693, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.377556246268153, \"yfit\": 1000.0158915360663, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.377527857861034, \"yfit\": 1000.0156620452179, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.377500829080384, \"yfit\": 1000.0154398986795, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.377475074173665, \"yfit\": 1000.0152247457164, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.377472672405961, \"yfit\": 1000.0152045027571, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.377450514033287, \"yfit\": 1000.0150162574698, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.377427075587937, \"yfit\": 1000.0148141252758, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.377404691257968, \"yfit\": 1000.0146180591329, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.377383298467374, \"yfit\": 1000.014427786318, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.377362839205421, \"yfit\": 1000.0142430501057, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.377343259632578, \"yfit\": 1000.0140636086115, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.377324509725609, \"yfit\": 1000.0138892337377, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.37731017196537, \"yfit\": 1000.0137541481563, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.377306542957246, \"yfit\": 1000.0137197101938, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.377289316006953, \"yfit\": 1000.0135548346121, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.377272788499198, \"yfit\": 1000.013394414731, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.377256922766248, \"yfit\": 1000.0132382686432, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.377241683633093, \"yfit\": 1000.0130862241087, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.377227038221834, \"yfit\": 1000.0129381179087, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.377212955774093, \"yfit\": 1000.0127937952769, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.377199407488892, \"yfit\": 1000.0126531093432, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.377186366375042, \"yfit\": 1000.01251592064, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.377180872715911, \"yfit\": 1000.0124575930096, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.377173807116371, \"yfit\": 1000.012382096644, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.377161705948359, \"yfit\": 1000.0122515113384, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.377150040545459, \"yfit\": 1000.012124044824, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.37713878991776, \"yfit\": 1000.0119995829508, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.377127934316267, \"yfit\": 1000.0118780169761, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.377117455145791, \"yfit\": 1000.0117592432414, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.377107334885181, \"yfit\": 1000.0116431628868, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.377097557013728, \"yfit\": 1000.0115296815724, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.377088105943397, \"yfit\": 1000.0114187092191, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.37707896695655, \"yfit\": 1000.0113101597778, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.37707784498586, \"yfit\": 1000.0112967472766, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.37707012614824, \"yfit\": 1000.0112039509991, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.37706157037318, \"yfit\": 1000.011100004231, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.377053287196569, \"yfit\": 1000.0109982442256, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.377045264848661, \"yfit\": 1000.0108985989542, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.377037492182675, \"yfit\": 1000.0108009994374, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.3770299586359, \"yfit\": 1000.0107053795924, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.377022654193548, \"yfit\": 1000.0106116760803, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.377015569355132, \"yfit\": 1000.0105198281636, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.377008695103486, \"yfit\": 1000.0104297775828, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.377002022875686, \"yfit\": 1000.0103414684276, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.376995544536237, \"yfit\": 1000.0102548470269, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.376995544536237, \"yfit\": 1000.0102548470269, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.37692952652325, \"yfit\": 1000.0093161649712, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.376873992222032, \"yfit\": 1000.0086285812022, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.376830058655536, \"yfit\": 1000.0077276419233, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.376795378289087, \"yfit\": 1000.0069580735277, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.376768093224237, \"yfit\": 1000.0063186072057, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.376740915844415, \"yfit\": 1000.0055991375846, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.376723334137429, \"yfit\": 1000.0051003514379, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.376707819788999, \"yfit\": 1000.0045896832065, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.376068964489889, \"yfit\": 999.9804597732768, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.373846483359987, \"yfit\": 999.8910672385099, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 13.371753165146687, \"yfit\": 999.7974103519512, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 12.51957913874374, \"yfit\": 957.3246316088764, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 11.158116147568292, \"yfit\": 889.4676177924539, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 9.944721290316238, \"yfit\": 828.9899056419587, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 8.863282479242711, \"yfit\": 775.0891257588218, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 7.899453191865545, \"yfit\": 727.0500120963366, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 7.0404458085522785, \"yfit\": 684.2351004225918, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 6.274861059753214, \"yfit\": 646.0762678903934, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 5.592539926723424, \"yfit\": 612.067172234608, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 4.984428390646894, \"yfit\": 581.756533761663, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 4.442457160577827, \"yfit\": 554.7421488334618, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 3.9594346127272857, \"yfit\": 530.6655528599762, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 3.528951320082706, \"yfit\": 509.20726400995346, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 3.145295091613481, \"yfit\": 490.08254341224745, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 2.8033749748739876, \"yfit\": 473.0376179029375, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 2.4986539776960868, \"yfit\": 457.8463108060257, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 2.227088683665774, \"yfit\": 444.3070418277189, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 1.9850721810307665, \"yfit\": 432.24018451257945, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 1.7693993217905877, \"yfit\": 421.48556381391757, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 1.5772053024176325, \"yfit\": 411.9004978904876, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 1.4059398156694678, \"yfit\": 403.35779877629045, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 1.25333023836527, \"yfit\": 395.74411017264225, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 1.1173515006580148, \"yfit\": 388.95840303524756, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.996199245159444, \"yfit\": 382.9106350765445, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.8882657994494116, \"yfit\": 377.520556439703, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.7921189424957479, \"yfit\": 372.7166445974199, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.7064827625872102, \"yfit\": 368.435154308124, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.6302206902595509, \"yfit\": 364.6192729459182, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.5623205543218747, \"yfit\": 361.21836725504915, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.501878917732303, \"yfit\": 358.1873014428241, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.501878917732303, \"yfit\": 358.1873014428241, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.4480976652596839, \"yfit\": 355.4858637210547, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.40026054661575566, \"yfit\": 353.0782046120222, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.35773209427696545, \"yfit\": 350.93237591225693, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.31994712744402853, \"yfit\": 349.01990571930395, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.28640287113531904, \"yfit\": 347.3154295318423, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.2566511460470513, \"yfit\": 345.7962820872246, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.25607526662493363, \"yfit\": 345.7667900510795, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.23029658826561636, \"yfit\": 344.44238201888265, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.20698459266813546, \"yfit\": 343.23572811154577, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.18640062733400725, \"yfit\": 342.16021803489167, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.17627629495223213, \"yfit\": 341.62661289058, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.1682644525372158, \"yfit\": 341.20169785531135, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.15232840721066715, \"yfit\": 340.3474693118396, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.13836728112834085, \"yfit\": 339.5860597073087, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.13783148662948466, \"yfit\": 339.55653263698133, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.12618223197627312, \"yfit\": 338.90751394835445, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.115794440974104, \"yfit\": 338.3145068699681, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.1155912304893521, \"yfit\": 338.30273800999595, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.10642979401577354, \"yfit\": 337.76369729937744, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.10184385008947873, \"yfit\": 337.4864334164462, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.09854779561082913, \"yfit\": 337.2832981611712, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.09242012178720055, \"yfit\": 336.8949774426054, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.0918058714533119, \"yfit\": 336.85514774498375, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.08607507596003962, \"yfit\": 336.4735654609477, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.08575133593041676, \"yfit\": 336.4513943790044, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.0812353572644752, \"yfit\": 336.13349435159944, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.08086208381061756, \"yfit\": 336.1064001425039, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.07717501456338206, \"yfit\": 335.83038325188085, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.07717501456338206, \"yfit\": 335.83038325188085, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.0743293396474954, \"yfit\": 335.6045348675477, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.07379069541462445, \"yfit\": 335.5601854472532, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.07208983728713078, \"yfit\": 335.416331658746, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.07098756391654881, \"yfit\": 335.3194475366853, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.07029760575895438, \"yfit\": 335.25710704150583, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.0688423320526823, \"yfit\": 335.12062436826335, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.06867940262257435, \"yfit\": 335.104876961745, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.06764547514091145, \"yfit\": 335.0023526778316, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.06678924280116602, \"yfit\": 334.9136435561508, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.06664995323183032, \"yfit\": 334.89884416733133, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.06581347553777316, \"yfit\": 334.8075126796056, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.0652487848254201, \"yfit\": 334.74318638499176, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.06510422290239648, \"yfit\": 334.7263290298651, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.06449788933740029, \"yfit\": 334.6536910553846, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.06399873669547419, \"yfit\": 334.59126628777335, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.06397566375148303, \"yfit\": 334.5883169429262, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.06352281354261924, \"yfit\": 334.52916850302927, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.06312767255710003, \"yfit\": 334.47539725520767, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.06298811100844025, \"yfit\": 334.45586659634904, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.06278091118044955, \"yfit\": 334.4263017819284, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.06247499945880416, \"yfit\": 334.38129758935327, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.06220380823641101, \"yfit\": 334.3398938307313, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.0621736361433762, \"yfit\": 334.33519160704634, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.061962309738307325, \"yfit\": 334.3016745548602, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.061746355275733834, \"yfit\": 334.26625810548666, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.06155246720190973, \"yfit\": 334.23344237303644, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.061518993483639685, \"yfit\": 334.22765610522146, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.06137777696515558, \"yfit\": 334.2028462386642, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.06121983276821428, \"yfit\": 334.1742893762416, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.0610765730422568, \"yfit\": 334.14757525727003, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.06099398737835453, \"yfit\": 334.1317908389352, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.06094624119978884, \"yfit\": 334.1225302569611, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.060827334422341506, \"yfit\": 334.0990065397737, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.06071856101324336, \"yfit\": 334.0768670691464, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.060618806070445966, \"yfit\": 334.0559928049079, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.06057371537237056, \"yfit\": 334.04636468152995, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.06052710335002283, \"yfit\": 334.036278195831, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.06044261216952152, \"yfit\": 334.0176292232188, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.060364598388713164, \"yfit\": 333.9999617323663, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.0602924186595763, \"yfit\": 333.9832002067216, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.06023779221336314, \"yfit\": 333.97022936328585, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.06022550731854644, \"yfit\": 333.9672766851233, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.06016336542760046, \"yfit\": 333.95212984002706, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.060105551572437584, \"yfit\": 333.93770418269054, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.06005167411164596, \"yfit\": 333.9239493928167, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.060001384601494664, \"yfit\": 333.91081972430067, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.0599696180034412, \"yfit\": 333.9023720843303, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.059954372156915146, \"yfit\": 333.89827304613294, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.059910358708874636, \"yfit\": 333.8862704208257, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.05986909521205025, \"yfit\": 333.8747777989953, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.05983035813136837, \"yfit\": 333.86376507253954, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.059793944749950007, \"yfit\": 333.85319705018765, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.05975574064802268, \"yfit\": 333.84188225458126, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.059585307219502066, \"yfit\": 333.7879925316676, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.059449578725562065, \"yfit\": 333.7399593093929, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.059341544428187384, \"yfit\": 333.69714755242825, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.05925558930058784, \"yfit\": 333.65899044875636, \"fit_type\": \"Efficient Frontier\"}, {\"stdev\": 0.059187223717716106, \"yfit\": 333.6249823012423, \"fit_type\": \"Efficient Frontier\"}]}}, {\"mode\": \"vega-lite\"});\n",
       "</script>"
      ],
      "text/plain": [
       "alt.LayerChart(...)"
      ]
     },
     "execution_count": 95,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "plt_df = comb_df.copy()\n",
    "plt_df = plt_df.round({'cost_effectiveness': 4, 'stdev': 4})\n",
    "\n",
    "#Create an interactive chart with the frontier\n",
    "points = alt.Chart(plt_df).mark_circle().encode(\n",
    "    alt.X('stdev:Q', scale=alt.Scale(type='log'),\n",
    "          axis=alt.Axis(title='Standard Deviation (DALY/1000USD)')),\n",
    "    alt.Y('cost_effectiveness:Q', scale=alt.Scale(type='log'),\n",
    "          axis=alt.Axis(title='Cost Effectiveness (DALY/1000USD)')),\n",
    "    color='source', \n",
    "    tooltip=['source','intervention','stdev', 'cost_effectiveness'],\n",
    "    opacity=alt.value(0.9)\n",
    ").properties(\n",
    "    width=700, #600, 400\n",
    "    height=450\n",
    ").interactive()\n",
    "\n",
    "## Just the frontier\n",
    "lines_df = pd.DataFrame.from_dict({\n",
    "    'stdev': frontier['risks'], \n",
    "    'yfit': frontier['returns'],\n",
    "    'fit_type': 'Efficient Frontier'\n",
    "})\n",
    "lines = alt.Chart(lines_df).mark_line().encode(\n",
    "    x='stdev',\n",
    "    y='yfit',\n",
    "    color='fit_type'\n",
    ")\n",
    "\n",
    "chart = points + lines\n",
    "##https://github.com/altair-viz/altair/issues/858, updated altair to solve\n",
    "chart.save('./data/outputs/meta-returns.html', embed_options={'actions': False})\n",
    "chart"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Conclusion\n",
    "\n",
    "* It seems like there are returns to risk taking for both the individual and combined estimates. This is useful to know because it means a a large error bound on a cost effectiveness estimate shouldn’t be disqualifying on it’s own.\n",
    "* Plots like these could be useful for identifying promising interventions, especially when many independent estimates point in the same direction.  This seems to be the case for many malaria, HIV, and smoking cessation interventions in the plot above.  \n",
    "* This framework could also provide a useful sanity check for future estimates.  For example, if an estimate is far above the existing frontier, it might be worth reviewing it for an incorrect calculation or poor assumption.  But it's important to be careful when doing this because these estimates only cover a small fraction of the possible actions one could take in the world.    \n",
    "* The intervention with the highest expected impact (and highest uncertainty) is research into diarrheal disease.  This suggests that uncertainty that comes with research is worth it in some cases.  This relationship might be even more clear if we were to add estimates from more esoteric forms of basic research, although some forms of research might not be amenable to this type of analysis."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# References\n",
    "\n",
    "[1] *Are there returns to risk taking in science, philanthropy, or public policy?* [https://pstblog.com/2017/12/02/risk-return](https://pstblog.com/2017/12/02/risk-return)\n",
    "\n",
    "[2] *Efficient Frontier.*  Wikipedia. [https://en.wikipedia.org/wiki/Efficient_frontier](https://en.wikipedia.org/wiki/Efficient_frontier)\n",
    "\n",
    "[3] *psthomas: efficient-frontier*.  GitHub.  [https://github.com/psthomas/efficient-frontier](https://github.com/psthomas/efficient-frontier)\n",
    "\n",
    "[4] *Global Health Cost Effectiveness Analysis Registry.* Tufts University.  [http://healtheconomics.tuftsmedicalcenter.org/ghcearegistry/](http://healtheconomics.tuftsmedicalcenter.org/ghcearegistry/)\n",
    "\n",
    "[5] The Cochrane Review Handbook. [http://handbook-5-1.cochrane.org/chapter_7/7_7_3_2_obtaining_standard_deviations_from_standard_errors_and.htm](http://handbook-5-1.cochrane.org/chapter_7/7_7_3_2_obtaining_standard_deviations_from_standard_errors_and.htm)\n",
    "\n",
    "[6] *Relationship between the range and the standard deviation.* Stack Exchange. \n",
    "[https://stats.stackexchange.com/questions/69575/relationship-between-the-range-and-the-standard-deviation](https://stats.stackexchange.com/questions/69575/relationship-between-the-range-and-the-standard-deviation)\n",
    "\n",
    "[7] *The Efficient Frontier: Markowitz portfolio optimization in Python.* Quantopian.  \n",
    "[https://blog.quantopian.com/markowitz-portfolio-optimization-2/](https://blog.quantopian.com/markowitz-portfolio-optimization-2/) "
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.4"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
